https://www.endosure.info/womenhealthlinksclinicca daily 1.0 2026-05-23 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/47af15ff-fee3-4a78-8835-7b97b05c6ca7/logo.jpg https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/72460e21-3183-4476-9492-4e8a29963957/qrCode+%281%29.png https://www.endosure.info/about daily 0.75 2026-03-31 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6fc8594a-202a-4fcc-ad00-6fa6fe407f4d/qrCode+%281%29.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1774736608352-Q50I7143AEOHMGGIWL9G/unsplash-image-l9gmNv3q7Z4.jpg https://www.endosure.info/contact daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c8b691a3-1f8b-4211-8c61-9e84b563dfb4/qrCode+%281%29.png https://www.endosure.info/about-2 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b4e60838-61a3-4064-a729-7d8580eab10e/EGG+for+endometriosis.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/050861ee-a4fe-44f9-bc94-cd812ed3d67e/NIH+26fd34ba-2c35-4afe-804b-961d6ef8d912.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b1014298-687f-4c6a-9fb1-4340d7a437b3/early+diagnosis.png https://www.endosure.info/about-3 daily 0.75 2026-04-15 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0bc09f94-3cd1-4455-be66-86a037e7d77d/lipiodol+1.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/87d39ff8-f079-4b32-986a-8c3f3af1ed2b/lipiodol+8.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0ed65ae2-c6c4-4007-a07a-aba483df24e6/dr-Azer-protocol-for-infertility-and-endometriosis-Apr-13%2C-12-25-PM-image-2+%281%29.jpg https://www.endosure.info/about-4 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/01be7b29-1f45-4cc4-bb33-5b180fa2b546/81ac2b0e-0347-4751-a7fa-220c4ec88733.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4820b8a9-5fc9-4454-9690-e35f825ed1dc/Gemini_Generated_Image_gtdvwgtdvwgtdvwg.png https://www.endosure.info/about-5 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cb615cd9-3ca4-4ed0-8ce4-adea0d1d685f/AMH.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9a8de85b-f4a4-42e3-ae5f-179e7af7e04c/metformin+and+pcos1.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4cc22911-afa1-4bf9-b626-3e7bce047a9f/pcos+2.png https://www.endosure.info/about-80 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/95baa2b5-de2c-4344-a43a-0b1a438bb84f/treatment+options.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a4a56a42-4f24-4990-91bd-c201aa16b938/multidimentional+menopause.png https://www.endosure.info/about-90 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d138a6e4-dc51-409c-bdff-682710f76080/perimenopause+and+body+alteration.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/682fd85c-5627-4007-bf9a-f5386e3c2203/perimenopause+integrative+approch.jpg https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/79397398-e2db-462d-b508-766a447511be/perimenopause+and+cvd.jpg https://www.endosure.info/about-23 daily 0.75 2026-03-29 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8a51fef5-98e7-4686-b611-12c3793c12b4/pcos+phenotype.jpg https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b0aa854f-e1ee-4b4c-9407-a52cdf4f901b/Untitled-2.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3494990f-bd9e-4b22-adb5-3809b2f3d391/pcos+treatment.png https://www.endosure.info/new-page daily 0.75 2026-05-18 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/79e26f3b-fd94-45b3-98b1-f42af08b8f7f/qrCode+%282%29.png https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/347c8c4f-4af1-4072-95b9-3da87b697344/qrCode+%283%29.png https://www.endosure.info/gallery-1 daily 0.75 2026-08-09 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4d5e93dd-6182-40e9-9a71-1ec04509054c/Adenomyosis-is-the-presence-of-endometrial-glands-and-stroma-within-the%E2%80%A6-image-1.jpg Gallery Infographic showing the impact of adenomyosis on fertility, including uterine anatomy, symptoms, diagnosis, treatment, and pregnancy management. Features an illustration of the uterus, symptoms like abnormal bleeding and pelvic pain, diagnosis methods, treatment options, and reproductive impact statistics. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fbc3a4e4-a26f-496a-a954-c42fc1293301/Lipiodol-%28oil-based-contrast-medium%29-used-during-hysterosalpingography%E2%80%A6-image-1.jpg Gallery Diagram illustrating lipiodol HSG in women with endometriosis and patent tubes. Sections include concept overview, clinical evidence (with bar graphs showing pregnancy and live birth rates over 6 months), mechanisms (tubal flushing, endometrial receptivity), clinical application (attempt natural conception in 6 months), and a take-home message emphasizing safety, simplicity, and transient benefits of lipiodol HSG for endometriosis-related infertility. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f1a6ee32-e231-4f4c-81b7-47cf77b03027/Most-SVTs-occur-in-patients-with-varicose-veins%2C15-yet-evidence-based-g%E2%80%A6-image-1.jpg Gallery Diagram of a clinical study on early endovenous thermal ablation (EVTA) for treating superficial venous disease (SVT). It shows patient selection, intervention with EVTA, and key outcomes in efficacy and safety, including pain reduction, VCSS, VEINES-QOL improvements, and safety data like DVT rate, recurrence, and bleeding. The timeline indicates a median follow-up of 14 months. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1bb4861f-6be3-4ad1-bf19-85af04227d34/Proposed-Optimal-Sequencing-Strategy-Based-on-the-mechanistic-rationale%E2%80%A6-image-1.jpg Gallery Diagram illustrating a proposed sequencing strategy for women with endometriosis-related infertility and patent tubes, including cycles of ovarian stimulation, IUI, ovulation, and IVF procedures, with a combination pathway diagram at the bottom. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4420e259-e1f6-41cd-8fb4-be10ce3fba8f/Summary-For-women-with-endometriosis-related-infertility-and-patent-tu%E2%80%A6-image-1.jpg Gallery Flowchart displaying the optimized treatment strategy for endometriosis-related infertility using patent tubes. It starts with a woman diagnosed with endometriosis-related infertility, proceeding to a patent fallopian tube test. The first-line intervention is oil-based tubal patency test using Lipiodol HSG. Up to six months later, if no pregnancy occurs, there are options: attempt spontaneous conception, ovary stimulation or intrauterine insemination (IUI), or proceed with in-vitro fertilization (IVF). Lipiodol HSG can lower treatment burden and cost, or IVF can be considered based on age and clinical factors. If pregnancy is confirmed within six months, no further action is needed. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7d43f20c-3ab0-4a49-b3d6-dd290e65580b/The-6-month-pregnancy-rate-of-48%25-with-lipiodol-in-the-FLUSH-trial-endo%E2%80%A6-image-1.jpg Gallery Flowchart illustrating treatment pathway for Lipiodol HSG, ovarian stimulation/IUI, and IVF, with comparative outcomes, costs, and key advantages of Lipiodol HSG infographics. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/90d55d75-16ce-4337-93ec-cea1d19fc833/Endometriosis-is-a-chronic-gynecological-disorder-that-affects-approxim%E2%80%A6-image-1.jpg Gallery Infographic titled 'Current Diagnostic and Therapeutic Strategies in Adolescent Endometriosis'. It illustrates aspects of adolescent endometriosis including prevalence, diagnostic pathways, clinical challenges, emerging innovations, and treatment strategies. Features include a diagram of the female reproductive system, icons for ultrasound, MRI, laparoscopy, and various medical devices, along with explanatory text and icons for pain, symptoms, diagnosis, and therapy goals. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7c8f411c-ae17-4f12-9778-97c98c7a53bd/Objective-Aim-To-evaluate-the-effectiveness-of-determining-the-fertil%E2%80%A6-image-1+%281%29.jpg Gallery Comparison chart of fertility window detection methods in women with idiopathic infertility, including ovul Device, urine test strips, and folliculometry, showing diagnostic performance, comparison Venn diagram, process diagrams, and key findings. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dc6cf007-cf84-4e5b-88f5-9cf5f33798d8/Objective-Aim-To-evaluate-the-effectiveness-of-determining-the-fertil%E2%80%A6-image-1.jpg Gallery A comparison chart displaying different methods for detecting ovulatory fertility in women with idiopathic infertility. It includes visual flowcharts, Venn diagrams, and summary tables. Sections illustrate the process flow from ovulation induction and natural cycle analysis to the use of ovulography, urine tests, and folliculometry, highlighting their diagnostic accuracy, sensitivity, and specificity. The chart emphasizes the high accuracy and home use benefits of ovulography compared to other methods. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cae4e3d2-5357-4dae-8066-91abf9fe1a56/The-impact-of-endometrioma-size-on-ovarian-reserve-remains-controversia%E2%80%A6-image-1.jpg Gallery Flowchart comparing cyst size and hormone levels in women with endometriomas and controls, highlighting increased AMH with larger cysts, and advising interpretation in context of endometrioma for ovarian reserve. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7c63fd8b-7bdc-460c-a51a-cb55bb0e537d/The-perception-that-hormonal-contraception-causes-weight-gain-is-a-gene%E2%80%A6-image-1.jpg Gallery A detailed infographic titled 'Impact of Hormonal Contraceptives on Weight Gain' that explains mechanisms, evidence, and perceptions surrounding hormonal contraceptives and weight gain. The infographic includes sections on patient perception versus scientific evidence, methods of contraception comparison, mechanisms of fluid retention and DMPA-induced fat gain, and misconceptions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/30f5f74d-f526-4dc1-a3ac-25487397d6ed/Endometriosis-is-a-chronic-gynecological-disorder-that-affects-approxim%E2%80%A6-image-1.jpg Gallery Infographic on adolescent endometriosis diagnosis and treatment. Sections include overview, diagnostic pathway, clinical challenges, emerging innovations, and therapeutic strategies. Visuals depict uterus, symptoms, diagnostics, treatment options, and improved quality of life. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/16ae6431-ea99-4f92-9e3a-8d5c0c89ee14/Objective-Aim-To-evaluate-the-effectiveness-of-determining-the-fertil%E2%80%A6-image-1+%281%29.jpg Gallery A scientific infographic comparing fertility window detection methods in women with idiopathic infertility, including ovulography devices, urine test strips, and folliculometry. It shows test procedures, diagnostic performance metrics, overlap of positive results, and key home use advantages. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f5b52d9d-8750-4d0a-a49e-fd605e70502d/Objective-Aim-To-evaluate-the-effectiveness-of-determining-the-fertil%E2%80%A6-image-1.jpg Gallery Diagram comparing fertility window detection methods in women with idiopathic infertility, including ovulometry, urine test strips, and folliculometry, with charts illustrating test overlap, performance metrics, and key benefits for home use. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4db346c1-d02e-4fae-84d2-34e41c943563/The-impact-of-endometrioma-size-on-ovarian-reserve-remains-controversia%E2%80%A6-image-1.jpg Gallery Study diagram comparing average serum AMH levels across different cyst size categories in women with and without endometriomas, including ultrasound images and statistical results. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e940c262-9b77-408d-bc55-c9fdcaf1b905/The-perception-that-hormonal-contraception-causes-weight-gain-is-a-gene%E2%80%A6-image-1.jpg Gallery A scientific infographic titled 'Impact of Hormonal Contraceptives on Weight Gain,' comparing patient perception versus scientific evidence. It includes three panels: Panel 1 showing women discussing contraception concerns; Panel 2 comparing hormonal contraceptive methods (pills, patch, ring), depot medroxyprogesterone acetate injections, and etonogestrel implants, with mechanisms and evidence; Panel 3 detailing mechanisms and misconceptions about fluid retention and fat gain, with diagrams of hormonal pathways and effect on weight. The figure legend notes evidence supports weight neutrality for most methods, except certain variants. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e22202df-2c57-4fac-9a65-8e7b12234cb6/%23%23%23-Practice-Guideline-The-American-Academy-of-Family-Physicians-re%E2%80%A6-image-1.jpg Gallery Infographic titled 'Fezolinetant (Voezah): Nonhormonal Therapy for Vasomotor Symptoms in Menopausal and Perimenopausal Women' covering population context, mechanism of action, drug label and administration, clinical positioning, efficacy summary, safety and monitoring, common adverse events, and other treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0f82a086-5fa0-431a-ac9c-e1494fee0698/Accurate-diagnosis-in-the-postmenopausal-population-is-further-complica%E2%80%A6-image-1.jpg Gallery Flowchart of diagnostic pathway for endometriosis in postmenopausal women, including imaging modalities—transvaginal ultrasonography, MRI, and CT—and details about their uses and limitations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d6fa6890-685e-42e4-85e4-8dc52e747822/BackgroundEndometriosis-is-a-hormone-driven-systemic-inflammatory-condi%E2%80%A6-image-1.jpg Gallery An infographic presenting an overview of endometriosis, study design and meta-analysis methods, and key findings. The first section illustrates symptoms like pain, fatigue, infertility, and endometrial-like lesions, noting it affects up to 15% of women worldwide. The second section details research methods including database searching, quality assessment, and meta-analysis. The third section shows that endometriosis patients have poorer sleep quality with high heterogeneity, persistent association with sensitivity analyses, and clinical implications for pain patterns and targeted interventions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c55667cd-cd82-4b91-9cb2-90220fa4bae6/Discussion-To-the-best-of-our-knowledge%2C-the-present-study-is-one-of-th%E2%80%A6-image-1.jpg Gallery Infographic titled 'Longitudinal Relationships Between Lifestyle Factors and AMH Levels/Decline' with sections on oral contraceptive use, smoking, BMI/central adiposity, coffee/tea consumption, PCOS & menstrual regularity, alcohol, and physical activity. It shows how these factors influence AMH levels and decline over time, including mechanisms, effects, and limitations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/539ed191-7260-4287-9af0-5f2500cbbb94/Does-surgery-for-endometriomas-correct-deformities-and-or-dysfunction-%E2%80%A6-image-1.jpg Gallery A detailed infographic titled 'Surgery for Endometriomas: Impact on Ovarian Reserve and Fertility Outcomes' divided into five sections. The first section explains endometrioma and clinical dilemmas, showing an illustration of a normal ovary and one with endometrioma, with questions on ovarian dysfunction and fertility. The second section depicts natural fertility outcomes without surgery, indicating 43% natural conception in one year. The third section compares surgical options: cystectomy reduces ovarian reserve (shown with a syringe removing tissue), while alternative hemostasis with suturing/sealants is less harmful and preserves ovarian reserve, with a note on cautious use. Sclerotherapy offers better preservation of ovarian reserve and higher pregnancy rates but should be used selectively. The fourth section addresses long-term considerations, showing high recurrence rates and indicating that repeat surgeries cause greater loss of ovarian reserve, emphasizing unilaterals don’t significantly reduce conception rates if both tubes are patent. The fifth section highlights individualized decision-making based on patient factors like age, ovarian reserve, endometrioma size, bilaterality, semen analysis, coital frequency, and infertility duration, stressing the importance of multifactorial assessment. A cautionary note emphasizes surgery’s modest fertility benefits and the importance of individualized management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7ebd9b50-29a1-4653-8146-56fa8316a958/Does-surgery-for-endometriomas-increase-the-success-and-decrease-the-co%E2%80%A6-image-1.jpg Gallery Comparison of endometrioma treatment: without surgery, healthy oocyte/embryo shown; after surgical removal, fewer oocytes/embryos and lower ovarian reserve highlighted. Includes illustrations of ovaries, endometrioma, and surgical procedure. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/60a79f79-8103-4092-88d0-832b44ac2a24/Does-surgery-for-endometriomas-relieve-suffering-Suffering-in-women-wi%E2%80%A6-image-1.jpg Gallery Diagram showing surgical management of endometriomas. The left side depicts pre-surgery with inflammation, deep lesions, endometrioma, and sensory nerve fibers causing pain. The right side shows post-surgery with removal of endometrioma and residual deep lesions, marked by surgical intervention, which aims to reduce pain and inflammation, but may decrease ovarian reserve. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/66474ed7-9f01-483b-90ec-2364eac68593/Does-surgery-for-endometriomas-save-lives-Is-it-necessary-to-rule-out%E2%80%A6-image-1.jpg Gallery Flowchart illustrating the comprehensive approach to endometrioma surgery and malignancy risk assessment. It includes imaging assessment, clinical and family history, physical examination, serum markers, holistic risk assessment, and decision-making for surgery or early malignancy detection. Features a diagram of a typical and atypical endometrioma, showing their differences and risk factors. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2640cae1-db2d-41cb-b115-40581d52844e/Endometriosis-is-an-estrogen-dependent-gynecological-disorder-character%E2%80%A6-image-1.jpg Gallery A scientific infographic titled 'Endometriosis in Postmenopausal Women: Persistence, Incidence, and Challenges,' featuring sections on endometriosis overview, classical disease paradigm, modern understanding, and incidence data and limitations. It includes diagrams of the female reproductive system, ovaries, endometrial glands, and stroma, as well as pie charts and timelines related to disease prevalence and research limitations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/21dd558a-018e-45a7-ab10-3753cb90cd7d/EVALUATION-AND-COUNSELLING-OF-PATIENTS-WITH-ENDOMETRIOMAS-A-thorough-as%E2%80%A6-image-1.jpg Gallery Infographic depicting the process of evaluating, imaging, planning, and managing endometriosis. Sections include initial assessment with history and ultrasound, MRI and ultrasound for lesion mapping, minimally invasive surgery for treatment, preoperative counseling for personalized care, and multidisciplinary approach with specialists like urologists, colorectal surgeons, and pain experts for patient-centered treatment. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6191c35b-cc3a-472a-b5ad-62b37d09b36a/Hot-flushes-and-brain-fog-are-among-the-most-common-symptoms-of-the-men%E2%80%A6-image-1+%281%29.jpg Gallery A scientific infographic titled 'Integrated Mechanisms and Management of Hot Flashes (Vasomotor Symptoms) and Brain Fog in Menopausal Transition.' It explains symptoms, underlying mechanisms, treatment modalities, and brain fog management with illustrations of a woman, brain with chemicals, medications, and graphs showing reduction percentages and analysis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3d4169ca-150e-49b4-a1fd-1e4bf9ae1dd1/Hot-flushes-and-brain-fog-are-among-the-most-common-symptoms-of-the-men%E2%80%A6-image-1.jpg Gallery A detailed infographic on menopause, vasomotor symptoms, treatments, risk management, and holistic approaches. Sections cover symptoms, mechanisms, age-related treatment considerations, FDA-approved therapies, risk factors, timing and formulation of treatments, contraindications, and holistic lifestyle management including exercise, diet, stress reduction, and sleep improvement. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/390ec476-6b39-441a-a366-8329b517cde7/illMechanisms-The-predominant-mechanism-is-loss-of-endogenous-estrogen%E2%80%A6-image-1.jpg Gallery Diagram showing mechanisms of menopause-related health effects, mortality impact of menopause types, and hormone therapy use timeline and risks. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fdb908cc-4a21-4bc2-a10a-e78a8df0ef45/Later-age-at-menopause-is-consistently-associated-with-longer-lifespan%2C%E2%80%A6-image-1.jpg Gallery Diagram depicting the inverse relationship between age at menopause and mortality risk. It shows four menopause stages—Premature, Early, Typical, and Late—with corresponding age ranges and associated mortality risks, life expectancy, and risk factors, emphasizing that higher age at menopause correlates with lower mortality risk and longer lifespan. It also illustrates mechanistic factors influencing longevity, such as cardiovascular and respiratory diseases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f37dffd7-e256-49bf-bd98-9bd867287f8c/Management-of-endometriosis-in-postmenopausal-women-presents-unique-cha%E2%80%A6-image-1.jpg Gallery Diagram illustrating comprehensive management of endometriosis in postmenopausal women, including surgical management, medical management, lifestyle approaches, risks, and multidisciplinary team involvement. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/33b55eb2-13d3-4807-b893-d47bf8c764bc/menThe-American-College-of-Obstetricians-and-Gynecologists-%28ACOG%29-recom%E2%80%A6-image-1.jpg Gallery A flowchart detailing cardiovascular care and hormone therapy recommendations for women with primary ovarian insufficiency, including blood pressure measurements, lipid profiling, lifestyle counseling, and ultrasound monitoring for specific conditions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6d1d5b45-efe4-4eb5-9005-48458761ef4a/Non-Pharmacologic-Interventions-Pelvic-floor-physiotherapy-%28PFP%29-is-rec%E2%80%A6-image-1.jpg Gallery Diagram presenting non-pharmacologic treatments for chronic pelvic pain in endometriosis, including pelvic floor physiotherapy, cognitive-behavioral therapy, botulinum toxin A injection, and transcutaneous electrical nerve stimulation, with descriptions of their benefits and effects on pain and quality of life. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/01db6412-9d4e-4db9-aba3-85efefb926c6/Out-of-438-screened-references%2C-14-%282%2C425%2C648-participants%29-were-includ%E2%80%A6-image-1.jpg Gallery Flowchart summarizing meta-analysis on oral contraceptive use and depression outcomes, showing data panels on depression risk, antidepressant initiation, and depressive symptoms scores from studies involving over 2.4 million participants. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/32dd5586-bb4d-42ba-9f6c-9a84614f1c53/Patient-Population-Key-Rationale-Strength-of-Evidence-References-Endome%E2%80%A6-image-1+%281%29.jpg Gallery Chart showing potential patient populations for GLP-1 receptor agonist use in endometriosis, including subgroups with varying levels of evidence support. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4dd8e4a1-8e0f-45de-8071-ff06e3a2463b/Patient-Population-Key-Rationale-Strength-of-Evidence-References-Endome%E2%80%A6-image-1.jpg Gallery Flowchart showing potential roles of GLP-1 receptor agonists in endometriosis patient subgroups. It includes sections on endometriosis plus obesity, deep infiltrating endometriosis with fibrosis, endometriosis plus PCOS overlap, fertility-seeking with nonhormonal pathway, and hormonal therapy—refractory or contraindicated. Each section indicates evidence strength, mechanisms, and treatment implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2aec2deb-cd16-4ed6-aef2-7e13ce1ae5ec/Rationale-for-Potential-Interest-Endometriosis-is-a-chronic-inflammator%E2%80%A6-image-1.jpg Gallery Diagram illustrating the mechanistic rationale and preclinical evidence linking GLP-1 receptor agonists to endometriosis. It shows disease mechanism with ectopic endometrial lesions, macrophages, and fibrosis, and explains the role of GLP-1RA in reducing inflammation, collagen fibrosis, and gland proliferation while alleviating IUA. The diagram also notes obesity/PCOS context, with chronic inflammation, fibrosis, and potential benefits of GLP-1RA in endometriosis. It highlights the lack of clinical models and the uncertain therapeutic role of GLP-1RAs. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/df3c0212-8568-419b-8f7e-6b3788b43dd5/Similar-to-premenopausal-endometriosis%2C-one-of-the-main-concerns-in-pos%E2%80%A6-image-1.jpg Gallery Flowchart illustrating risks and features of malignant transformation in postmenopausal endometriosis, comparing pre- and postmenopausal women, including clinical triggers, imaging findings, histotypes, and sites of malignant transformation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c9af1d3b-31d8-4b1b-89c6-5043ec0c6601/Sleep-disturbances-are-highly-prevalent-during-menopausal-transition-an%E2%80%A6-image-1.jpg Gallery A detailed infographic illustrating the relationship between menopausal transition, sleep disturbances, and associated symptoms. It features data on insomnia prevalence, the multifactorial mechanisms involved, pharmacological and non-pharmacological treatments, biological pathways, and future research directions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9f80dcbd-c172-4b42-b71b-3a0b2a395e5c/The-likelihood-of-underdiagnosis-is-higher-in-postmenopausal-women%2C-as%E2%80%A6-image-1.jpg Gallery A medical infographic contrasting endometriosis presentation and risk factors between reproductive-age and postmenopausal women. It highlights cyclical pelvic pain, dysmenorrhea, and infertility in reproductive women, versus non-cyclical pelvic pain, adnexal mass, and urinary disturbances in postmenopausal women. The section explains diagnostic pathways, emphasizing that postmenopausal endometriosis often lacks hallmark symptoms, leading to delayed diagnosis and increased underdiagnosis risk, with clinical implications noted for overlooked cases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6ca4ecd9-c84c-4d73-8b74-319df20d97df/The-literature-on-predictors-of-treatment-response-in-refractory-endome%E2%80%A6-image-1.jpg Gallery A detailed infographic titled 'Predictors of Treatment Response in Refractory Endometriosis.' It outlines clinical and molecular factors influencing therapy success, including graphs, diagrams, and checkmarks indicating positive or negative predictors for pain, sensitivity, and recurrence. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/deb5ac9e-df4a-47f0-816f-4b0b9e96a567/The-pathophysiology-of-endometriosis-remains-incompletely-understood%2C-a%E2%80%A6-image-1.jpg Gallery Diagram explaining the pathophysiology of postmenopausal endometriosis, including sources of estrogen, estrogen's role, lesion origins, and hormone resistance, with detailed subsections and illustrations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8ec2345f-8aae-4d4a-a57b-91698f46adaa/This-meta-analysis-found-that-approximately-30%E2%80%9340%25-of-women-with-endome%E2%80%A6-image-1.jpg Gallery A detailed infographic showing the bidirectional association between endometriosis and endometrial polyps, including epidemiology, risk gradients by endometriosis stage and age, shared pathogenesis factors like genetic predisposition and estrogen sensitivity, clinical implications, and therapeutic targets. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c3397894-19e4-4bb4-8350-91eefb61ae49/What-menopause-tells-us-about-longevity-Timing-matters.jpg Gallery An infographic titled 'How Menopause Timing Shapes Healthspan and Longevity in Women' with four panels explaining menopause and aging. Panel 1 shows menopause timing and lifespan correlation, Panel 2 discusses biological aging mechanisms, Panel 3 details health risks and interventions, and Panel 4 covers ovarian aging pathways and opportunities. The infographic includes diagrams of female aging, organs, DNA markers, and lifestyle factors. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dd94d560-2411-43c5-9b44-67e4093f310d/Within-this-substantial-cohort-of-women-with-a-history-of-RM%2C-the-RR-of%E2%80%A6-image-1.jpg Gallery A scientific infographic showing the impact of miscarriage management methods and caesarean section history on future miscarriage risk in women with recurrent miscarriage. It includes cohort overview, management strategies, effects of caesarean section, future miscarriage risk, limitations, and conclusions with success rates of cytogenetic testing, and illustrations of risk percentages. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c677eb41-d5db-49a6-ac66-f360e435badc/0aca7028-3236-464b-9b13-38b02dc3634f.jpg Gallery Timeline diagram of the process of embryo implantation in human fertility, from fertilization to complete implantation over 14 days, including stages like embryo cleavage, blastocyst formation, uterine arrival, attachment, invasion, and integration with maternal tissue. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/afbab723-1129-4207-8050-817aeb698c30/1a816652-3cbb-4d2d-8d23-fac8da171630+%281%29.png Gallery An infographic explaining the definition, symptoms, screening, treatment options, and outcomes of Genitourinary Syndrome of Menopause (GSM). It includes symptoms like vaginal dryness, itching, dyspareunia, urinary urgency, and recurrent UTIs. The diagnostic flowchart guides treatment decisions, highlighting nonhormonal options and FDA-approved medications. Special considerations for breast cancer survivors emphasize personalized oncology input and shared decision-making. Outcomes focus on improved vaginal health, sexual function, urinary control, and overall well-being. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1814b626-2596-48b0-8b69-da71ed2f2704/1a816652-3cbb-4d2d-8d23-fac8da171630.png Gallery Flowchart explaining the definition, symptoms, screening, treatment options, and outcomes for Genitourinary Syndrome of Menopause (GSM), including symptoms like vaginal dryness, itching, dyspareunia, urinary urgency, and recurrent UTIs, and highlighting considerations for breast cancer survivors. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/675bf7c4-4598-4188-92c2-0c83f2a5e10d/1c7cdf8b-66a0-4e80-9d33-b7b19fb88cc7.jpg Gallery Diagram illustrating the stages of human embryo implantation, from apposition, adhesion, invasion/penetration, to post-implantation development, showing cellular interactions, signals, and blood vessels. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fb11a20e-6094-4919-9278-7efef25ec8a0/2ce998c5-3c7e-4940-adee-e719226994e7.png Gallery Diagram illustrating five stages of fertilization in human reproduction: 1. Sperm capacitation, showing sperm acquiring fertilization ability and membrane changes. 2. Acrosome reaction, with sperm releasing enzymes to digest the egg's zona pellucida. 3. Sperm-egg fusion, where the sperm penetrates the egg membrane allowing the sperm nucleus to enter the egg cytoplasm. 4. Cortical reaction, triggering release of zona pellucida proteins to prevent polyspermy. 5. Zygote formation, completing fertilization and demonstrating the first mitotic division of the diploid zygote. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/05a79814-2a85-4366-874f-dc18dbd37436/5ddce987-738d-4dba-b5ba-8f4623f9eab5.jpg Gallery Diagram illustrating the impact of estrogen and progesterone hormones on endometriosis, showing phases of tissue proliferation, inflammation, lesion growth, and cell death. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/136ea6a7-8c1a-465a-bccb-0057694f5d2a/21dd74a1-5994-4070-a30d-a4d88f4d83ba.png Gallery A scientific infographic on endometriosis research. It covers epidemiological investigations, basic research mechanisms, clinical presentations, and future directions. Includes diagrams of risk factors like pain and infertility, study population diversity, diagnostic procedures, and suggested future research strategies. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/180697b5-9940-4cfd-a453-4a11a233d936/98d7f7d6-96d0-4443-b1d4-ac457f3c502b.png Gallery A detailed infographic on laparoscopic surgery for endometriosis, focusing on its impact on fertility and ovarian reserve. It includes sections on fertility outcomes by disease stage, predictors of postoperative fertility, impact on ovarian reserve, surgery versus IVF/ICSI comparison, and clinical recommendations. Key data, charts, and illustrations are presented to highlight fertility rates, ovarian reserve decline, and surgical guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c1f59bf3-a942-4016-81d2-e59c34e8cf7d/495aad72-ecd2-41fb-aaaf-7ba29eae71b4.png Gallery Diagram showing age-dependent prevalence and clinical pathways of ovarian endometriomas. Includes an age distribution chart, a timeline of morphology and pathophysiology, and a flowchart of clinical management based on patient age and cyst size. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f5393cff-0157-413f-b30b-6973213203f1/732cc053-922b-4249-b5ca-6f448fca3451.png Gallery Infographic illustrating the cardiovascular risk analysis of hysterectomy with bilateral oophorectomy for endometriosis, including risk factors, age-related risk changes, and data from NHSII study showing increased risk of coronary heart disease in women under 46 without estrogen use. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3290368c-6918-4e57-9248-2b844f7a959c/4057de03-4989-4077-9dd6-1117f82e0f8f.png Gallery Bar graph showing age-related variation in surgical indications: pelvic pain, endometriomas, fibroids, and adenomyosis with color-coded age groups: ≤25 years, 25-35 years, 35-45 years, and >45 years. Pelvic pain is most common across all ages, while endometriomas are more frequent in the youngest group. Fibroids and adenomyosis are most common in women over 45. The summary notes pelvic pain as the most prevalent indication, with endometriomas increasing with age and fibroids and adenomyosis most common in women over 45. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/09ca2139-44d1-428f-9f67-abd3ea2120f1/Abstract-Endometriosis-is-a-chronic-gynecological-disease-characterize%E2%80%A6-image-1.jpg Gallery Infographic titled 'Diagnostic Accuracy of a Salivary miRNA Signature in Infertile Women With Endometriosis.' It includes sections on disease overview, symptoms, diagnostic methods, study design, main results, clinical implications, and conclusion banner, providing details about endometriosis detection using salivary miRNA testing. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fd3c3011-a241-4dae-89b7-4f58f1009d1a/ad64a232-b83e-4e8f-95d0-a605f2b304e6+%281%29.png Gallery Infographic on migraines during the menopausal transition, showing causes related to hormonal fluctuations, new symptoms like hot flashes, sleep disturbance, and migraine patterns, treatment considerations including personalized approach with symptom management via vasomotor symptoms, sleep, vascular risk, and treatment options such as hormonal therapy or nonhormonal therapy. The center features a woman with biological icons around her representing symptoms and treatment considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2fe152b4-3b4d-4fb0-b8e1-ec0e03be44db/ad64a232-b83e-4e8f-95d0-a605f2b304e6.png Gallery An infographic titled 'Migraine During the Menopausal Transition: A Plain Language Summary' explains hormonal fluctuations causing migraines, symptoms like hot flashes, sleep disturbance, and migraine patterns, treatment options including personalized approaches with symptom management and hormone therapy, and the need for stronger research in this area. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/63a569a3-bb83-426d-986c-7748b86849d2/adenyosis+poster.png Gallery An informational poster about Adenomyosis Awareness Month in April, highlighting symptoms, importance of awareness, diagnosis, management, and participation tips. Features illustrations of female health issues, medical tools, and floral decoration. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4e69a119-e84f-41f2-9e2d-8139f29210de/afc8f2c7-1a86-43fb-a35b-9a72d283b57a.png Gallery Summary of surgical complexity, histologic progression, clinical implications, and study models related to fibrosis across different age groups, illustrated with graphs and diagrams. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ad693428-f2e1-4605-b574-535fcc0d9081/c297340c-e6a2-4838-8a50-74e8c2ace651.png Gallery Diagram illustrating common endometriosis lesions in the pelvis, showing locations of various implants and adhesions on female reproductive organs and surrounding structures. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d6ea1d14-c659-4634-b339-11664148ab0b/canvas-image-1-1774836451851.jpg Gallery Diagram explaining evidence-based hormonal treatment for symptomatic endometriosis, including mechanisms, treatment algorithms, and patient-centered approach. Shows pathophysiology with endometriotic lesions, nociceptive pain, peripheral sensitization, and CNS involvement. Lists hormonal therapy mechanisms like ovarian suppression and clinical results such as improved HRQoL and halted lesion progression. Describes pharmacologic treatment algorithms with first-line therapies (progestogens, estrogen-progestogen combinations), second-line therapies (GnRH agonists and antagonists), and add-back strategies. Emphasizes shared decision-making, clinical expertise, evidence-based strategies, and patient values. Mentions neuro- and nociplastic pain, decision points for treatment failure, and special populations like adolescents and young women. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9ac96112-bc46-483a-b340-127a1815c217/canvas-image-1-1774836457965.jpg Gallery Diagram illustrating the impact of female reproductive disorders and insulin resistance on inflammation and reproductive health, highlighting the kynurenine pathway, its dysregulation, and interventions like exercise and improved insulin sensitivity. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d8ba705b-d81f-4426-8be1-286f1b857453/canvas-image-1-1774836469230.jpg Gallery Diagram illustrating fertility-enhancing mechanisms of lipiodol hysterosalpingography, showing mechanical debris flushing and immunobiological effects, including lipiodol injection improving implantation conditions. Timeline depicts transition from routine test in the 1970s to fertility enhancer in the 2000s. Clinical evidence indicates repeat lipiodol treatment boosts fertility, especially in endometriosis cases, with potential future research needed for IVF failure cases. Flowchart of lipiodol's benefits as a simple, low-cost fertility treatment and its promising role in endometriosis-related infertility. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1cf76346-519c-4b83-90a8-78123fd34063/canvas-image-1-1774836485033.jpg Gallery A medical infographic comparing total EVLA and EVLA with mini phlebectomy. It shows treatment methods, outcomes comparison including complication rates, pain levels, recovery time, and return to work, as well as practical notes on procedure training, operation time, and cost. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1aa5cfe2-6002-4f11-a6f3-c0b608003ae5/canvas-image-1-1774836493466.jpg Gallery A detailed infographic explaining a medical procedure for diagnosing and treating uterine polyps. Includes indications and contraindications, equipment setup, step-by-step procedure, and advantages and limitations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fd93fcc9-bb80-4e13-82f5-985a3ff32fd1/canvas-image-1-1775272402327.jpg Gallery A chart discussing non-pharmacological management strategies for PCOS during perimenopause and menopause, including lifestyle modifications like diet and physical activity, chronic pain management, complementary approaches such as supplements, and their effects on mental health and quality of life. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/74d85f48-0968-4d17-b888-fd729f34d843/canvas-image-1-1775273295909.jpg Gallery An infographic titled 'Cardiovascular Risks and Clinical Guidance in Endometriosis: Impact of Hysterectomy, Oophorectomy, and Estrogen Therapy,' divided into four sections. Section I shows the risk overview for women with endometriosis, highlighting baseline risk and increased risk with hysterectomy and bilateral oophorectomy under age 46, and increased risk without estrogen therapy for women aged 46-49. Section II presents guideline-based surgical decision-making, suggesting ovarian conservation lowers cardiovascular risk, mortality, and cancer risk, while hysterectomy with oophorectomy for women under 50 carries substantial risk. Section III discusses informed consent and risks of early hysterectomy, noting increased cardiovascular disease, metabolic, and mental health disorders, especially related to surgical menopause. Section IV describes alternative approaches, like conservative surgical excision to reduce chronic inflammation, improve endothelial function, and avoid surgical menopause or increased cardiovascular risk. A caption emphasizes that estrogen therapy does not fully mitigate cardiovascular risk and that ovarian conservation is recommended when possible, with surgical menopause avoided before age 50. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4b3622a6-6a99-429c-9138-71dcd8869dad/canvas-image-1-1775273303791.jpg Gallery Diagram showing the classification and outcomes of adenomyosis in the uterus. It includes sections on adenomyosis classification (intrinsic and extrinsic), associated disease prevalence, reproductive outcomes, and future directions for clinical impact. The image features a labeled illustration of female reproductive organs, a bar graph comparing disease prevalence, and icons representing clinical procedures and research. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e998ac08-f4f8-4313-bdc8-999f4a02b40c/canvas-image-1-1775273310124.jpg Gallery Diagram illustrating an evidence-based clinical pathway for hormonal management of endometriosis pain. The pathway begins with pathophysiology overview, showing nerve pathways involved in pain. Therapeutic goals focus on reducing ovarian cysts and amenorrhea. The patient-centered decision-making includes clinical expertise, patient preferences, and best evidence to personalize treatment. The treatment ladder starts with first-line hormonal therapy using progestogens and estrogen-progestogen combinations, with options to quickly escalate to second-line GnRH agonists and antagonists if the experience is unpromising. Add-on therapy involves personalized hormonal add-backs. The ultimate goal is therapeutic effect, such as improved quality of life, halted lesion progression, and preserved reproductive potential. Failure criteria involve treatment failure or neuroomodulator notes and drug efficacy limitations. The diagram emphasizes the importance of early intervention in adolescents and young women to improve quality of life and fertility preservation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0762bb09-fcd2-4371-9cca-f752c4c7e47a/canvas-image-1-1775273324709.jpg Gallery Flowchart titled 'MRI-Based Treatment Selection Framework for Adenomyosis: Pharmacological and Minimally Invasive Approaches.' The flowchart shows disease heterogeneity and diagnosis with images of focal and diffuse adenomyosis, MRI-based subtyping indicating localized lesion and diffuse myometrial thickening, patient symptom and severity stratification with icons representing bleeding, pain, severe disease, and fertility desire, treatment modalities including pharmacological treatments (GnRH antagonists, LNG-IUS, Dienogest) and minimally invasive treatments (HIFU, Endometrial Ablation), and a treatment selection framework based on MRI subtype (localized, diffuse, symptom dominance, reproductive intention). https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b8c2b232-43a2-4d9d-ac98-8945a005e8f6/canvas-image-1-1775273333090.jpg Gallery A comprehensive infographic about adenomyosis, including its pathology, clinical manifestations, diagnosis, treatment options, effects on fertility, management during pregnancy, and counseling methods. It features diagrams, pie charts, and medical icons. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/06cc9e9d-7209-490d-8441-24afb989c9e3/canvas-image-1-1775273341174.jpg Gallery Graphic illustrating the use of Lipiodol in hysterosalpingo-graphy (HSG) for fertility assessment, showing real-time monitoring with oil-based contrast, effects of Lipiodol on spontaneous pregnancy rates, mechanisms of action, safety profile, and clinical decision pathways. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e2971d41-f813-4a70-839d-9f30e14b6a81/canvas-image-1-1775273352507.jpg Gallery A detailed infographic depicting the use of menopausal hormone therapy (MHT) in women with endometriosis and hysterectomy from Finnish registry data between 1996 and 2019. It includes illustrated panels of women at reproductive age, postmenopausal women, and surgical menopause, study groups by age, MHT usage statistics, types of MHT with pie charts, and a callout about clinical guidance and knowledge gaps. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/862f54d5-b44d-48b9-a57e-a98fb91ad88a/canvas-image-1-1775273360606.jpg Gallery A scientific infographic detailing clinical and reproductive implications of intrinsic versus extrinsic adenomyosis, including uterine anatomy, review workflow, summary table of findings, ART outcomes, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6af93a14-6659-460b-aa8b-f33cd8668e50/canvas-image-1-1775273377222.jpg Gallery Flowchart outlining management pathways for endometriosis-related subfertility when fertility is a priority. It includes steps such as multidisciplinary assessment, evaluation of endometriosis location (not involving bowel, bladder, ureter), options for surgical excision or ablation, and further management like ovarian endometrioma removal or deep endometriosis surgery. The outcomes focus on improving the chance of spontaneous pregnancy, with additional notes against hormone therapy alone. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f80c7fe7-e02d-4da8-8d22-059aa3d91bc9/canvas-image-1-1775273387389.jpg Gallery Flowchart illustrating management options and clinical considerations for ovarian endometriomas and deep endometriosis, including overview, surgical options, deep endometriosis detail, hormonal treatment, and practice impact. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/92c4e808-9c3b-4f9f-9c96-c698bbc1e10e/canvas-image-1-1775273396773.jpg Gallery Infographic titled 'Chronic Pelvic Pain Disorders: Endometriosis & Adenomyosis' showing a diagram of female reproductive organs highlighting endometrial lesions and adenomyosis, and illustrating reproductive age impact. The section on 'Current Management & Rationale for Lifestyle Focus' depicts standard care with medication and procedures, questioning what works and emphasizing the need for evidence. 'Lifestyle Interventions Evaluated' lists dietary modification, exercise programs, mindfulness, yoga, social connection, and self-management with icons and potential benefits or limited evidence. 'Evidence Gaps & Future Directions' discusses insufficient evidence, underreported adenomyosis, outcomes like quality of life and mental health often unassessed, and calls for larger, high-quality trials and comprehensive lifestyle assessment. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4ddb93e9-f8d3-445c-8607-10b56c1a694d/canvas-image-1-1775273421674.jpg Gallery Summary of a study comparing outcomes of SGLT2i plus metformin versus metformin alone in endometriosis patients with T2D. Includes cohort design, primary all-cause mortality results showing significantly lower mortality with SGLT2i+metformin, cardiovascular outcomes with no significant difference, and renal endpoint trends indicating higher risk of severe CKD with SGLT2i. The study involved 3,072 participants over approximately 2.8 years. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cca00053-ea27-4f2c-9f01-af6321f09150/canvas-image-1-1775273429006.jpg Gallery A scientific poster comparing endovenous microwave ablation (EMA) and endovenous laser ablation (EVLA) for treating great saphenous vein (GSV) insufficiency. It shows study background, design, methods, intervention detail, timelines, and endpoints, along with results including occlusion rates, VCSS and AVVQ scores over time, Kaplan-Meier survival plot, and safety profile. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f2b2d490-e528-4ed7-b191-15b3dfb3d4f6/canvas-image-1-1775273440189.jpg Gallery Overview of breast cancer survivorship, treatment options, clinical decision-making, multidisciplinary approach, and summary for managing symptoms and treatment. Includes diagrams of body symptoms, medication options, decision scales, and healthcare team discussions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/269ff1e9-e3fc-4dcc-9cb8-523ed13fb213/canvas-image-1-1775273457321.jpg Gallery Diagram of total endovenous laser ablation for varicose veins, showing guideline overview, historical limitations, technological advances, procedure steps, laser types, and clinical outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/044c33bf-0795-497a-9837-6a7735f246b9/canvas-image-1-1775273466855.jpg Gallery Flowchart illustrating the endovenous laser ablation (EVLA) procedure for varicose veins, including evaluation, vein access, cannulation, anesthesia, vein ablation, and post-procedure care. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/698ad910-6e21-43ec-b3d5-5f809cb92025/canvas-image-1-1775273640018.jpg Gallery A detailed infographic depicting the pathophysiology, screening model, barriers, solutions, health and societal impacts of adolescent dysmenorrhea, including diagrams and flowcharts. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/832d6eec-96f3-4b05-bf84-01d982c5eb3d/canvas-image-1-1775273652866.jpg Gallery Infographic titled "Impact of Endometriosis on Women's Lives: A Qualitative Study" showing women with endometriosis affecting daily life, work, relationships, sexuality, and family planning, with related icons and color-coded sections. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0eccd038-c75e-4242-bc25-22807e980a61/canvas-image-1-1775342909980.jpg Gallery A scientific infographic displaying a study comparing anthropometric, metabolic, hormonal, and body composition profiles in adolescents with PCOS versus healthy controls. It includes sections on study design overview, key group comparisons in blood pressure, androgen levels, SHBG, and metabolic/body composition, subgroup analyses of lean versus obese PCOS adolescents, correlation/associations between waist circumference, FAI, SHBG, HDL-C, and adiposity, and a take-home message emphasizing early cardiovascular and hormonal changes in adolescents with PCOS. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ba30f223-7bb0-4119-aca2-d590fb63396b/canvas-image-1-1775342920416.jpg Gallery Diagram showing Utah ENDO study on endometriosis and ovarian endometriomas. Top left: flowchart of study participants, comparing women with no endometriosis, endometriosis, and preoperative serum AMH levels. Top right: illustration of uterus with stages I to IV endometriosis, highlighting stage III and IV with a red bar. Bottom left: bar chart illustrating decrease in AMH levels across no endometriosis, incident endometriosis, and stage III-IV endometriomas, with percentage declines. Bottom right: summary box indicating that stage III-IV and ovarian endometriomas are associated with markedly lower AMH, especially in women with infertility, with trend towards lower AMH in all endometriosis subtypes versus normal pelvis, regardless of surgery. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5b1af00a-be86-471b-a9de-a0da8020aa93/canvas-image-1-1775438868470.jpg Gallery Flowchart comparing surgical outcomes for endometriosis, including evidence summary, disease severity and type, surgical limitations, and considerations, with detailed statistics and diagrams of reproductive organs. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8ca6003d-749b-4d98-82b5-71c35ac1048b/canvas-image-1-1775438883703.jpg Gallery A scientific infographic about the use of Lipiodol in endometriosis. It includes four sections: A) Efficacy of Lipiodol versus controls, showing improved pregnancy and live birth rates with Lipiodol; B) Durability of Lipiodol effect, indicating early and transient benefits; C) Real-world outcomes, showing pregnancy rates, live birth rates, and median time to pregnancy under different conditions; D) Clinical decision and mechanistic summary, illustrating indications for surgery and Lipiodol use, treatment mechanisms, and timing. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/35518bf5-6af9-4fa6-842b-2026c3b29e58/canvas-image-1-1775438931722.jpg Gallery A detailed infographic on the relationship between hysterectomy approaches, age, estrogen use, and cardiovascular disease risk in women with endometriosis. The graphic compares no surgery, hysterectomy with bilateral oophorectomy, and hysterectomy with ovarian conservation, highlighting risk levels, hazard ratios, and counseling points. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/09281cb5-02f6-4d1d-9f76-0569e364e9a5/canvas-image-1-1775438948618.jpg Gallery A detailed infographic about cardiovascular risks and clinical guidance in endometriosis. It includes sections on cardiovascular disease risk overview in women with endometriosis, guideline-based surgical decision-making, informed consent regarding hysterectomy, and alternative approaches like conservative surgical excision. The infographic highlights the impact of hysterectomy and oophorectomy with estrogen therapy versus no estrogen therapy on cardiovascular risk, and emphasizes age-related risk distinctions and the benefits of conservative surgery. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fdd3bbc8-8352-4e84-b53e-59a54d8bb5ec/canvas-image-1-1775439197701.jpg Gallery A scientific infographic titled "Localization of Adenomyosis and Its Association with Infertility & Reproductive Outcomes". It includes schematic diagrams of the uterus, bar graphs, and icons illustrating study methods and conclusions. Sections cover adenomyosis classification, disease prevalence, reproductive outcomes, research gaps, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/37267040-8aff-4458-959a-5a61cfb51107/canvas-image-1-1775439210849.jpg Gallery Diagram displaying an evidence-based clinical pathway for hormonal management of endometriosis pain. It includes sections on pathophysiology overview with nerve pathways; therapeutic goals targeting ovarian cysts and amenorrhea; patient-centered decision-making emphasizing personalized treatment based on clinical expertise, evidence, and patient preferences; a hormonal treatment ladder with first-line therapy using progesterogens and estrogen-progesterone combinations, second-line with GnRH agonists/antagonists, and add-on therapy for personalized approaches; therapeutic effects including improved quality of life, halted lesion progression, and preserved reproductive potential; failure criteria with criteria for discontinued treatment; a box on the importance of early intervention in adolescents and young women to improve HRQoL; and notes on the limited efficacy of neuromodulatory drugs for neuropathic pain associated with endometriosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fc4625ad-d03e-4319-894b-72444bb40371/canvas-image-1-1775439285766.jpg Gallery Flowchart of MRI-based treatment selection for adenomyosis, including disease heterogeneity, symptom stratification, treatment modalities, and framework. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/57e6d00c-f10d-4451-bd0e-14871476b2b8/canvas-image-1-1775439294966.jpg Gallery An infographic explaining adenomyosis, including its pathophysiology, clinical manifestations, diagnosis, treatment options, impact on fertility, management during pregnancy, and counseling. It shows diagrams of the uterus, ultrasound and MRI imaging, statistics on symptoms and reproductive outcomes, and illustrations of medical and surgical treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/027727f2-82ed-44ac-ae99-696a6e670f68/canvas-image-1-1775439387867.jpg Gallery An infographic about Lipiodol in hysterosalpingo-graphy (HSG) and its effects on infertility treatment. It explains HSG procedure, compares oil-based and water-based HSG, highlights recent study results, discusses mechanisms of fertility enhancement, safety profile of Lipiodol HSG, and clinical decision pathways for women with infertility. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/632d0fc2-ce0c-4eb7-b7c7-58c7b2d23134/canvas-image-1-1775439496329.jpg Gallery Chart illustrating menopausal hormone therapy (MHT) use in women with endometriosis and hysterectomy, based on Finnish registry data from 1996 to 2019. The image includes an overview panel showing reproductive age woman, postmenopausal woman, and different surgical procedures like hysterectomy and bilateral oophorectomy. Study groups are divided by age and endometriosis status, with reference groups. Bar charts display MHT usage percentages: 90% for women ≤45 years with endometriosis, 70% for women >45 years with endometriosis, and 40% for the reference group. Pie charts show that 80% of women under 45 receive estrogen-only therapy and 60% of women over 45 receive combined estrogen-progestogen therapy, with increasing combined therapy over time. A note discusses clinical guidance on progesterone and therapy risks/benefits. The conclusion emphasizes women with endometriosis are more likely to use MHT post-hysterectomy, estrogen-only therapy is most common, combined therapy is increasing, and evidence on MHT risks/benefits is limited. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0ae94e27-f39a-48a3-837d-7616a8fe638e/canvas-image-1-1775439525329.jpg Gallery Flowchart summarizing clinical and reproductive implications of intrinsic versus extrinsic adenomyosis, including anatomical localization, systematic review workflow, key findings, ART outcomes, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/67731578-77b4-4c52-929e-47801fae1a85/canvas-image-1-1775439667844.jpg Gallery Flowchart titled 'Management Options and Clinical Considerations for Ovarian Endometriomas and Deep Endometriosis.' It includes sections on overview, surgical options, deep endometriosis detail, hormonal treatment, and practice impact. The overview discusses ovarian endometrioma larger than 3 cm and deep endometriosis affecting bowel, bladder, or ureter. Surgical options compare cystectomy and ablation/drainage, showing no significant difference in pregnancy rate. Deep endometriosis detail suggests discussing impact on pregnancy outcomes. Hormonal treatment includes combined medication with laparoscopic surgery, with outcomes on pregnancy rate and live birth rate. Practice impact shows balanced options with minimal resource impact. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/bbc77a85-05ee-4370-a52d-d7c32b8c6506/canvas-image-1-1775439693629.jpg Gallery A comprehensive infographic on managing chronic pelvic pain disorders, focusing on endometriosis and adenomyosis. It includes diagrams of the female reproductive system highlighting endometrial lesions and adenomyosis, an overview of current standard care practices, potential lifestyle interventions like dietary modifications, exercise, and mindfulness, as well as their potential benefits and limited evidence. The infographic emphasizes social connection and self-management and discusses evidence gaps and future research directions in lifestyle modifications for pelvic pain related to endometriosis and adenomyosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6c316a52-22e5-4618-8aef-e918a773f79c/canvas-image-1-1775439771695.jpg Gallery Infographic showing a study comparing SGLT2i plus Metformin versus Metformin alone in endometriosis patients with T2D, highlighting reduced all-cause mortality and cardiovascular outcomes, with a renal endpoint trend toward higher risk of severe CKD with SGLT2i. The panels include study design, mortality rates, cardiovascular outcomes, and renal risk. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/acf4ee0d-1ab0-439e-a249-a1bf92d4234b/canvas-image-1-1775439806226.jpg Gallery A scientific infographic presenting a study comparing endovenous microwave ablation (EMA) and endovenous laser ablation (EVLA) for GSV insufficiency, including background, methods, intervention details, results with graphs showing occlusion rates, scores, Kaplan-Meier survival, safety profile, and conclusion. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1fa13c07-cea3-4350-840f-2e3a701e8f50/canvas-image-1-1775439839382.jpg Gallery A detailed infographic titled 'Hormone Therapy for Premature Ovarian Insufficiency' with sections on therapy overview, recommended regimens, safety routes, and monitoring. It includes diagrams of the human reproductive system, drug dosing information, and icons illustrating therapy and safety considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/692f0e38-f952-415b-8339-5b4efbcf8092/canvas-image-1-1775439848329.jpg Gallery Infographic about premature menopause and increased cardiovascular disease risk, showing risk levels by age, mechanisms of increased risk such as body fat redistribution, reduced glucose tolerance, dyslipidemia, elevated blood pressure, hyperlipidemia, hypertension, type 2 diabetes, endothelial dysfunction, and vascular inflammation, and clinical management guidelines including hormone therapy, monitoring, lifestyle modifications, and cholesterol guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5fae8734-d341-46e9-bf80-1e68be4e7b40/canvas-image-1-1775439860427.jpg Gallery Chart titled 'Migraine Across the Menopausal Transition: Pathophysiology, Comorbidities, and Therapeutic Strategies'. It includes sections on migraine epidemiology and hormonal influence, migraine subtypes and stroke risk, midlife comorbidities, therapeutic approaches and evidence, and clinical recommendations. The chart features icons of people, hormones, a brain, pills, and medical symbols, with color-coded sections and arrows illustrating relationships and processes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9b0793ec-001c-43ff-a51b-92609f181d86/canvas-image-1-1775439876758.jpg Gallery Diagram summarizing a study on postmenopausal women, showing cohort size, study timeline, and health transitions; illustrating menopause age groups from premature to normal, and a multi-state progression model from healthy to first chronic disease, multimorbidity, and death; highlighting key findings such as increased risks associated with menopause and age. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d16a521a-c92e-466c-b1e1-de03718530fd/canvas-image-1-1775439891859.jpg Gallery Flowchart of study design for laparoscopic surgery in women, showing screening, surgery, and classification into iSPE or no endometriosis groups, with data on pain outcomes and predictors, timeline assessment graphics, symptom subtypes, and key findings. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d0d94bc5-3ef3-4cb8-826e-e5fdaf89a240/canvas-image-1-1775439908825.jpg Gallery A detailed medical infographic titled 'Hysteroscopic Diagnosis and Management of Adenomyosis: Outpatient Approach' with sections on patient symptoms, imaging, hysteroscopic visualization, classification, biopsy technique, outpatient treatment, and future directions, including illustrations, diagrams, and charts. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/385fc89f-ce7f-4a9b-8d98-0753235ba2c1/canvas-image-1-1775439925276.jpg Gallery Flowchart illustrating the diagnostic and therapeutic role of hysteroscopy in adenomyosis, including clinical overview, diagnostic modalities, hysteroscopic findings & treatment, and future directions; features illustrations of the uterus and hysteroscope. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f0d12b95-8155-4b2e-b0c4-ccda7be2d056/canvas-image-1-1775439978491.jpg Gallery Infographic outlining IVF process and alternatives, including overview of IVF stages, barriers, diagnostics, and options such as ovulation medications, intrauterine insemination (IUI), lifestyle interventions, and structured support programs. It also compares costs, invasiveness, and success rates of various fertility treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cdfa2c28-179b-4c99-8cd3-48d05d055685/canvas-image-1-1775439992490.jpg Gallery A scientific infographic showing the risk of endometriosis, adenomyosis, and related symptoms in female offspring conceived by assisted reproductive technology (ART). It includes study design overview, main results with adjusted hazard ratios, and comparison between groups. Key findings indicate increased risks of endometriosis, menstrual pains, pain during intercourse, and heavy menstrual bleeding in ART-conceived female offspring. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f7615cd4-920c-4996-8539-b93af2fb5d69/canvas-image-1-1775440061157.jpg Gallery A scientific infographic from the Utah ENDO Study showing that endometriosis and ovarian endometriomas are associated with lower levels of anti-Müllerian hormone (AMH). The top left section illustrates the study design comparing women with no endometriosis, endometriosis, and preoperative serum AMH quantification in women aged 18-44. The top right diagram depicts the female reproductive system with stages of endometriosis severity (minimal to severe) and highlighted association with stage III-IV. The bottom left bar graph shows AMH levels across different endometriosis statuses, with a notable reduction in AMH in stage III-IV endometriomas. The bottom right box emphasizes that stage III-IV endometriomas are linked to markedly lower AMH and that endometriosis is most strongly associated with infertility. The overall message is that all endometriosis subtypes trend toward lower AMH compared to normal, regardless of surgical intervention. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4f96ec07-f99c-4250-980d-83b9ce50585d/canvas-image-1-1775617215703.jpg Gallery A clinical infographic presenting a study on intrauterine synechiae, showing study design, cumulative incidence, clinical implications, and risk factors. It features diagrams of the female reproductive system, hospital and patient icons, statistical data, and risk factor illustrations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c68532f2-0a2a-4903-b780-88fb35e98d5c/canvas-image-1-1775617222996.jpg Gallery A medical infographic showing a study comparing cure rates of chronic endometritis associated with endometrial polyps after treatment with conventional resectoscope versus tissue removal device. It includes diagrams of the female reproductive system, flowcharts of patient groups, and data on cure rates. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f4664f11-c438-4644-a73e-c26cbaf06647/canvas-image-1-1775617233594.jpg Gallery Diagram showing shared placenta-specific genetic associations underlying uterine fibroids and endometriosis, including disease background, study workflow with GWAS and multi-trait analysis, major results of shared and placenta-specific genes, interpretation and model, and tissue comparison. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/50b27eae-3164-4382-a8b9-c69633dc4311/canvas-image-1-1775617244312.jpg Gallery A detailed infographic about hormone therapy for premature ovarian insufficiency, including therapy overview, recommended regimens, safety considerations, and monitoring guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7a7d3dbd-9b15-481a-b67c-f4edc5f88e6f/canvas-image-1-1775617251780.jpg Gallery An infographic titled "Premature Menopause and Increased Cardiovascular Disease Risk: Pathophysiology and Clinical Management". It details menopause age groups and associated cardiovascular risks, mechanisms of increased risk, and clinical management guidelines including hormone therapy, monitoring, lifestyle modifications, and cholesterol guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f6b1c8ae-7eb0-40ca-8757-fe1335aa2a22/canvas-image-1-1775617260745.jpg Gallery Infographic depicting migraine across the menopausal transition, including epidemiology, subtypes, comorbidities, therapeutic approaches, and clinical recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5988b71f-1c9d-42fc-b313-a739fda9746d/BackgroundChronic-venous-insufficiency-%28CVI%29-is-a-prevalent-vascular-di%E2%80%A6-image-1.jpg Gallery Comparison chart of outcomes for NBCA, EVLA, and RFA treatments for chronic venous insufficiency, including study overview, key results such as vein occlusion rate, procedure time, pain scores, return to activities, complications, and conclusions about procedure effectiveness, durability, procedure time, pain, recovery, and recommendations for technique selection. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7964fcf3-2f41-4dc4-b144-177a1b8d0eba/export-1779077153018.png Gallery A chart showing the 2023 international evidence-based guidelines for diagnosing polycystic ovary syndrome (PCOS). It includes endorsed organizations, criteria for diagnosis requiring any two of three criteria, key simplifications, and recent updates including the use of AMH as an alternative diagnostic criterion. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6db4ce32-6fb4-4fc4-b13c-130bafbf85c4/export-1779077162461.png Gallery 2023 international evidence-based guideline for diagnosing polycystic ovary syndrome (PCOS); endorsed by 39 organizations including Endocrine Society, ESHRE, and ASRM; criteria include clinical/biochemical hyperandrogenism, ovulatory dysfunction, and polycystic ovarian morphology or elevated serum anti-müllerian hormone; updated in 2023 with AMH as an alternative to ultrasound; key points highlight when both hyperandrogenism and ovulatory dysfunction are present, diagnosis is simplified, and ultrasound/AMH testing may be unnecessary. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/12065c9f-b38f-4026-b018-7e76950389eb/export-1779094432083.png Gallery A scientific infographic titled 'Hyperandrogenism: Key Diagnostic Markers' describing clinical and biochemical hyperandrogenism, including guidelines for testing testosterone and free testosterone, and the diagnostic accuracy of key markers in PCOS, with a bar graph showing pooled sensitivity percentages for free testosterone (70.6%), total testosterone (36.3%), and mFG threshold (4-6). https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/244d7e7b-0ac0-4c2a-9719-678607e17acb/export-1779094635856.png Gallery Flowchart illustrating diagnostic criteria for ovulatory dysfunction and primary amenorrhea. It details age groups, menstrual cycle patterns, and diagnostic steps including hormone testing and timing. Primary amenorrhea by age 15 or after three years post-telarch. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/55a8dd44-3bd9-471c-9019-e1b3d529bbce/export-1779094690865.png Gallery Infographic explaining criteria for ovulatory dysfunction, including normal puberty transition, diagnostic criteria, and key takeaways, with statistics on anovulation and methods of confirming ovulation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/41cb45cd-c6b4-43a2-ab6f-574d307908a0/export-1779094775668.png Gallery Chart of 2023 updated PCOM ultrasound thresholds for transvaginal and transabdominal approaches, detailing markers, thresholds, and clinical performance metrics. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ae08d70a-5df3-49a6-992f-7f7841cd020f/export-1779094812662.png Gallery A chart titled '2023 Updated PCOM Ultrasound Thresholds' showing ultrasound approaches, markers, and thresholds for ovarian assessment, including transvaginal and transabdominal methods, with diagnostic criteria related to follicle number, ovarian volume, and follicles per section, along with accuracy metrics for the Follicle Number Per Ovary marker. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0bf35cf3-81bb-4785-be17-b1145ea09736/export-1779094915682.png Gallery Comparison infographic of ultrasound and serum AMH as guidelines for PCOM, highlighting the criteria, sensitivity, specificity, and key considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f431ebdf-a390-4ab4-ac7b-1b62b63ae2ea/export-1779094967678.png Gallery An infographic explaining AMH as an alternative to ultrasound for diagnosing PCOM in adults, with details on serum AMH and ultrasound, accuracy statistics, and usage guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dab7e1ff-ada2-4194-858d-7f6f107bb071/export-1779095058865.png Gallery Diagram showing four distinct metabolic risk profiles for PCOS based on Rotterdam criteria: Phenotype A (classic/full), Phenotype B (classic), Phenotype C (ovulatory), and Phenotype D (non-hyperandrogenic). Each profile presents features, metabolic risk levels, prevalence, impact, controversy, and clinical recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a445190e-eade-4e03-8105-ecebc64170ec/export-1779095116562.png Gallery Chart detailing Rotterdam-based phenotypes of PCOS, including criteria and risk levels for four types: Classic/Full, Classic, Ovulatory, and Non-hyperandrogenic, with associated features, metabolic risks, and prevalence estimates. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d9eddbef-cbaf-4369-9492-97757b026750/export-1779095255290.png Gallery 2023 guideline infographic for adolescent-specific criteria for PCOS diagnosis, detailing diagnostic steps, core requirements, times and ultrasound use, exclusions, and management for incomplete cases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d4ec934f-c8c8-4428-9b41-23578f8e3cd3/export-1779095326196.png Gallery 2023 PCOS guideline infographic for adolescent-specific diagnosis, detailing diagnostic criteria, principles, and key reminders for managing PCOS in adolescents. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7acc046b-eeeb-4097-9f2c-c5a605e5a480/export-1779095426713.png Gallery A chart titled 'Mandatory Exclusions in Diagnostic Frameworks' listing conditions like nonclassical congenital adrenal hyperplasia, thyroid disease, hyperprolactinemia, Cushing syndrome, androgen-secreting tumors, primary ovarian insufficiency, and hypothalamic amenorrhea. It details recommended screening tests and key notes for each condition, including hormones like 17-hydroxyprogesterone, TSH, prolactin, testosterone, DHEAS, FSH, estradiol, LH, and estradiol, with a note on routine biochemical exclusion and additional testing guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/98f28ad6-8af9-4672-8559-a3724fecff4e/export-1779095477633.png Gallery A chart titled 'Mandatory exclusions in diagnostic frameworks' listing conditions like nonclassical congenital adrenal hyperplasia, thyroid disease, hyperprolactinemia, Cushing syndrome, androgen-secreting tumors, primary ovarian insufficiency, and hypothalamic amenorrhea, along with recommended screening tests, key notes, clinical clues, and routine biochemical exclusions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8d6f54bd-cad9-42fd-a9d9-665528b4ab56/export-1779095616328.png Gallery Diagram illustrating the relationship between insulin resistance and PCOS, showing prevalence, core pathophysiology with impaired GLUT4 translocation, effects like hyperinsulinemia and hyperandrogenism, reproductive dysfunction, and diagnostic guidelines including surrogate indices and metabolic screening. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d7bb8f11-659e-4f39-902d-bb21fa05285b/export-1779095727072.png Gallery Educational infographic on the role of insulin resistance in PCOS, showing prevalence, surrogate indices, pathophysiological role, and diagnostic guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5f2ea999-85de-423c-a267-cc8f44cef5eb/export-1779095864393.png Gallery Infographic explaining the pathophysiology of insulin resistance in PCOS, highlighting core mechanisms involving hyperinsulinemia, hyperandrogenism, liver sex hormone-binding globulin production, and reproductive dysfunction, along with guidelines for measuring and diagnosing insulin resistance. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c2ed2ea8-f294-4834-86a5-27496d97c955/export-1779096036161.png Gallery A chart showing 2023 international guidelines for diagnosing PCOS in adults and adolescents. Adults need 2 of 3 criteria: hyperandrogenism, ovulatory dysfunction, and polycystic ovary morphology. Adolescents need both hyperandrogenism and ovulatory dysfunction, but PCOM/AMH should not be used for diagnosis in adolescents. Key updates include raised follicle threshold to 20 follicles per ovary and phenotyping for metabolic risk. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/df0c48ac-f6e4-4b9d-92df-71706418eb8c/export-1779096042625.png Gallery Infographic of 2023 international guidelines for diagnosing PCOS. It compares criteria for adults aged 18+ and adolescents under 18. Adult diagnosis requires 2 of 3 criteria: hyperandrogenism, ovulatory dysfunction, PCOM/AMH. Adolescents require both hyperandrogenism and ovulatory dysfunction. Key updates include raising follicle threshold for follicle count to 20 and using AMH as an alternative in adults. PCOM/AMH should not be used for diagnosing adolescents. The infographic emphasizes early risk assessment through phenotyping and metabolic risk management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/bacfb270-0058-406c-9656-c6d5e7ab728c/export-1779096465048.png Gallery An infographic explaining the diagnostic criteria and pathways for Polycystic Ovary Syndrome (PCOS). It covers adult diagnosis with two out of three criteria - hyperandrogenism, ovulatory dysfunction, and PCOM or high AMH, and adolescent diagnosis with stricter rules. It highlights excluded tests, risk categories, four phenotypes, insulin resistance, and metabolic health considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8a3e0625-f9b2-4b5e-b7b9-bdede8582725/export-1779096565053.png Gallery Infographic explaining Polycystic Ovary Syndrome (PCOS). It includes an illustration of a woman, a diagram of the female reproductive system, and sections titled 'Adult Diagnosis,' 'Adolescent Diagnosis,' 'The Four PMOS Phenotypes,' and a note on insulin resistance. The infographic outlines criteria for diagnosis, symptoms, and tests for PCOS. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/01393000-20a3-4114-b257-97b366aa45c9/export-1779097244822.png Gallery An infographic explaining insulin resistance in PCOS, highlighting key statistics, cellular mechanisms, liver effects, phenotypes, and IR severity, with diagrams of skeletal muscle and liver functions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a451dd72-49e2-4407-be88-01dabcedd7c2/export-1779097258488.png Gallery Diagram illustrating insulin resistance in PMOS, focusing on cellular mechanisms involving skeletal muscle, insulin signaling, and liver. Features control and PMOS conditions, phenotypes, and clinical guidelines. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/10c96ba2-dc6e-4e08-a153-dddf0f5f4697/export-1779128129424.png Gallery Clinical summary infographic on testosterone therapy for postmenopausal women, focusing on hyposexual sexual desire disorder, its benefits, and guidelines for treatment including biopsychosocial assessment, formulation, monitoring, and safety considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0a594568-a16f-4ff6-8505-aa989fe6e48e/export-1779128239888.png Gallery Infographic titled "Testosterone Therapy for Postmenopausal Women: Clinical Summary" explains indications, benefits, and guidelines for testosterone therapy. Features include a testosterone decline graph, a section on therapy benefits, warnings, prescribing recommendations, and contraindications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b324b5bf-eaac-4463-97fa-932b641f8683/Abstract-BackgroundTelangiectasia-and-reticular-veins-are-usually-not-a%E2%80%A6-image-1.jpg Gallery Flowchart comparing efficacy of liquid versus foam sclerotherapy with/without herbal gel for telangiectasia and reticular veins, showing study design, treatment groups, and outcome results with high resolution, better patient satisfaction, faster improvement, and minimal adverse events in foam sclerotherapy with herbal gel group. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e0b9cdc3-a3e3-469e-ba9d-68482feab9c4/Abstract-Introduction-Whether-endovenous-thermal-ablation-%28EVTA%29-can-b%E2%80%A6-image-1.jpg Gallery A scientific infographic about early endovenous thermal ablation in CVI with SVT, showing study timeline, intervention methods, outcomes, and follow-up details. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6eee2e4a-9029-4d89-aede-5b2a07183616/Abstract-Objectives-Endovenous-laser-ablation-%28EVLA%29-of-the-great-saph%E2%80%A6-image-1+%281%29.jpg Gallery A detailed medical infographic comparing simultaneous versus delayed venous vein treatment following endovenous laser ablation, including study design, outcomes, adverse effects, patient satisfaction, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/de6c82e6-e0c4-4d27-845b-21b8f0897077/Abstract-Objectives-Endovenous-laser-ablation-%28EVLA%29-of-the-great-saph%E2%80%A6-image-1.jpg Gallery Chart comparing outcomes, techniques, and benefits of simultaneous versus delayed venous vein treatment following endovenous laser ablation (EVLA) with illustrations of study design, key results, clinical implications, and patient satisfaction. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f770a1da-6ea5-45f5-9710-8f15c4400e55/Endometriosis%2C-particularly-ovarian-endometrioma%2C-is-associated-with-a%E2%80%A6-image-1.jpg Gallery Diagram illustrating endometriosis and ovarian cancer risks, molecular links, diagnostic challenges, and clinical management strategies, including hormonal therapy, surgical intervention, prophylactic surgery, and personalized multidisciplinary care. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8f3cc488-cdd0-408e-be85-acf78e535222/export-1779075213151.png Gallery Packaging of Trimbow inhaler with a digital world map in the background, highlighting global reach, and text detailing its triple therapy for respiratory health. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8a4850b6-699e-4232-b32b-fa0b445b2a07/Impact-of-Laser-Wavelength-on-Outcomes-of-Flush-Endovenous-Laser-Ablati%E2%80%A6-image-1+%281%29.jpg Gallery Diagram comparing lower limb anatomy using 1470 nm and 1940 nm lasers, showing differences in energy delivery, complications, pain scores, early occlusion, and postoperative improvement scores; includes graphs and data summaries. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f1fbef28-ced1-4e5f-83c3-1957a4f9a371/Impact-of-Laser-Wavelength-on-Outcomes-of-Flush-Endovenous-Laser-Ablati%E2%80%A6-image-1.jpg Gallery Diagram comparing lower limb anatomy and effects of 1470 nm and 1940 nm lasers. Includes illustrations of veins, complications, pain scores, and postoperative improvement scores. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/337a0138-ac58-40f1-9ee4-48dd61cc763a/In-this-issue-of-CMAJ%2C-research-by-Milne-and-colleagues-shows-an-increa%E2%80%A6-image-1.jpg Gallery An infographic discusses barriers and solutions in endometriosis care, highlighting current burdens like diagnostic delays, symptoms, and under-recognition, barriers such as limited imaging access and need for surgery, and solutions involving empowering primary care, advanced imaging, and specialized multidisciplinary teams to improve patient outcomes in Canada. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9bf068e9-c367-4b77-b641-99064fa51079/Clinical-Efficacy-of-GLP-1-Receptor-Agonists-for-Ovulation-in-PCOS-Evid%E2%80%A6-image-1.jpg Gallery A detailed infographic explaining the clinical efficacy and positioning of GLP-1 receptor agonists for ovulation induction in PCOS, comparing evidence, clinical algorithms, safety considerations, and key gaps in data. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ab0c50af-c935-48b6-a53b-9ae6f60d3bf4/Context-and-the-case-for-a-new-name-The-term-polycystic-ovary-syndrome%E2%80%A6-image-1.jpg Gallery Infographic explaining the rationale for renaming Polycystic Ovary Syndrome (PCOS) to address misconceptions and multisystem impact. It shows the difference between a misnomer of polycystic ovary and a normal ovary, lists multisystem features like endocrine, metabolic, dermatological, reproductive, psychological aspects, and highlights misconceptions, delayed diagnosis, poor communication, stigma, and distress, with emphasis on fertility. It discusses the consensus for a new, accurate, multisystemic name supporting care, research, and adoption, and illustrates research and policy challenges due to complexity. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4a42bea4-c921-40e5-852a-8d76d82fb0c9/export-1778467449755.png Gallery A detailed chart showing endometrial histology across the menstrual cycle, including phases from menstrual to premenstrual, with diagrams and descriptions of glands, stroma, vessels, endometrial thickness, and hormone levels. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9be8203e-034b-43a1-aef2-9858c7e975ed/export-1778467459771.png Gallery Histological chart of endometrial changes throughout the menstrual cycle. Shows different phases: menstrual, proliferative, and secretory, with detailed microscopic images at high power. The chart illustrates glands, stroma, and vessels in the endometrium. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/38a519ef-754e-425b-8463-d65e5f99cd72/export-1778468102906.png Gallery A detailed infographic illustrating the mechanisms of weight-independent GLP-1 receptor action on the hypothalamic-pituitary-gonadal (HPG) axis, including central, pituitary, ovarian, and peripheral mechanisms, and their effects on reproductive functions in women with PCOS. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3792ee8f-c7aa-4c79-9a3c-092df4a02962/export-1778468110755.png Gallery Infographic detailing the weight-independent GLP-1 RA action on the HPG axis in lean PCOS, illustrating mechanisms across hypothalamic/central, RAS1/RAS4/AKT/GnRH, ovarian/peripheral, pituitary, and reproductive evidence, with implications for future trials. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/123d183c-927b-48d1-afd7-c2862fd2197b/export-1778468571671.png Gallery Diagram explaining PCOS follicular dynamics and follicle development stages, comparing normal ovary and PCOS ovary, with illustrations of follicle stages, immature follicles, thickened stroma, and key features. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3b59829c-d001-490c-aea9-97b9a7deceaf/export-1778468577929.png Gallery Diagram comparing normal ovary with PCOS ovary, showing follicular development stages, immature small follicles arranged peripherally, and thickened collagen-rich stroma in PCOS ovary. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/36eae8f7-52e7-4585-bf8f-739e12ff3f65/Gemini_Generated_Image_zh9ynyzh9ynyzh9y.png Gallery An infographic about women's health at Links Clinic Edmonton, highlighting issues like PCOS and uterine bleeding, with sections on reproductive health, weight management, mental health, and compassionate care. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/91747cca-b4d8-4291-bdc0-b91fdff3aaec/Highlights-%E2%80%A2-The-use-of-OCs-was-associated-with-a-31%25-increased-relativ%E2%80%A6-image-1.jpg Gallery Flowchart of a meta-analysis on oral contraceptives and depression outcomes in women, including population characteristics, outcomes, subgroup analysis, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e5a3816d-39ff-43bf-b421-9f61319caeab/How-should-endometriosis-be-diagnosed-in-women-undergoing-infertility-e%E2%80%A6-image-1.jpg Gallery Flowchart outlining the diagnostic approach for endometriosis in women with infertility, including steps from initial clinical suspicion, assessment, imaging, laparoscopic evaluation, biomarker testing, to final summary and management recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/06b1bd61-a6cf-41d4-b31b-03853159651f/Insulin-resistance-is-documented-in-clamp-studies-in-75%25-of-women-with%E2%80%A6-image-1.jpg Gallery A scientific infographic titled "Insulin Resistance and GLP1-RAs in PCOS Pathogenesis and Treatment" illustrates six sections on PCOS, molecular defects, treatment approaches, mechanisms of GLP1-RAs, fertility improvement, and clinical promise, with diagrams and icons explaining the processes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5916af3c-0080-4051-868c-ca013192485c/Introduction-Flush-endovenous-laser-ablation-%28fEVLA%29-has-been-introduc%E2%80%A6-image-1.jpg Gallery Diagram comparing 1470 nm and 1940 nm laser procedures for vein treatment, showing procedural steps, complications, energy density graphs, recurrence data, and clinical outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/91ad790a-34eb-4421-bf74-304638370cf6/Key-messages-%E2%80%A2-Polycystic-ovary-syndrome-affects-more-than-170-million%E2%80%A6-image-1.jpg Gallery Infographic explaining the renaming of Polycystic Ovary Syndrome to Polyendocrine Metabolic Ovarian Syndrome, detailing the global consensus process, anticipated impacts, and implementation efforts. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0c128def-3dbd-445c-b265-74b99e952517/Key-points%E2%80%A2-Endometriosis-associated-infertility-is-multifactorial-and%E2%80%A6-image-1.jpg Gallery Infographic titled 'Endometriosis-Associated Infertility: Mechanisms, Diagnosis, and Treatment' with five sections explaining the impact of endometriosis on fertility. Section 1 shows hormonal impact and reproductive outcomes. Section 2 depicts clinical evaluation with ultrasound and MRI diagnostics. Section 3 illustrates mechanisms like inflammation and oxidative stress. Section 4 describes ovarian endometrioma and post-surgery ovarian reserve reduction. Section 5 outlines treatments such as hormonal therapy, reproductive gain, and ovarian preservation, mentioning surgery for women only. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/710cde10-1e5b-4121-84f1-e70b8aee083f/Mechanisms-of-Ovulation-Restoration-Weight-Dependent-and-Weight-Indepe%E2%80%A6-image-1.jpg Gallery Diagram illustrating mechanisms, treatment comparison, safety, and clinical management of GLP-1 receptor agonists in ovulation restoration for PCOS. Sections include pathway of GLP-1 RA, comparison with standard therapies, safety considerations, and a clinical algorithm for PCOS management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/88f281b2-0173-4cde-8f95-81240514d4fc/Objective-This-debate-paper-aims-to-examine-the-effects-of-glucagon-li%E2%80%A6-image-1.jpg Gallery Diagram illustrating the impacts of GLP-1 receptor agonists on fertility, contraception, and pregnancy. It includes sections on fertility effects such as weight loss and improved insulin sensitivity, contraceptive efficacy through oral pills with fewer GI side effects using long-acting reversible methods, and pregnancy outcomes recommending washouts before conception. The diagram shows process flow with blue arrows, green checkmarks indicating reliability, and red Xs for cautions, featuring icons of a woman, man, doctor, and various medical devices. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/77b95e8a-530f-4165-b380-37d0bc3574ee/omething-is-quietly-reshaping-reproductive-medicine-%E2%80%94-and-many-patients%E2%80%A6-image-1.jpg Gallery A comprehensive infographic explaining how GLP-1 receptor agonists are reshaping PCOS management and reproductive outcomes. It details the pathophysiology of PCOS, including insulin resistance, androgen levels, and irregular cycles. The infographic illustrates how GLP-1 receptor agonists improve insulin sensitivity, decrease ovarian androgens, and restore ovulation, leading to menstrual regularity. It also highlights the reproductive outcomes, such as increased chances of pregnancy and the importance of timing GLP-1 before conception, while warning that unplanned pregnancies may result from these treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/53445f9d-a335-4294-bbb4-89e304d0c3ca/Polycystic-ovarian-syndrome-%28PCOS%29-is-the-most-common-endocrinopathy-in%E2%80%A6-image-1.jpg Gallery Diagram comparing traditional therapy with estradiol-progesterone and incretin mimetics for PCOS, showing effects on ovarian morphology and GIP activity, including classes of incretin mimetics, outcomes like weight loss and insulin sensitivity, and a note on further research needs. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9e505a30-f204-4066-9d22-84941dd0141f/Recommendations%E2%80%A2-Management-of-endometriosis-associated-infertility-sho%E2%80%A6-image-1.jpg Gallery Flowchart depicting an integrated management algorithm for endometriosis-associated infertility. It includes assessment of disease phenotype, reproductive goals, and additional factors. The approach emphasizes structured clinical and imaging procedures, prioritizes laparoscopic excision of superficial lesions, and selective excision of ovarian endometriomas based on specific criteria. It recommends counseling for fertility preservation in at-risk women and prioritizing ART for specific indications such as prolonged infertility, diminished ovarian reserve, advanced disease, tubal damage, or failed prior surgery. No hormonal treatment is used for fertility improvement. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/96ee2118-1c5e-4bf4-a5d5-b5a80bee4582/The-preclinical-evidence-for-weight-independent-mechanisms-by-which-GLP%E2%80%A6-image-1+%281%29.jpg Gallery A scientific diagram illustrating the weight-independent GLP-1 RA modulation of the HPG axis in PCOS. It includes sections on schematic overview of the hypothalamic-pituitary-gonadal axis, hypothalamic mechanisms, neuroanatomical connectivity, ovarian-level mechanisms, the RASA1/Ras/AKT/GnRH pathway in PCOS, kisspeptin hierarchical signaling, and future clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7f692740-f0f2-4107-90e6-fb230dce67a3/The-preclinical-evidence-for-weight-independent-mechanisms-by-which-GLP%E2%80%A6-image-1.jpg Gallery A detailed diagram showing the mechanisms regulating the hypothalamic-pituitary-gonadal axis in weight-independent GLP-1 RA modulation of HPG axis, including schematic overview of brain, ovaries, and related pathways, with sections on hypothalamic mechanisms, ovarian mechanisms, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/85bb1313-31a0-4aa3-97b7-96edc05c9532/This-news-highlights-a-significant-population-based-study-published-in%E2%80%A6-image-1.jpg Gallery A detailed infographic summarizing a study on maternal endometriosis and the risk of congenital anomalies in Ontario from 2006 to 2021. It includes sections on study design, risk visualization, specific anomalies like cleft palate, hypospadias, and pulmonary artery stenosis, contributing factors such as systemic inflammation, IVF usage, and delayed childbearing, and clinical implications emphasizing prenatal risk assessment. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a2199664-06af-4c59-808f-5e1b3ea43e84/This-unprecedented-and-comprehensive-international-health-policy-initia%E2%80%A6-image-1.jpg Gallery A detailed infographic titled 'Global Renaming and Implementation of PCOS to Polvnedocrine Metabolic Ovarian Syndrome (PMOS): Consensus Process, Rationale, Disease Features, and Transition Strategy' showing sections on global consensus, key features, and transition plan. Sections include diagrams, charts, and icons depicting processes, abnormalities, and strategies for implementation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c5e1e894-0ad6-419e-a16a-5d4305ea714b/What-is-the-impact-of-endometriosis-on-female-fertility-Endometriosis-a%E2%80%A6-image-1.jpg Gallery Diagram titled 'Impact of Endometriosis on Female Fertility' showing how endometriosis affects various aspects of female reproductive health, including anatomical distortion, ovarian function impairment, inflammatory pathways, and endometrial receptivity, with evidence from oocyte donation models. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8c76d7f4-7943-423b-a36c-b6ea8498dcc7/Women-of-reproductive-age%2C-especially-those-with-polycystic-ovarian-syn%E2%80%A6-image-1.jpg Gallery An infographic showing the effects of GLP-1 receptor agonists on ovarian physiology and reproductive outcomes in women with PCOS. The diagram includes sections on clinical overview, ovarian mechanism action, clinical trial outcomes, animal study outcomes, and knowledge gaps. It illustrates how GLP-1 receptor therapy affects menstrual regularity, body weight, hormone levels, and ovarian function, and summarizes benefits and detriments from clinical and animal studies. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6f1baa53-6237-4361-b50a-a0962898b3c4/Women%E2%80%99s-health-care-is-notoriously-under-researched-and-underfunded.jpg Gallery Diagram explaining the renaming and reframing of women's health syndrome from PCOS to PMOS. The image includes sections on historical context, why the name change, and patient impact. The historical context notes the term 'Polycystic Ovary Syndrome' was coined in 1935, based on visualized cysts which are actually follicles. The name change to PMOS in 2025 reflects understanding of metabolic and hormonal factors, with a focus on mental health, weight, and skin changes. The patient impact highlights 170 million affected worldwide, with 1 in 10 Canadian women during reproductive years facing issues like irregular periods, infertility, hirsutism, obesity, mental health issues, and skin changes. The diagram emphasizes the slow challenge of changing official terminology and advocates for improved diagnosis, care, and awareness over the next ten years. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/998951dd-9205-4b8f-9433-00c4a9ba0468/For-endometriosis-The-hypothesis-is-complicated-by-local-aromatase-dri%E2%80%A6-image-1.png Gallery Infographic explaining endometriosis and related therapies. Sections show systemic estrogen suppression via GnRH agonist, endometriotic lesion with local estrogen production, clinical consequences like persistent symptoms and therapy options such as aromatase inhibitor therapy and postmenopausal endometriosis. Diagrams include pelvic cross-section, hormone pathways, and affected ovaries. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/952b5cdf-1ff5-4991-a91a-6abd384dde60/Summary-Comparison-Parameter-GnRH-Agonists-GnRH-Antagonist-%2B-Add-Back-G%E2%80%A6-image-1.png Gallery Comparison chart of GnRH Agonists, GnRH Antagonist + Add-Back, and GnRH Antagonist Monotherapy for uterine fibroids, detailing efficacy, safety, onset, duration, side effects, administration, and best use cases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/80cd8932-a223-435a-8ca7-9a994474aad0/The-Estrogen-Threshold-Hypothesis-in-Endometriosis-and-Fibroids-Origin%E2%80%A6-image-1.png Gallery Diagram illustrating the estrogen threshold hypothesis, showing tissue sensitivity hierarchy from most sensitive to least sensitive, based on estradiol E2 levels. It displays low, optimal, and high E2 zones with associated effects, and a therapeutic window for serum estradiol levels. The figure includes tissue types such as calcium metabolism, gonadotropin secretion, vaginal growth, lipid metabolism, liver protein production, breast cancer, and endometriosis/fibroids, with their corresponding estradiol concentration ranges. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0dc6bea1-1ef7-4e6d-b182-0edf0d4f9bb9/The-Volume-Reduction-vs+%281%29.png Gallery Diagram showing the relationship between volume reduction and symptom control in estrogen suppression for menopause treatment, including preoperative volume reduction with GnRH agonist and long-term symptom management with GnRH antagonist and add-back therapy. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f6841135-2284-4b0f-8ae5-41400cac98cf/The-Volume-Reduction-vs.png Gallery Chart comparing volume reduction and symptom control in estradiol suppression treatments for ovarian conditions, with sections on preoperative volume reduction, chronic symptom control, clinical goals, required E2 levels, achievable with, key evidence, and treatment objectives. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fb023605-eabb-4a06-8ee7-ad0f17ce4f51/A-2024-review-in-the-NEJM-noted-that-oral-GnRH-antagonist-combinations%E2%80%A6-image-1.png Gallery Diagram of treatment for symptomatic uterine fibroids using oral GnRH antagonists, showing mechanism of action, effects during treatment, limitations, recurrence, and fertility considerations with surgery only for preoperative volume reduction. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a91d4eb1-1b1f-4f4b-b597-e171f6210960/Background-We-aimed-to-evaluate-the-feasibility-and-safety-of-hysteros%E2%80%A6-image-1.png Gallery Flowchart illustrating the safety and feasibility of hysteroscopic myomectomy (HM) in infertile patients with FIGO type 0, I, and II uterine fibroids. It includes steps for patient selection, HM procedure, immediate post-op protocol, follow-up timeline, clinical pathways and outcomes, secondary procedures and outcomes, safety and complication data, and conclusion. The flowchart shows that HM is safe, with 78% conception rate, 42% live birth rate, and 12% developed intrauterine adhesions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d03bb244-b69e-45b8-b03a-cc6ac8c3e515/Diagnostic-Challenges-Symptom-Overlap-Core-symptoms-overlap-substantial%E2%80%A6-image-1.png Gallery Table comparing diagnostic symptom overlap between fibroids and endometriosis, listing features such as pelvic pain, dysmenorrhea, heavy menstrual bleeding, infertility, dyspareunia, and bowel/bladder symptoms, with respective characteristic features and distinguishing clues. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d74d725a-64be-47f0-a11d-cf82e13d57a6/Evidence-Gaps-and-Emerging-Data-The-most-critical-gap-is-the-absence-of%E2%80%A6-image-1.png Gallery A detailed infographic titled 'Management and Knowledge Gaps in Intramural (FIGO Type 3) Uterine Fibroids and IVF Outcomes' divided into five sections explaining fibroid location, evidence gaps, meta-analysis data, management pathway, and key research takeaways, with diagrams, arrows, and text. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/57c9a20c-99a3-4676-af52-cf9c2a34fb5b/export-1780109692427.png Gallery Diagram of a uterus with multiple fibroids and polycystic ovarian morphology, showing the uterus, cervix, vagina, fallopian tubes, and ovaries with measurements and descriptions of fibroids. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/538b1acc-0c5c-4cf5-8a44-9570ecbe0b9f/export-1780109805543.png Gallery A medical illustration of female reproductive anatomy showing the uterus, endometrium, bladder, rectum, ovaries, and fallopian tube. It highlights a retroverted uterus and features a detailed inset of the posterior compartment, depicting fixed uterine retroflexion, ovarian immobility, and ovaries behind the cervix. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/abdb7e8e-9352-46dd-98f5-8da89e531a7b/export-1780109967124.png Gallery Diagram of female reproductive system with labeled parts including ovaries, fallopian tubes, uterus, endometrium, myometrium, cervix, vagina, and bladder. Shows fibroids and other structures. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7c7ee1cc-e0cf-46e8-a8c0-498bbde81b94/Inflammatory-and-Immune-Mechanisms-Both-conditions-involve-chronic-infl%E2%80%A6-image-1.png Gallery Diagram illustrating shared and distinct inflammatory, immune, and genetic mechanisms in uterine fibroids and endometriosis, showing tissue origins, genetic mutations, immune pathways, and cellular activity alterations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/28a4c175-06ed-4ebc-9c53-1646c8a001de/Medical-Pretreatment-Before-Fertility-Treatment-GnRH-Agonists-The-Only%E2%80%A6-image-1.png Gallery A chart comparing the effects of GnRH agonists on endometriosis and fibroids, showing clinical study data, effectiveness, regrowth, and expert recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/63de4dc7-7a2c-43bc-8c58-81a45803a87c/Mendelian-randomization-meta-analyses-combining-FinnGen-and-UK-Biobank%E2%80%A6-image-1.png Gallery Diagram illustrating the mechanistic and genetic links between endometriosis, uterine fibroids, and uterine leiomyomas. It highlights shared risk factors, the WNT/β-Catenin pathway, and genetic risk loci involving chromosome 1 and the WNT4 gene. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/29617cd3-bf8f-4c85-83b6-83064c03a608/Polyendocrine-metabolic-ovarian-syndrome-%28PMOS%29%2C-which-was-recently-cha%E2%80%A6-image-1.png Gallery Diagram providing an overview of polycystic ovary syndrome (PCOS) and its related diagnostic criteria, comorbidities, and lifestyle impacts. The image includes sections on the definition and history of PMOS, diagnostic criteria involving chronic anovulation, hyperandrogenism, and polycystic ovaries, comorbidities like obesity, metabolic syndrome, and cardiovascular disease, early diagnosis heterogeneity, and lifestyle interventions leading to improved symptoms and outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fc5fe8c0-552e-4a03-9276-b5ec247dcdc5/Polyendocrine-Metabolic-Ovary-Syndrome-%28PMOS%29-is-recognized-as-the-most%E2%80%A6-image-1.png Gallery Overview infographic of diagnosis and management pathways for Polycystic Ovarian Syndrome (PCOS). Sections cover diagnostic criteria, work-up, clinical features, risks, management strategies, and special populations. Visuals include diagrams, icons, and text descriptions of symptoms, tests, and treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3473ee00-2d0a-462a-bd9a-40f709226d21/Practical-recommendation-Surgeons-performing-myomectomy-in-fertility-p%E2%80%A6-image-1.png Gallery Diagram presenting guidelines on ovarian endometriosis treatment, including patient counseling, surgical risks, and prevention strategies. Sections cover endometriosis management options, risks of ovarian reserve loss from excision and myomectomy, and adhesion formation prevention methods. Visuals include diagrams of the female reproductive system and surgical procedures. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d9939166-e5a4-40fe-a300-44670d87840c/Progesterone-Signaling-Shared-Pathway%2C-Divergent-Roles-Progesterone-pl%E2%80%A6-image-1.png Gallery Diagram illustrating progesterone signaling pathways: shared pathway in endometriosis and fibroids, highlighting divergent roles. Endometriosis shown with progesterone resistance, and fibroids with progesterone-driven growth, including therapeutic implications of drug progesterone and progestins. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2f53cc43-c1a6-46f7-bce8-8468a40a4c14/Relugolix-combination-40-mg-%2B-E2-1-mg-%2B-NETA-0.png Gallery A detailed infographic explaining relugolix combination therapy for endometriosis and fibroids, including FDA-approved mechanisms, efficacy data, treatment challenges, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1ad5e41e-338a-48ea-8d37-60882db0e9de/Shared-Pathophysiology-Estrogen-Dependence-and-Local-Estrogen-Productio%E2%80%A6-image-1.png Gallery Diagram showing shared pathophysiology of estrogen dependence in endometriosis and uterine fibroids. The left side depicts endometriosis, with illustrations of normal endometrial tissue and ectopic endometriotic lesions, highlighting cellular mechanisms involving androgen and estrogen, aromatase CYP19 enzyme, and estrogen-rich microenvironment. The right side shows uterine fibroids (leiomyomas), with fibroid cells producing aromatase and promoting tumor growth, alongside normal myometrium. Central link indicates estrogen dependency and shared features like aromatase overexpression and local estrogen biosynthesis in both conditions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cf7055bf-08e0-457b-a577-ec76c768b81a/Summary-Uterine-fibroids-and-endometriosis-co-occur-3%E2%80%937-times-more-freq%E2%80%A6-image-1.png Gallery Infographic summarizing the shared pathophysiology, genetic basis, clinical challenges, pharmacological and surgical approaches to uterine fibroids and endometriosis, highlighting genetic links, diagnostic challenges, treatment strategies, and importance of considering endometriosis in certain surgical cases. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fa447800-3003-4e03-aa43-c816a9429b47/Surgical-Co-Occurrence-Data-Surgical-series-consistently-reveal-unexpec%E2%80%A6-image-1.png Gallery An infographic about the surgical co-occurrence of endometriosis at myomectomy, showing overview of findings, key independent predictors, subgroup modifiers, and a world map with geographic variation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/15cedd37-1ce1-4550-a857-7e670848059a/The-presence-of-uterine-fibroids-impacts-fertility-through-multiple-mec%E2%80%A6-image-1.png Gallery Diagram showing mechanisms by which uterine fibroids impact fertility and management strategies, including uterine anatomy, fertility outcomes, clinical algorithms, assisted reproduction, and obstetric outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6b89d297-139b-4d10-a764-326150420c00/A-multimodal-approach-combining-pharmacologic-and-behavioral-interventi%E2%80%A6-image-1.jpg Gallery Flowchart showing pharmacologic and behavioral interventions for vasomotor symptoms and perimenopause, including medications like HT, SSRIs, Fezolinetant, Gabapentin, and lifestyle tips such as diet, exercise, and supplements. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/97f8490a-3125-4da1-8262-8a8331126fc1/Abstract-Background-Fluoroscopic-hysterosalpingography-%28HSG%29-with-Lipi%E2%80%A6-image-1.png Gallery Infographic about safety and efficacy of outpatient ultrasound-guided lipiodol HSG in unexplained infertility. Includes study workflow, outcomes timeline, complications, and conclusions. Shows 52 participants, safe procedure, no major complications, 57% biochemical and 53% clinical success rates, with thyroid monitoring recommended. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3fd7324b-f99c-45ac-aea2-5bea9a34af4c/Based-on-the-abstract-provided%2C-here-is-a-summary-of-the-key-findings-r%E2%80%A6-image-1.jpg Gallery Diagram comparing healthy endometrium and endometriosis-associated infertility. Left shows healthy tissue with normal epithelial and stromal cells and successful embryo implantation. Right shows endometriosis with altered cell interactions, decreased ESR1 and PGR, impaired embryo implantation, and AI analysis confirming correlation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/13e94d37-71b1-46d1-9d60-55f130c46e90/export-1779537814461.png Gallery A comprehensive infographic discussing HRT and sarcopenia, including clinical evidence, observational evidence, resistance exercise, and biological mechanisms in skeletal muscle. It features graphs, key findings, and scientific data supporting the benefits of HRT and exercise on muscle mass, strength, and gene expression. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/98a9a1b0-066e-4483-a545-3c2c78fe7010/export-1779537821853.png Gallery A detailed infographic comparing hormone replacement therapy (HRT) and sarcopenia, focusing on biological mechanisms and clinical evidence, including meta-analyses, key metrics, and exercise impact on muscle mass and strength in postmenopausal women. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c0c46243-9f6b-496d-ac7a-f81ffe55f84b/export-1779537841762.png Gallery Infographic about menopause and sarcopenia, discussing biological mechanisms, clinical consequences, diagnosis, and actions for muscle health during aging. Includes charts, icons, and summary points. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a8c45bd0-0e5d-46a9-acea-2cbcbafda469/export-1779537848784.png Gallery An infographic titled "Menopause & Sarcopenia: The Complex Decline and Accelerated Muscle Loss" explains the biological mechanisms and clinical consequences of muscle loss during menopause. It highlights the decline in muscle density starting at the premenopause stage, with a notable jump during the transition to postmenopause. Key mechanisms include falling estradiol and rising FSH levels leading to metabolic shifts, increased visceral fat, and anabolic resistance. The clinical consequences discussed include osteosarcopenia, metabolic health issues, and reduced brain-muscle link. The infographic also summarizes the reduction in lean mass and muscle strength, and provides diagnostic thresholds and a questionnaire for sarcopenia detection. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/365a51ac-1a81-4c95-99ab-7757b252e0aa/export-1779537862624.png Gallery Infographic titled 'Testosterone Therapy for Postmenopausal Women: Clinical Summary' with sections on physiology, efficacy, what testosterone does not improve, prescribing recommendations, warnings, safety, contraindications, and key takeaways. Graphics include charts, icons, and checklists. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a4259767-45f3-4b26-a687-1001d71861d8/export-1779537870258.png Gallery Infographic about testosterone therapy for postmenopausal women, highlighting the evidence-based indication for hyposexual sexual desire disorder, safety profile, prescribing recommendations, and contraindications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7e36c9b5-9373-4129-9a4a-9e9e2d27ad2e/export-1779541972246.png Gallery An infographic titled 'The Yearning for Movement Framework' explains the process of managing endometriosis-related chronic pain through movement. It includes four phases: The Yearning, Monitoring & Assessing, Adapting & Taking Action, and Healthcare Support Gap. The illustration shows a woman contemplating her desire to move, a filter for pain levels, energy, and social costs, and pathways for action. Additional sections highlight the cycle of desire to move, clinical implications like validation and tailored support, and the pillars of support and individual well-being. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/57e6dd6a-d555-48a9-90d7-4c3ec358391b/export-1779543260663.png Gallery A comparative diagram showing the dysregulation of ESR1 and PGR in endometriosis-associated infertility versus healthy receptive endometrium. It highlights differences in epithelial and stromal layers, receptor expression levels, and molecular signatures, illustrating implantation success in healthy endometrium and failure in endometriosis with signs of epithelial overexpression, aberrant receptor levels, and reduced ESR1. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/96bbeb0c-236d-4891-b9d8-7f55ef0a5e7b/export-1779543272052.png Gallery Diagram illustrating the effects of dysregulation of ESR1 and PGR in endometriosis-associated infertility. It compares healthy receptive endometrium with endometriosis-associated infertility, showing hormonal regulation, cellular changes, molecular signatures, and clinical implications, including decreased ESR1 and PGR levels and their impact on endometrial receptivity. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3e2d4f0f-c479-45ab-8609-edcbfec70138/export-1779588830799.png Gallery An infographic illustrating menopause transition, hormone optimization, and their effects on health and longevity. The left side shows declining estrogen, increased cardiovascular risk, metabolic dysregulation, bone density loss, and cognitive and mood changes. The right side highlights hormone support with estradiol, progesterone, and testosterone to optimize energy, balance, strength, and vitality. The background features a sunset landscape with mountains and a woman silhouette transitioning from disintegration to vitality. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/21921434-2764-4a6e-8557-fd1652704b4f/export-1779588836744.png Gallery An infographic illustrating menopause transition and hormone optimization for female longevity. It shows the decline of estrogen and associated health risks such as cardiovascular risk, metabolic dysregulation, bone density loss, and mood changes. On the right, there are molecular structures of estrogen, progesterone, and testosterone with their benefits. The bottom emphasizes optimizing cardiovascular resilience, metabolic balance, skeletal strength, and cognitive vitality to turn menopause from decline into longevity. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5daf7ffc-82c0-4cb9-be6c-6d3b6b98d0ac/export-1779589671341.png Gallery Infographic explaining menopause transition as a systemic metabolic shift, highlighting neurological, cardiovascular, and metabolic health, and emphasizing the importance of early intervention and lifestyle changes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fccb86f0-f0ac-4b32-863e-2ab74387bb40/export-1779589677933.png Gallery An infographic titled 'The Menopausal Transition: A Systemic Metabolic Shift' explaining the effects of ovarian function cessation on body systems. It features three pillars: Neurological, Cardiovascular, and Metabolic, detailing health changes during menopause. The neurological pillar lists brain health changes, cognitive aging, mood regulation issues, and sleep disturbances. The cardiovascular pillar mentions heart health shifts, vascular decline, increased risk, and lipid changes. The metabolic pillar notes energy use, metabolic rate, weight gain, and insulin sensitivity alterations. The diagram highlights the 'Critical Juncture' as a key window for intervention to prevent health decline. It recommends clinical hormone therapy and lifestyle changes to support long-term health. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5f6942d2-c51b-47f0-8bf2-b08d26cbd2ac/export-1779590007601.png Gallery An infographic titled 'The Blueprint for Women's Longevity' illustrating a life-course approach to women's health, from early drivers of long-term health to later years, emphasizing prevention, health management, and specialized focus areas, with sections on foundational health, reproductive years, early adulthood, midlife, postmenopause, and later years, including key health pillars like medical management, physical function, nutrition, mental well-being, and lifelong partnership. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a643db88-165f-4959-9c4a-5052a0a4c882/export-1779590016045.png Gallery Infographic titled 'The Blueprint for Women's Longevity: A Proactive Life-Course Approach to Women's Health'. It shows a timeline from 20s to 80s+ highlighting early conditions like PCOS and Endometriosis affecting gynecological health earlier, and the 'vital window' around age 40 for estrogen decline, bone health, cardiovascular and cognitive health. The infographic emphasizes a shift from reactive to proactive care through preventive strategies, early intervention, multidisciplinary support, and the role of gynecologists and longevity physicians in chronic disease prevention. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c2a6ac9c-68cc-4b88-99df-c5dee8aa2776/export-1780024121205.png Gallery Diagram showing the relationship between PCOS, hormonal features, and breast cancer risk. It illustrates the hormonal regulation involving hypothalamus and pituitary, and their effects on estrogen, androgens, and PCOS ovaries. The diagram highlights factors influencing tissue in breast tissue, such as estrogen exposure, cell proliferation, inflammation, and epigenetic changes. It mentions that evidence on the link between PCOS and breast cancer risk is inconclusive, with some factors like hormonal disturbances and metabolic health playing a role. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f1a791e3-b4c9-47b2-a687-8ce5a0aacef6/export-1780024127792.png Gallery Diagram illustrating hormonal modulation and epidemiological trends in PCOS and breast cancer risk. Shows hormonal regulation background, mediating metabolic pathways like insulin resistance, obesity, type 2 diabetes, and inflammation, affecting breast tissue through altered hormone signals, endocrine, and metabolic environment, influencing breast growth, development, and cancer risk. Includes studies, conflicting data, and research methods. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cd91fe7b-4523-4be4-82e4-5fd8a9a56c81/export-1780025529619.png Gallery Infographic about ovarian cysts in polycystic ovary syndrome (PCOS), showing differences between PCOS 'polycystic' appearance and pathogenic cysts, ultrasound images, and statistics on features and risk factors. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0b59c133-5bae-480f-b332-4c3fc6218a9e/export-1780025536102.png Gallery Chart comparing ovarian morphology in PCOS and normal ovaries, with ultrasound images and statistics on ovarian features and prevalence. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2fff1dc7-6348-470c-b685-91ba4492653e/Maintaining-hormonal-equilibrium-is-a-key-determinant-of-women%27s-health%E2%80%A6-image-1.png Gallery Diagram illustrating transdermal hormone therapy in menopausal and postmenopausal women's health, including hormonal changes during menopause, therapeutic modalities (oral vs. transdermal), and modern clinical integration for improved health outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e00675e8-cf14-4979-87d8-8f7042da9245/Objective-Across-the-lifespan%2C-more-women-than-men-report-abdominal-bl%E2%80%A6-image-1.png Gallery A scientific infographic showing factors affecting abdominal bloating severity during menopause transition. It depicts a study with 291 women across different stages, urine sample collection, and modeling of age and reproductive aging. Key findings include that tension, anxiety, age, and testosterone levels influence bloating severity, with tension and anxiety increasing severity, while age and testosterone levels have protective effects. The infographic includes a legend indicating severity and menopause stages. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6d1d042b-02f1-4c58-89ee-ff4c8ed906f5/Perimenopause-and-job-Analyzed-query%2C-searched-for-evidence-Perimenopau%E2%80%A6-image-1+%281%29.jpg Gallery An infographic titled 'Evidence-Based Workplace Interventions to Support Work Ability and Cognitive Function During Perimenopause'. It includes statistics about perimenopausal symptoms, work impact, and recommendations. The infographic is divided into sections on symptoms, work impact, workplace recommendations, and interventions including therapy, exercise, mind-body practices, menopause clinics, medication, and integrative approaches. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7c04ad66-9c2c-476f-8304-6e57ff827143/Perimenopause-and-job-Analyzed-query%2C-searched-for-evidence-Perimenopau%E2%80%A6-image-1.jpg Gallery Infographic titled "Perimenopause, Symptoms, and Impact on Work Performance" divided into sections: 1) Prevalence and Symptom Burden showing 80% of perimenopausal workers experience symptoms like fatigue (54%), sleep difficulty (47%), poor concentration (44%), and poor memory (40%), with 27.5% experiencing frequent symptoms. 2) Work Outcomes illustrating lower at-work productivity due to menopause symptoms such as presenteeism (12-17%), absenteeism (9-13%), and increased sick leave (18%). 3) Workplace Recommendations including flexible scheduling, ability to take breaks, manager education, environmental modifications, and healthcare coverage. 4) Evidence-Based Interventions and Clinical Management with workplace interventions like CBT, exercise, yoga, clinic consultation, and symptom management options including hormone therapy, non-hormonal options, and integrative approaches. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4c8afb87-cf32-4eaa-838b-4e7563dfaa58/Perimenopause-and-job-Analyzed-query%2C-searched-for-evidence-Perimenopau%E2%80%A6-image-1.png Gallery An infographic titled 'Evidence-Based Workplace Interventions to Support Work Ability and Cognitive Function During Perimenopause' showing statistics, symptoms, and recommendations. Key points include 80% of perimenopausal workers experience symptoms, with a 65% reduction in work performance, costing $1.8 billion annually in the US. Common symptoms listed are fatigue (54%), difficulty sleeping (47%), poor concentration (44%), poor memory (40%), mood/psychological issues, and hot flashes/night sweats. Impact on work outcomes includes presenteeism, absenteeism, reduced career development, and high job demands. Workplace recommendations include flexible scheduling, manager education, environmental modifications, and healthcare plan review. Evidence-based interventions are categorized into cognitive-behavioral therapy, exercise, mind-body approaches, menopause clinic consultations, diet and health education, hormone therapy, non-hormonal medications, and integrative approaches. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a6c13d09-9f4e-4c08-9861-b48ab229416a/Perimenopause-significantly-impacts-work-performance%2C-productivity%2C-and%E2%80%A6-image-1.jpg Gallery Infographic titled 'Perimenopause Impacts Work.' It includes illustrations of women and data points about menopause symptoms, work performance, and career impact; a pie chart showing 80% experience symptoms, bar and percentage data on work impairment, a calendar illustration about sick leave, and icons representing job demands and stress. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/745c753b-e7b2-4888-8ed4-cd43cd652f5c/Perimenopause-significantly-impacts-work-performance%2C-productivity%2C-and%E2%80%A6-image-1.png Gallery An infographic about perimenopause impacts at work displaying five sections: 1) Perimenopause impacts work with illustrations of women and charts; 2) Symptom prevalence at work shown as a pie chart indicating 80% experience symptoms and common symptoms like fatigue, difficulty sleeping, poor concentration, and poor memory; 3) Cognitive impacts highlighting differences between premenopausal and perimenopausal women with icons for attention and memory; 4) Work outcomes with data on presenteeism, absenteeism, career impact, and high job demands, including charts and icons; 5) Key findings summary emphasizing symptoms, cognitive impacts, absenteeism, and career effects. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0c7beb97-9111-422b-a86a-213fd430bc1b/The-most-common-workplace-challenges-during-perimenopause-are-neurocogn%E2%80%A6-image-1.jpg Gallery An infographic illustrating the impact of perimenopause symptoms in the workplace, including prevalence among healthcare workers, specific symptoms like fatigue, sleep difficulty, poor concentration, brain fog, and their effects, along with symptoms specific to work, career consequences, environmental factors, workplace support recommendations, and the support gap. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dcdb4daa-6da4-4ccc-9ec0-7fa16fa2cb7a/The-most-common-workplace-challenges-during-perimenopause-are-neurocogn%E2%80%A6-image-1.png Gallery An infographic titled 'Impact of Perimenopause Symptoms in the Workplace' with three sections. The first section shows symptom prevalence among healthcare workers, highlighting fatigue (54%), difficulty sleeping (47%), poor concentration (44%), poor memory (40%), and brain fog (~70%). The second section describes symptom-specific and broader work effects, including cognitive fog, vasomotor symptoms, and psychological changes, and their career consequences like presenteeism, absenteeism, and job exit. The third section illustrates workplace environmental factors causing support gaps, such as insufficient restrooms and long hours, and offers recommendations like open culture, flexible scheduling, temperature control, and manager training, noting only 2-6% of workplaces provide adequate menopause support. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8d088283-cb79-48b9-8220-ce9b06d6f4ed/The-relationship-between-PCOS-and-breast-cancer-risk-has-been-histori%E2%80%A6-image-1.png Gallery Illustration showing the evolution of evidence linking PCOS and breast cancer risk. Sections include: no association with historical studies; modest risk detection in emerging evidence; reasons for discrepancies such as short follow-up and small cohorts; biological pathways in postmenopausal PCOS including hormone and receptor changes, inflammation, and obesity; and guideline positions emphasizing no screening change. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/53c5f151-b1ab-48df-b8e8-8f91521f4ae6/A-growing-body-of-literature-has-revealed-that-patients-with-endometrio%E2%80%A6-image-1.png Gallery Diagram illustrating endometriosis, its association with ovarian endometriomas, superficial peritoneal lesions, deep infiltrating endometriosis, and clinical complications like pain and infertility. It depicts comorbidity risks such as endometriosis increasing ovarian cancer and cardiovascular disease risks, and highlights gaps in global epidemiological research, emphasizing the need for diverse, population-specific studies to improve understanding and management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/32bd343b-e16c-407b-b344-6ac3244917c4/Abstract-Purpose-Adolescent-endometriosis-%28EMs%29-imposes-substantial-ph%E2%80%A6-image-1.png Gallery A flowchart illustrating the relationships between parental rearing patterns, psychological resilience, social support-seeking, and coping styles in adolescent girls with endometriosis. It shows that positive parental rearing promotes resilience and active coping, while high-pressure parenting negatively impacts resilience, leading to more passive and avoidant coping styles. The chart includes data on adolescent girls with endometriosis, with 168 participants, highlighting the effects of different childhood experiences on psychological resilience and coping mechanisms. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/50574daf-32fa-4b0f-8119-90b9c6d8f9c5/Activity-of-dienogest-on-human-endometrium-The-strong-progestational-ac%E2%80%A6-image-1.png Gallery A scientific chart presenting pharmacodynamic and pharmacokinetic activity of dienogest on the human endometrium and ovary, including sections on comparative oral potency of progestins, effects on ovarian steroidogenesis, uterotropic index visualization, and clinical implications panel for endometriosis, menopause, and contraception. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8db502f1-d543-44eb-bf22-4ad10d22eff7/Background-and-purpose-This-study-evaluated-the-impact-of-physical-act%E2%80%A6-image-1.png Gallery A scientific infographic showing the impact of physical activity on dementia risk among pre- and postmenopausal women with different BMI levels. It highlights that regular or moderate physical activity reduces dementia risk across both groups, with specific focus on light physical activity (LPA) and moderate-to-vigorous physical activity (MVPA). The infographic includes data on brain health, dementia types, and BMI categories, emphasizing that physical activity benefits women with higher BMI. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d353b544-d706-41d1-882b-a07c13e83529/Endocrine-pharmacological-findings-Dienogest-exhibits-moderate-binding%E2%80%A6-image-1.png Gallery infographic explaining the endocrine pharmacological findings and antiandrogenic actions of Dienogest, including its high selectivity, receptor binding, and effects on androgen receptors, with diagrams illustrating molecular interactions, effects on vocal fold elasticity, and impact on human skin fibroblast https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e9b9c855-f2ad-432a-8af4-0b460e68f09a/Endometriosis-and-adenomyosis-are-common-gynecologic-disorders-associat%E2%80%A6-image-1.png Gallery Diagram showing distinct pathogenic pathways in endometriosis and adenomyosis, illustrating the proliferation-fibrosis divergence model with central mitochondria. Left side depicts proliferative phenotype with processes like hypoxia tolerance, oxidative stress response, angiogenesis, cellular survival, and metabolic reprogramming driven by common stimuli such as tissue injury, estrogen, inflammation, oxidative stress, and mitochondrial dysfunction. Right side depicts fibrotic phenotype with processes such as fibrosis, ECM remodeling, tissue stiffening, mechanical stress adaptation, calcium homeostasis, and smooth muscle hyper-contractility. Central mitochondria integrate these pathways, with a legend explaining the divergence model and therapeutic implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/03086d12-d66a-4600-a868-b2b56782cbad/News-Endometriosis-%E2%80%9CGame-changing%E2%80%9D-new-tests-may-speed-up-diagnosis-in%E2%80%A6-image-1.png Gallery Flowchart showing the process of diagnosing endometriosis, including traditional invasive pathways with long wait times, and game-changing non-invasive tests leading to earlier diagnosis in primary care, resulting in improved fertility outcomes and reduced healthcare burden. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/566ead2c-e452-451c-909b-5a36387bf1ac/News-Endometriosis-%E2%80%9CGame-changing%E2%80%9D-new-tests-may-speed-up-diagnosis-in%E2%80%A6-image-3.png Gallery An infographic about improving endometriosis diagnosis methods. It shows that endometriosis affects 1 in 10 women, causes chronic pelvic pain and fertility issues, and currently involves invasive, delayed diagnosis with long wait times. The infographic highlights new non-invasive tests, NICE recommendations, and advantages such as faster, accessible, and accurate diagnosis, reducing delays and improving outcomes for women and communities. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b30bde0d-722a-46e8-9b87-dd9883916b51/Pharmacokinetics-of-dienogest-Dienogest-is-almost-completely-absorbed-a%E2%80%A6-image-1.png Gallery Diagram of oral delivery of a bioavailable dihydrotestosterone prodrug, showing its absorption, tissue penetration, and effects on the prostate and microbial transformation, with related pharmacokinetic information. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6cf30d5f-b2c4-4ff0-9d0f-bf7f2f8ceb52/Toxicity-The-reproductive-toxicological-studies-did-not-suggest-any-ter%E2%80%A6-image-1.png Gallery Diagram titled "Toxicological Safety and In Vivo Results" illustrating three sections related to dieongest, rat liver bioassay, and human liver metabolism. Section A shows safety profile of dieongest with no toxic effects in rodents, no mutagenic activity, and no carcinogenicity in rats/mice. Section B confirms no tumor-initiating activity in rat liver bioassay with healthy liver and good oral bioavailability. Section C explains the mechanism of metabolic stability in human liver, highlighting the inhibition of cytochrome P450 enzymes, preventing reactive intermediate formation and oxidative attack, resulting in excellent metabolic stability. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5898dc5f-12ff-4396-b2d4-bbd4c6fe0000/Gemini_Generated_Image_wpnblqwpnblqwpnb.png Gallery Infographic explaining Ziwig Endotest, a non-invasive saliva test for endometriosis, detailing steps from saliva collection, micro-RNA signature analysis, artificial intelligence sequencing, to results interpretation and diagnosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/49d26329-6f08-4bb3-a083-a6b2e30f4612/Hysterectomy-%E2%80%94-even-with-ovarian-conservation-%E2%80%94-is-associated-with-an-i%E2%80%A6-image-1.png Gallery Infographic titled 'Hysterectomy and Long-Term Cardiometabolic Risk: Clinical and Mechanistic Insights.' It compares different hysterectomy methods: with BSO (bilateral salpingo-oophorectomy), with ovarian conservation, and no surgery (reference). The chart shows relative risk (hazard ratio) for various outcomes like metabolic syndrome, diabetes, hypertension, cardiovascular disease, etc., with red arrows indicating increased risk after BSO. The right side has a graph showing hazard ratios by age at surgery, highlighting higher risks for those operated at or before age 35. There's a section on hormone replacement therapy (HRT), suggesting it may mitigate some risks. The bottom includes clinical implications and recommendations, emphasizing routine cardiometabolic screening and considering alternatives to hysterectomy for benign conditions. https://www.endosure.info/new-page-1 daily 0.75 2026-05-23 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5da8c15e-9dac-4a9c-88c7-fe0e76054dd3/Women%E2%80%99s-health-care-is-notoriously-under-researched-and-underfunded.jpg https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e0f81961-89c2-4337-9a47-79d5226b714c/Gemini_Generated_Image_zh9ynyzh9ynyzh9y.png https://www.endosure.info/new-page-2 daily 0.75 2026-07-04 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/141df96c-fbe4-4d97-adf9-904d2be31e50/Gemini_Generated_Image_wpnblqwpnblqwpnb.png https://www.endosure.info/infographic2 daily 0.75 2026-08-09 https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ad40242a-d626-4049-a3fa-a67ca8fe9415/A-New-Era-in-Endometriosis-Diagnosis-One-of-the-most-significant-advanc%E2%80%A6-image-1.jpg infographic2 A comprehensive infographic titled 'A New Era in Endometriosis Diagnosis' outlining the diagnostic journey, beyond the pelvis, human impact, symptom diversity, biological complexity, multidisciplinary care, and future research directions in endometriosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/de898856-90ea-44c8-8245-887d4ba4062b/Aims-hypothesis-Endometriosis-is-a-heterogeneous-inflammatory-conditio%E2%80%A6-image-1.jpg infographic2 Title: Endometriosis increases type 2 diabetes risk - Study overview chart. Study population from Utah database with nearly 2.94 million people, diagnosed with endometriosis (about 100,000 cases). Main exposure: endometriosis, with subtypes including ovarian, pelvic peritoneal, and other site endometriosis. Outcomes: increased risk of type 2 diabetes measured via incident cases. Effect modifications include premenopausal and postmenopausal status, BMI categories, and history of gestational diabetes. Main results: risk ratios for any endometriosis 1.46, for specified other site 2.67, for unspecified other site 2.47, all with 95% confidence intervals. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b935fb3b-aa3c-4260-85ab-dc20354fab89/Background-and-aims-Endometriosis-affects-%E2%88%BC10%25-of-women-of-reproductiv%E2%80%A6-image-1.jpg infographic2 Chart showing the relationship between endometriosis and increased long-term risk of venous thromboembolism (VTE). It features diagrams of female reproductive organs, a woman, and graphs comparing cases in women with endometriosis and controls, highlighting increased VTE risk. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4b3a1d3f-0c2e-4f23-bb24-05abe3839987/Does-surgery-for-endometriomas-increase-the-success-and-decrease-the-co%E2%80%A6-image-1+%281%29.jpg infographic2 Infographic comparing different patient groups and interventions for endometriosis, showing ART outcomes, pregnancy and complication outcomes, and overall obstetric outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e274727f-16c6-44d8-8ce7-def576aa40fa/Does-surgery-for-endometriomas-increase-the-success-and-decrease-the-co%E2%80%A6-image-1+%282%29.jpg infographic2 An infographic comparing patient populations and interventions, ART outcomes, pregnancy and complication outcomes, and overall obstetric outcomes related to endometriosis. Includes illustrations of the female reproductive system, surgery, and pregnancy scenarios. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/eeb1e519-3c0e-473a-94b4-30233186fab9/Does-surgery-for-endometriomas-relieve-suffering-Suffering-in-women-wi%E2%80%A6-image-1+%281%29.jpg infographic2 A detailed infographic titled 'Clinical Dilemmas and Outcomes in Surgery for Endometriomas'. It includes sections on pathology and suffering, surgical strategies and impact, fertility outcomes, management decisions and recurrence, and factors influencing treatment choice. The illustration explains endometrioma pathology, surgical approaches like excision, alternative techniques, and impacts on ovarian reserve and fertility. It presents data on natural versus ovarian function post-surgery, and offers guidelines on treatment decisions, emphasizing avoiding surgery unless clearly indicated and considering hormonotherapy for selected patients. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/68ca7a04-9026-40c7-a999-3b6bc8e5d717/Endometriosis%2C-affecting-10-15%25-of-women-of-reproductive-age%2C-is-more-c%E2%80%A6-image-1.jpg infographic2 Diagram illustrating four theories explaining left laterality of endometriosis in female pelvis: anatomical, physiological, hormonal, and vascular. The central diagram shows a female pelvis with labeled organs. Each of the four surrounding sections describes a theory with visual representations and brief explanations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/81440fa3-d6e3-42d8-ae21-64ae125412d2/gimg_1786022127637_h3k3eeqx+%281%29.png infographic2 Poster about surgical management and evaluation of endometriomas. It covers comprehensive evaluation, indications for surgery, surgical approaches like minimally invasive surgery and laparotomy, personalized surgical planning, counseling and fertility considerations, and best practices for surgical care. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d7eefee0-d8c3-42b7-9e61-70ca29ea18e2/gimg_1786022127718_cwp6045i+%281%29.png infographic2 An infographic detailing surgical management and evaluation of endometriomas. It includes sections on comprehensive preoperative evaluation with ultrasound and MRI, critical patient assessment and counseling focusing on symptoms, pain analysis, and fertility goals, and minimally invasive surgical approaches like laparoscopy and robotic surgery. The infographic emphasizes principles of good surgical practice such as multidisciplinary teamwork and informed consent, highlighting advantages like shorter hospital stay, faster recovery, and better visualization of deep lesions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f04d3a0e-52c4-45fb-85d3-a2b1ceaffd53/gimg_1786022194706_x77lhig4+%281%29.png infographic2 Infographic explaining what surgery for endometriomas offers, including relief of pain, diagnosis clarification, lower risk of complications, and tissue diagnosis. It details how surgery can save lives by reducing ovarian cancer risk, emphasizing that the absolute risk remains low in premenopausal women. The infographic covers why imaging alone can be misleading, highlighting cyst appearance variability, bleeding, and cyst enlargement. It advocates a comprehensive diagnosis approach with imaging, history, physical exam, and additional tests, stressing collaboration with healthcare providers for the best outcome. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1c85a722-1c9b-4943-9929-9a8ee4e747e4/gimg_1786022194782_oyurrsyg+%281%29.png infographic2 Infographic titled 'Surgery for Endometriomas: Decision-Making & Malignancy Risk.' It illustrates the diagnostic process with imaging and clinical assessment, risks of ovarian cancer associated with endometriomas, key considerations for premenauspal context, and the importance of understanding the comprehensive approach to diagnosis, including imaging, clinical history, physical exam, and additional procedures. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/927a88b6-4df3-4cee-aba7-72370a14249f/gimg_1786022237926_pm3nqlw8+%281%29.png infographic2 Infographic titled "Endometriomas: The Surgical Dilemma" comparing benefits and drawbacks of ovarian cyst removal surgery versus ovarian preservation. Sections cover pain, infertility, surgery impact, delivery options, and recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/eadd47c8-621c-4dc8-9a55-2195f2009e2b/gimg_1786022238006_cp2qp6ws+%281%29.png infographic2 An infographic explaining the surgical dilemma of managing ovarian endometriomas, highlighting risks and benefits. The left side shows the impact on suffering, with illustrations of endometriotic lesions causing pain and infertility, rare isolated endometriomas, and surgical outcomes. The right side compares ovarian reserve and fertility, showing how cystectomy reduces risks but decreases ovarian reserve, while preserving reserve maintains fertility but may have higher recurrence. It discusses natural pregnancy rates before and after surgery, alternatives for reserve preservation such as sclerotherapy and other techniques, and factors like cyst size and recurrence risks. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/46ca5d1e-58ea-44d3-bab6-8c4c8500c29e/gimg_1786022308298_7s26cxnw+%281%29.png infographic2 A detailed infographic comparing outcomes and risks of endometrioma surgery with and without assisted reproductive technology (ART). It highlights that no surgery before ART results in similar live birth and pregnancy outcomes, higher oocyte yield, and lower infection risk, while surgery prior to ART does not improve live birth or pregnancy rates and carries surgical risks. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a0fe0b80-3cb8-4666-b341-7b1ae07b51f4/gimg_1786022308376_nxluz08a+%281%29.png infographic2 A detailed infographic comparing outcomes and risks of endometrioma surgery versus no surgery, emphasizing similar live birth rates, differences in ovarian reserve, infection risk, and pregnancy outcomes. The infographic includes color-coded sections, icons, and references. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a83a30f8-c3fa-4e25-9e20-f2b6a724472e/gimg_1786022585451_6nmj4vbu+%281%29.png infographic2 An infographic on rethinking surgical intervention for ovarian endometrial, emphasizing that for most women, risks of surgery outweigh benefits, highlighting a shift towards non-surgical management strategies like hormone therapy and assisted reproductive technology. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9f429b9c-95de-4f3d-a487-938a49ccb89e/gimg_1786022585525_hdu44upj+%281%29.png infographic2 Flowchart titled 'Rethinking Surgical Intervention for Ovarian Endometriomas.' It outlines a decision-making process for patients with ovarian endometriomas, starting with evaluation of traditional surgical indications, complication assessment, exploring non-surgical options, and reserving surgery for specific cases such as coexistence of deep lesions or planned endometrioma removal. Emphasis is on reconsidering surgery to prioritize the principle 'First, do no harm'. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/795076e1-651e-4f29-bf6d-e692af7567ac/Imagine-a-frequently-performed-surgical-procedure-that-carries-a-notabl%E2%80%A6-image-1.jpg infographic2 An infographic titled 'Surgical Management and Counseling for Endometriomas' with sections on indications for surgery, evaluation and diagnostics, surgical techniques, risks and hazards, and counseling. It includes icons and illustrations representing diagnostic procedures, surgical methods, and patient care considerations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d3afc444-7fdf-4631-931c-249cc416289e/Introduction-Endometriosis-is-a-common%2C-chronic%2C-estrogen-dependent-gy%E2%80%A6-image-1.jpg infographic2 Diagram showing research on salivary miRNAs as biomarkers for endometriosis. It includes sections on endometriosis overview, study design with patient groups (untreated, treated, healthy controls), miRNA sequencing and analysis, pathway target analysis, and clinical significance. The pathway diagram highlights the PTEN/PI3K/AKT/mTOR pathway and miRNA's role in downregulating PTEN, influencing disease activity. The figure emphasizes non-invasive diagnosis, disease monitoring, and molecular insights. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/44339fd5-ce20-4c2a-a509-b2be6ebefd0e/The-reduction-in-sex-hormone-levels-during-the-menopausal-period-substa%E2%80%A6-image-1.jpg infographic2 Diagram illustrating the integrated approach to managing peri- and postmenopausal women with psycho-emotional and neurological disorders. It includes pre-menopausal and peri- and postmenopausal stages, hormonal changes, clinical guidelines, use of menopausal hormone therapy, interdisciplinary team involvement, development of consensus and treatment algorithms, and clinical management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a74924ad-8765-48d3-b707-a4063bc1576b/The-three-fundamental-indications-for-surgery-%E2%80%93-saving-lives%2C-alleviati%E2%80%A6-image-1.jpg infographic2 Chart titled 'Rethinking Surgical Management of Ovarian Endometriomas' comparing traditional surgery, surgical complications, and alternative management options, including non-surgical and exceptional surgical indications, with illustrations and descriptions of each approach. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/96d48d18-61d3-4e18-a980-cdeaa82c26a2/WHAT-DOES-SURGERY-FOR-ENDOMETRIOMAS-OFFER-Notwithstanding-the-above%2C-t%E2%80%A6-image-1+%281%29.jpg infographic2 An infographic titled 'Assessing Surgery for Endometriomas: Risks, Cancer Considerations, and the Need for Comprehensive Diagnosis.' It is divided into three panels. The first panel discusses indications for surgery, highlighting symptoms, cyst size, and risks of complications like rapid growth or rupture, with a warning about insufficient evidence for surgery decisions. The second panel presents data on ovarian cancer risk with endometriomas, showing increased relative risk but very low absolute risk, especially in premenopausal women. The third panel emphasizes comprehensive diagnosis before surgery, including ultrasound imaging, clinical assessment, and laboratory tests, to minimize unnecessary surgery and detect early malignancy. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e9692f9b-6df3-488c-86ce-c3d2ed2f7420/Background-Persons-diagnosed-with-endometriosis-report-deleterious-eff%E2%80%A6-image-1.jpg infographic2 An infographic titled "Couples Coping with Endometriosis: Shared Challenges and Coping Strategies" showing a couple with endometriosis, with arrows pointing to shared challenges on the left, such as compounded illness burden, psychological barriers, and undermined agency; and coping strategies on the right, including mutual support, psychological resilience, lifestyle changes, acceptance, and emotional support. The infographic emphasizes relational and multidisciplinary support recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ca88ea16-062c-440d-adb6-00bcc92de41c/Discussion-Principal-findings-In-this-systematic-review-and-meta-analys%E2%80%A6-image-1.jpg infographic2 A comprehensive infographic titled 'Semaglutide in Obesity-Related HFpEF: Clinical Impact, Mechanisms, and Safety'. It details six sections: 1. Patient Population Context showing diverse obese individuals; 2. Semaglutide Intervention with a stylized medication illustration; 3. Principal Findings indicating reduced NT-proBNP, increased KCCQ health status, decreased HF hospitalization risk, increased 6-minute walk and VO2 peak, decreased weight, and inflammation marker; 4. Mechanistic Insights with metabolic effects decreasing adiposity and anti-inflammatory effects decreasing CRP, cardiac filling pressure, and systemic inflammation; 5. Safety Profile with gastrointestinal adverse effects being mild, serious adverse events rare, and no increase in cardiovascular harm; 6. Comparison with Other HFpEF Therapies showing greater KCCQ score improvement; and 7. Limitations & Future Steps emphasizing need for further trials. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d3381d9f-0315-46cd-9c45-5eafd6962840/gimg_1785768842062_bytujj97.png infographic2 Infographic about the effects of Semaglutide in obesity-related heart failure with key clinical findings, including improvements in biomarkers, reduced heart failure hospitalization risk, enhanced functional capacity, anti-inflammatory effects, and metabolic targeting, featuring a heart illustration and icons. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/473143e4-7102-4430-9b86-f356237484b8/gimg_1785768842142_hp5agwew.png infographic2 An infographic titled 'Semaglutide in Obesity-Related HfPEF: Key Clinical Findings' with four sections highlighting biomarkers and symptoms, hospitalization risk, functional capacity, and anti-inflammatory effects and metabolic targeting. The biomarkers section shows NT-proBNP levels and KCCQ health scores. The hospitalization risk section illustrates reduced heart failure hospitalizations with Semaglutide. The functional capacity section compares peak oxygen consumption and walk distance improvements. The anti-inflammatory section displays reductions in C-reactive protein levels. Central to the infographic is a diagram of a human heart with labeled anatomical parts. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3237036f-4594-42a2-bcf2-10bdecaec014/gimg_1785773353032_fgtczjuh.png infographic2 A scientific infographic titled 'Psychosocial Factors and Menstrual Distress: Applying Health Psychology Models in a Non-Clinical Sample' contains sections on theoretical framework, key findings, learning about menstruation, social support, implications, study sample, limitations and future directions, and conclusions. It includes charts, icons, and statistics about menstruation perceptions, distress, social factors, and research methods. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/059d8941-1e77-4255-92d3-7d325a7e4d5c/gimg_1785773353112_xlwnd37o.png infographic2 Infographic titled 'Investigating Psychosocial Factors in Menstrual Distress Experiences: A Non-Clinical Study.' The graphic presents four sections: 1) Study Overview & Context, highlighting aims to explore psychosocial factors in a large UK non-clinical sample, theories based on biopsychosocial and Illness Representations Model, with note on menstrual health impact on quality of life; 2) Key Findings & Associations, illustrating that menstrual distress is linked to illness perceptions with icons of a brain and bar charts, noting that negative perceptions are associated with higher distress, and cross-sectional data cannot determine causality; 3) Additional Observations, including sexual orientation and social support's influence on distress and perceptions, with icons of diverse groups and speech bubbles; 4) Conclusions & Implications, emphasizing that negative perceptions relate to higher distress, supporting a biopsychosocial approach, with implications for interventions, societal education, and future research directions, shown with icons of books, gears, and a scientist. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/aa7addeb-75b6-4358-be0d-c98bed814b86/gimg_1785777917820_vaf8qsz9.png infographic2 Informational poster about endometriosis, showing a human body with highlighted affected areas, symptoms, diagnosis delay, and multidisciplinary care options. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5e5f7513-205e-40d5-bf6d-1a9c44c344d2/gimg_1785777917895_bfpem0qp.png infographic2 An infographic illustrating the transition in endometriosis diagnosis and treatment. It highlights new early detection methods using non-invasive technologies, such as saliva tests analyzing microRNAs and abdominal sensors measuring electrical activity. It describes endometriosis as a complex multisystem disease with various extrapelvic manifestations beyond textbook descriptions, involving inflammation, immune dysregulation, and nerve sensitization. The infographic emphasizes multidisciplinary care approaches, including gynecology, colorectal surgery, orthopedics, and psychological support, to improve quality of life, confidence, mental health, and relationships, advocating for compassionate, evidence-based care. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b3bc54c6-02df-4f35-bc8e-f50ad6919cf8/gimg_1785936454674_8rjl9kz2.png infographic2 An infographic titled 'Beyond PCOS: A Unifying Framework for Women's Health' compares PCOS and PMOS, explains the reproductive-metabolic axis, current care fragmentation in gynecology, endocrinology, dermatology, and the proposed integrated RMA framework. It discusses hormone regulation, ovarian function restoration, and research questions on GLP-1 receptor agonists. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ba164913-acf9-4d38-8552-eb74d0917311/gimg_1785936454727_ge36mbc2.png infographic2 A detailed infographic illustrating current fragmented clinical management of conditions like PCOS across gynecology, endocrinology, and dermatology, and proposing an integrated reproductive-metabolic axis approach focusing on insulin resistance, androgen excess, and reproductive health, emphasizing the GLP-1 agonist era and hormonal contraceptive decision-making. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1320decb-a6a8-47c4-948b-ab9a6251d847/gimg_1785962693918_r7nl2qhp.png infographic2 Diagram of the weight loss-adaptation cycle showing key hormonal changes, energy expenditure, behavioral changes, and clinical implications. Includes key hormones like leptin, PYY, GLP-1, CCK, ghrelin, and neuropeptide Y, and strategies like nutrition, physical activity, sleep management, pharmacotherapy, and bariatric surgery. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f03261fb-188f-4da5-92f2-1146eae69f5a/gimg_1785962693999_lgp51auq.png infographic2 Diagram titled 'Metabolic adaptations to weight loss and the cycle of weight regain,' showing the process from overweight to healthy weight, involving initial weight loss and weight regain. It illustrates physiological changes like increased appetite and neurobehavioral reward pathways, metabolic effects such as altered resting metabolic rate and food thermic effect, and strategies for clinical mitigation, including medical, behavioral, dietary, exercise, pharmacotherapy, and surgical interventions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/cb268609-d2eb-4c50-97cc-189aec392d55/gimg_1786022127637_h3k3eeqx.png infographic2 Poster titled 'Surgical Management and Evaluation of Endometriomas' outlining steps for diagnosis, indications for surgery, surgical approaches, planning, counseling, and follow-up. Includes images of ultrasound and an ultrasound monitor, with various icons and text descriptions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b72a0736-d7ea-4b9d-be31-769fcf6e9464/gimg_1786022127718_cwp6045i.png infographic2 Diagram illustrating surgical management and evaluation of endometriomas, including preoperative assessment, critical patient evaluation, minimally invasive surgical approaches, and principles of good surgical practice. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1d4c466b-31b8-4c45-904b-256b827825e2/gimg_1786022194706_x77lhig4.png infographic2 Infographic about endometrioma surgery benefits, risks, diagnosis, and approach, including illustrations of ovaries, cysts, and medical procedure icons. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b26b6124-bab7-4c8b-a486-5198c49a5248/gimg_1786022194782_oyurrsyg.png infographic2 Infographic about surgery for endometriomas, including decision-making, risks, imaging, clinical assessment, and key considerations for a premenopausal context, with risk multipliers for ovarian cancer, and emphasizing improved imaging techniques and early malignancy detection. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/88e242d1-c23a-45ae-9463-ceb39f6f03e2/gimg_1786022237926_pm3nqlw8.png infographic2 An infographic titled 'Endometriomas: The Surgical Dilemma' compares the effects of surgery on endometriomas, highlighting benefits of preserving the ovarian reserve versus removing disease. It discusses pain, infertility, surgery impact on ovarian reserve, fertility outcomes, and illustrates surgical options like cystectomy, drainage, laser vaporization, and sclerotherapy. The bottom emphasizes weighing benefits against ovarian impact and preserving fertility. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/87a7f36f-fb15-433c-84a7-ca5b22a4ffd7/gimg_1786022238006_cp2qp6ws.png infographic2 Diagram illustrating the surgical dilemma of managing ovarian endometriomas, highlighting a balance of risks and benefits. It shows the impact on suffering from pain and infertility versus ovarian reserve and fertility, with details on natural pregnancy outcomes before and after surgery, and explores alternative preservation techniques like sclerotherapy and IVF. The diagram also notes endometrioma pain origins, rare occurrence, and outcomes of surgical excision. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/35d77e7c-0d1d-47da-8ac3-bd24801eae1b/gimg_1786022308298_7s26cxnw.png infographic2 A detailed infographic comparing outcomes and risks of endometrioma surgery and Assisted Reproductive Technology (ART). It highlights that no surgery before ART results in slightly increased cyst size but no impaired ovarian response, while surgery can lower oocyte yield and live birth rates without improving pregnancy outcomes. It notes similar fertilization and embryo development rates regardless of surgery, low infection risk with no surgery, and potential surgical risks like infection and bleeding. The infographic concludes routine removal of endometriomas is not justified for improving ART success or pregnancy outcomes, emphasizing individualized decisions based on symptoms and ovarian reserve. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/766981eb-5bf6-4556-9cd4-f5aa00984dcf/gimg_1786022308376_nxluz08a.png infographic2 Chart comparing outcomes and risks of endometrioma surgery versus no surgery, including live birth rates, ovarian reserve, infection risk, and pregnancy outcomes, with conclusions about the lack of evidence to justify routine removal of endometriomas. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9e7862b4-1637-43f6-a5a8-87e2c7fb85aa/gimg_1786022585451_6nmj4vbu.png infographic2 An infographic about rethinking surgical intervention for ovarian endometriomas, discussing traditional indications, complications, alternative management strategies like hormonal therapy and ART, planning surgery considerations, key takeaways, and ethical principles. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/11fb5c5f-b5f9-46fc-be62-872705e83770/gimg_1786022585525_hdu44upj.png infographic2 Flowchart titled 'Rethinking Surgical Intervention for Ovarian Endometriomas' outlining decision steps for treating patients with ovarian endometriomas, including evaluation of surgical indications, complication assessment, exploration of alternatives, and conditions for surgery or conservative management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0eca86ac-1860-475a-a9f8-35437a738c09/Highlights-%E2%80%A2-Semaglutide-improves-biomarkers-and-symptoms-in-obesity-re%E2%80%A6-image-1.jpg infographic2 infographic titled 'Semaglutide in Obesity-Related HFpEF: Clinical Benefits and Mechanisms' outlining clinical benefits of Semaglutide for heart failure and obesity. Shows improvements in biomarker and symptom scores; reduced heart failure hospitalizations; enhanced functional capacity with increased walking distance and peak VO2; decreased inflammation with lower CRP; and potential metabolic targeting for treatment. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4bac2d48-c315-429d-a1d7-5e26c19a921d/Polycystic-ovary-syndrome-%28PCOS%29%2C-proposed-by-some-investigators-to-be%E2%80%A6-image-1.jpg infographic2 Diagram of polycystic ovary syndrome (PCOS) overview, reproductive-metabolic axis framework, and emerging research questions. Includes sections on PCOS/PMOS prevalence, reproductive and metabolic factors, hormone influences, and therapeutic research needs, with illustrations of ovaries, liver, pancreas, heart, adipose tissue, test tubes, microscope, and flask. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d3b9ed5f-9da6-4d67-8702-7123fa40940c/Principal-findings-The-management-of-venous-disease-includes-a-broad-ra%E2%80%A6-image-1.jpg infographic2 A detailed infographic summarizing key findings and recommendations on the multilateral consensus regarding chronic venous disease (CVD) and varicose vein (VV) management. It is divided into sections for surgical, conservative, and medical management approaches, showcasing assessment techniques, treatment options, decision-making criteria, ongoing challenges, and future directions in the field. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/499ad6d7-67f6-474b-b977-ff9fea6d0e34/Study-objective-To-estimate-prevalence-of-pelvic-floor-tension-myalgia%E2%80%A6-image-1.jpg infographic2 Summary of a study on pelvic floor myalgia in endometriosis. Includes study population details, pelvic floor examination, setting, prevalence findings, key participant characteristics, significant associated conditions, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2bb627c6-3fd6-42b7-b023-d0410d4fce5d/The-purpose-of-this-study-was-to-investigate-the-role-of-psychosocial-f%E2%80%A6-image-1.jpg infographic2 A flowchart titled 'Investigating Psychosocial Factors in Menstrual Distress' with sections on models, hypotheses, perceptions, social support, influences, limitations, and implications. It includes diagrams of models, diagrams of social groups, and icons representing symptoms and research methods. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/495cc98a-aca5-4f7b-aeb2-dd1b4d5f36a3/%23%23%23-Practice-Guideline-The-American-College-of-Radiology-%28ACR%29-reco%E2%80%A6-image-1.jpg infographic2 A medical infographic about HSG with oil-soluble contrast medium in unexplained infertility, showing diagrams of female reproductive organs, key results comparing oil versus water HSG, and charts on pregnancy rates, mechanisms of fertility enhancement, key risks, and clinical utility. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/70e7ce98-3ae1-4953-88fa-28eba5375571/1.jpg infographic2 A scientific infographic explaining how liraglutide (GLP-1 RA) improves metabolic and reproductive outcomes in women with polycystic ovary syndrome (PCOS). It shows benefits like weight loss, increased menstrual regularity, and higher natural pregnancy rates. It describes mechanisms involving modulation of hormone secretion, improved follicular development, and activation of hypothalamic-pituitary ovarian pathways. It also compares IVF pregnancy rates with liraglutide and metformin, highlighting higher success with combination therapy. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a4918517-d9ed-4456-ba5c-d3e711bbedc6/2+%281%29.jpg infographic2 Infographic on pregnancy safety and the 'Ozempic Babies' phenomenon with GLP-1 receptor agonists. It covers pathophysiology, animal and human data, and clinical recommendations, including FDA guidance, endocrine society guidelines, and advice to discontinue GLP-1 RAs before pregnancy. Highlights that GLP-1 RAs enhance fertility in women with PCOS and obesity, with minimal placental transfer and no significant adverse fetal outcomes found in meta-analyses. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/62cadbc9-0dc2-42d2-90bc-85e8352930d0/2.jpg infographic2 An infographic titled 'Endometriosis: Disease Burden and Costs' showing the impact of endometriosis. It includes sections on direct healthcare costs with icons for imaging, laparoscopy, medications, and surgical interventions; indirect costs such as lost productivity, absenteeism, and reduced quality of life with corresponding icons; annual direct medical costs for Sweden, Australia, USA, UK, and China with cost figures; burden on quality of life with icons for physical, emotional, social, infertility, and stress; and workplace and societal impact with illustrations of absenteeism, limited career opportunities, economic impact, and challenges due to invisible symptoms. The chart highlights underreporting and rising costs related to endometriosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/42cd3874-0d25-404a-98b6-01e870131660/3.1-Genetic-Factors-3.1.jpg infographic2 Diagram showing factors contributing to endometriosis development, including genetic, environmental, hormonal/immune pathways, and lifestyle factors; central illustration of female reproductive system with endometriotic lesion. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dd6a5118-0136-494d-8d3c-2e9e3d1b843a/4.1-Inflammation-and-Immune-Dysregulation-4.1.jpg infographic2 Diagram illustrating factors involved in ectotic endometrial lesion. It is divided into five sections: 1) Inflammation & Immune Dysregulation showing cytokines, chemokines, macrophages, T cells, NK cells and effects; 2) Epigenetic Regulation with DNA methylation, histone modifications, and non-coding RNAs; 3) Hormonal Imbalance illustrating estrogen and progesterone pathways; 4) Oxidative Stress showing sources, reactive oxygen species, antioxidants, and inflammation; 5) Abnormal Cell Invasion & Proliferation with ECM degradation, cell adhesion, invasion, and proliferation. Central circle depicts ectopic endometrial lesion on peritoneal surface. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/545f70cf-b13c-43a7-8a83-b338881f40a7/5-Diagnosis-of-Endometriosis-Section-5-systematically-reviews-the-diagn%E2%80%A6-image-1.jpg infographic2 Flowchart illustrating a comprehensive diagnostic workflow for endometriosis, including traditional methods, novel biomarkers, and future directions. It covers clinical history and physical exam, imaging modalities like TVUS, MRI, and CT scan, invasive procedures like laparoscopy, and noninvasive biomarkers such as serum, urine, and endometrial markers. The workflow emphasizes integrating symptoms, clinical evaluation, imaging, biomarkers, and AI/machine learning for early, accurate, and noninvasive diagnosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/be8362b3-6587-4ca9-a57b-97c2b6c94d49/5-Diagnosis-of-Endometriosis-Section-5-systematically-reviews-the-diagn%E2%80%A6-image-1.png infographic2 Diagram of comprehensive diagnostic workflow for endometriosis, including traditional methods like clinical history, physical exam, imaging modalities (TVUS, MRI, CT scan), direct visualization via laparoscopy, noninvasive biomarkers (serum, urine, endometrial), and integrated algorithms using AI/machine learning for early, accurate, noninvasive diagnosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/039c370c-4b34-4b4e-a5b8-143298eaf08b/6-Management-of-Endometriosis-Section-6-presents-a-stratified%2C-patient-%E2%80%A6-image-1.jpg infographic2 Flowchart for endometriosis management outlining diagnosis, hormonal therapies, surgical interventions, emerging therapies, fertility preservation, and decision-making process. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/69a63808-c344-48c1-aa7b-554b2e2f4d48/11-oxygenated-androgens-are-a-class-of-adrenal-derived-steroids-that-ha%E2%80%A6-image-1+%281%29.jpg infographic2 An infographic describing the pathway of 11-oxygenated androgens, their stability across age and menstrual cycle, diagnostics for endometriosis, and clinical applications and limitations. It includes diagrams of hormone synthesis, blood and tissue levels, and advantages and cautions for hormone testing. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f283e7d0-86ed-4436-a6d0-1bbf16bc9f4d/11-oxygenated-androgens-are-a-class-of-adrenal-derived-steroids-that-ha%E2%80%A6-image-1.jpg infographic2 An infographic showing the overview of 11-oxygenated androgen pathway, diagnostic power in endometriosis, compartmentalized androgen dysregulation, and clinical applications. It includes pathways, stability across age and cycle, serum profiling, and androgen levels in blood and tissue, with advantages and limitations of current diagnostic methods. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c0494a57-4913-4402-9d9d-5f3f8bc32cbb/1785038801002.png infographic2 Infographic showing the impact of improved diagnostic tools for endometriosis on patient outcomes. It illustrates the typical 9+ years of uncertainty in diagnosis, frequent doctor visits, and chronic pain, followed by the introduction of endometrial testing and endoseure. The infographic highlights benefits such as faster decision-making, less invasive procedures, empowered treatment, and better quality of life, supported by quotes from medical professionals and patients. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/79c88703-c495-4079-bce1-df78a05e49ec/A-growing-body-of-literature-has-revealed-that-patients-with-endometrio%E2%80%A6-image-1.png infographic2 Diagram titled 'Endometriosis: Heterogeneity, Comorbidity Risks, and the Need for Population-Specific Studies' with three panels. Panel A shows ovarian endometrioma, deep infiltrating endometriosis, superficial peritoneal lesions, and their symptoms like pain and infertility. Panel B highlights comorbidity risks such as endometriosis' connection to ovarian cancer risk, peritoneal lesions, deep infiltrating endometriosis, and cardiovascular disease risk, with icons and diagrams. Panel C discusses global epidemiological research needs, emphasizing diverse datasets and incorporation of geography, ancestry, location, and symptoms, with a world map, icons, and a legend. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0b0e3f08-a11e-467d-98e3-838e7db8c3d2/Abstract-Purpose-Adolescent-endometriosis-%28EMs%29-imposes-substantial-ph%E2%80%A6-image-1.png infographic2 Flowchart showing the relationships between parental rearing patterns, psychological resilience, coping styles, and mental health in adolescent females with endometriosis. Supports and fosters autonomy are linked to positive-parenting; controlling and demanding behaviors are associated with high-pressure parenting. Higher psychological resilience correlates with supportive parenting, leading to active problem-solving coping styles and better health, while high-pressure parenting is linked to negative emotions, poor adherence, and delayed intervention. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e42d6002-e4be-4c42-8b61-e4a60296c20c/Activity-of-dienogest-on-human-endometrium-The-strong-progestational-ac%E2%80%A6-image-1.png infographic2 Diagram of the pharmacodynamic and pharmacokinetic activity of Dienogest on the human endometrium and ovary, including comparative oral potency of progestins, uterotropic index visualization, effects on ovarian steroidogenesis, and clinical implications panel. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/84661edb-f907-4787-86cb-776921e9734e/Background-and-purpose-This-study-evaluated-the-impact-of-physical-act%E2%80%A6-image-1.png infographic2 A scientific infographic titled 'Impact of Physical Activity on Dementia Risk in Pre- and Postmenopausal Females by BMI,' comparing dementia risks for women based on activity levels, menopausal status, and BMI. It shows diagrams of walking figures, brain images, and a color-coded BMI scale. The infographic highlights that regular or moderate physical activity reduces dementia risk in women, especially those with higher BMI. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9209c401-3538-41d7-8b49-3a126c4e529a/Background-Endometriosis-has-been-associated-with-a-higher-risk-of-car%E2%80%A6-image-1.jpg infographic2 Flowchart illustrating a study on endometriosis and cardiovascular disease risk, including study population details, exposure outcomes, mediation mechanisms, key findings, and implications for further research. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0eb48d51-4e45-47f8-a95e-fe9acf141a70/Effective-multimodal-pain-management-in-endometriosis-requires-addressi%E2%80%A6-image-1+%281%29.jpg infographic2 Flowchart illustrating the comprehensive multimodal treatment pathway for chronic pelvic pain in endometriosis, including hormonal suppression, neuromodulators, pelvic physical therapy, and psychological interventions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c34efa4b-d7b8-4a4d-a85e-4379f42c6767/Effective-multimodal-pain-management-in-endometriosis-requires-addressi%E2%80%A6-image-1.jpg infographic2 Diagram illustrating a comprehensive multidisciplinary treatment pathway for chronic pelvic pain in endometriosis, including hormonal suppression, neuromodulators, pelvic floor physical therapy, and psychological interventions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c7daffb8-388f-4e61-8ae8-d6505e477a6c/Endocrine-pharmacological-findings-Dienogest-exhibits-moderate-binding%E2%80%A6-image-1.png infographic2 Diagram illustrating the endocrine pharmacological findings of Dienogest and its antiandrogenic actions, including effects on androgen receptors, gene expression, and comparisons with other progestins, with illustrations of cell types and tissues. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b7d73667-2316-4891-a587-1e35ac1ef75e/Endometriosis-and-adenomyosis-are-common-gynecologic-disorders-associat%E2%80%A6-image-1.png infographic2 Diagram illustrating distinct pathogenic pathways in endometriosis and adenomyosis, showing how mitochondria act as central integrators in proliferation and fibrosis divergence model, with influences like common stimuli, pathological features, and therapeutic implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6ad07bb4-1eeb-4cee-b7d3-3ce53eeb29bf/Gemini_Generated_Image_wpnblqwpnblqwpnb.png infographic2 Flowchart describing Ziwig EndoTest: non-invasive saliva test for endometriosis with steps from saliva collection to diagnosis, featuring illustrations of a healthcare professional and test equipment. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ad03282d-a2c3-4954-9a66-5634d5a54a96/gimg_1785072101681_4qrlaq1v.png infographic2 An infographic comparing fragmented specialty-based care and integrated reproductive-metabolic approach for PCOS/PMOS, highlighting the shift from syndrome-based to axis-based treatment, with sections on reproductive health, metabolic health, androgen excess, cardiovascular risk, mental health, and holistic patient-centered care. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/337881ff-c172-4db7-b0f5-6b52a923c9a3/gimg_1785072101732_4dbbchih.png infographic2 Diagram comparing the fragmented specialty-based approach to the unified reproductive-metabolic axis framework for PCOS/PMOS. The left side shows specialists like gynecologists, endocrinologists, and dermatologists with their focus areas. The right side presents a Venn diagram illustrating a hypothesis-generating framework that emphasizes understanding beyond surface features, interconnected clinical management, and clinical investigation, with an emphasis on shifting to an integrated metabolic-reproductive approach. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/30ced17c-f552-455c-86c3-5bf58e7d7afa/gimg_1785300472862_vz5f7bit.png infographic2 A detailed infographic comparing Letrozole and Clomiphene Citrate for treating PCOS, covering clinical guidelines, evidence from trials, mechanisms of action, dosing protocols, and key outcomes such as live birth and ovulation rates. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f02b5d84-f8be-4265-a864-fc690c8cf2b8/gimg_1785335873826_uzqi0m44.png infographic2 Timeline showing the evolution of PCOS diagnostic criteria from 1990 to 2023, highlighting key guidelines, changes, and new additions over the years, with icons and color-coded text for different elements. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dea3014a-b070-4af8-9d05-c48bdbb34580/gimg_1785335873900_3y80bw6s.png infographic2 A timeline infographic showing the evolution of PCOS diagnostic criteria from 1990 to 2023, including key milestones like NIH 1990, Rotterdam 2003, Androgen Excess Society 2006, and 2023 International Guideline, with descriptions of criteria requirements at each stage. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/46eaaae2-ec84-46a0-acbe-3aa0b2def76d/gimg_1785452514356_1baheiiw.png infographic2 Summary of key women's health considerations including PCOS, pregnancy safety, oral contraceptives, menopause, cardiovascular outcomes, breast cancer, endometrial and ovarian cancer, bone health, lean mass, gallbladder disease, with clinical implications and references. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fb781b70-5765-488c-8c81-ea1822e3c277/gimg_1785452514432_f4gzhvx2.png infographic2 Summary of 10 key women's health considerations including PCOS, pregnancy safety, oral contraceptives, menopause metabolism, cardiovascular outcomes, breast and ovarian cancer, bone health, lean mass, and gallbladder disease, with clinical implications and references. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/47364689-b2e5-477f-bfb4-3e5f17adb080/gimg_1785460486613_gq4o9ady+copy.png infographic2 Infographic comparing traditional and new pathways for endometriosis diagnosis, emphasizing faster, less invasive biomarker testing in primary care, with timelines, test options, and benefits for patients and healthcare providers. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ed0e60fd-93f3-45f2-8f68-db65722f6ca9/Hysterectomy-%E2%80%94-even-with-ovarian-conservation-%E2%80%94-is-associated-with-an-i%E2%80%A6-image-1.png infographic2 A detailed infographic comparing hysterectomy with blood supply removal, hysterectomy with ovarian preservation, and no surgery, showing risks, clinical implications, and guidelines for long-term cardiometabolic health. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/bbf0ec3c-df43-412a-80a1-77665b4a7122/Inflammation-is-a-major-but-not-sole-cause-of-pain-in-endometriosis%E2%80%A6-image-1.jpg infographic2 A detailed infographic illustrating the pathophysiology and pain mechanisms in endometriosis-associated pelvic pain. The diagram is divided into three main sections: Nociceptive Pain, Neuropathic Pain, and Nociplastic Pain, showing processes like inflammation, nerve growth, immune response, and brain interaction. It also includes a graph indicating poor lesion-pain correlation, and a box listing therapeutic implications such as NSAIDs, hormonal agents, neuromodulators, and central therapies. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c750bb3b-d216-4e1f-81e2-0cb03e8af277/Introduction-Deep-endometriosis-%28DE%29-involving-the-bowel-presents-a-co%E2%80%A6-image-1.jpg infographic2 Flowchart showing long-term outcomes of conservative hormonal management versus surgery in bowel deep endometriosis. The chart includes patient cohort, exclusion criteria, follow-up and assessment tools, conservative management results, and eventually required surgery statistics. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a9ddbbdb-f997-4a55-9abd-d31b762fe927/News-Endometriosis-%E2%80%9CGame-changing%E2%80%9D-new-tests-may-speed-up-diagnosis-in%E2%80%A6-image-1.png infographic2 An infographic explains the transition from traditional invasive diagnosis to game-changing non-invasive tests for endometriosis in UK primary care. It compares endometriosis overview, traditional invasive procedures with long wait times, to non-invasive testing methods that allow earlier diagnosis with shorter wait times, leading to improved fertility outcomes and reduced healthcare burden. The infographic includes illustrations, graphs, and a legend for icons. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c0b0252b-ec47-462e-a635-fd547a0419a4/News-Endometriosis-%E2%80%9CGame-changing%E2%80%9D-new-tests-may-speed-up-diagnosis-in%E2%80%A6-image-3.png infographic2 Infographic about diagnosing endometriosis, showing statistics, affected organs, symptoms, current invasive diagnostic pathway, new non-invasive tests like Endose® and Ziwig® Spit Test, and benefits of rapid diagnosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6557417f-e187-420e-b681-6e99999b7760/No-head-to-head-trial-directly-compares-lipiodol-HSG-to-IUI-OS-with-a%E2%80%A6-image-1+%281%29.jpg infographic2 Chart comparing pregnancy outcomes after Lipidol HSG versus Clomiphene-IUI across different age groups, showing declines in efficacy with age, and recommended fertility management pathways based on age. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/40d1cd28-c067-406b-a681-fb4d74308dfc/No-head-to-head-trial-directly-compares-lipiodol-HSG-to-IUI-OS-with-a%E2%80%A6-image-1.jpg infographic2 A detailed infographic comparing pregnancy outcomes and fertility treatment recommendations based on age, including graphs, tables, and icons. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/212c0861-85e5-4c13-a476-24ffbe19768a/Objective-Endometriosis-is-a-chronic%2C-hormone-dependent-condition-affec%E2%80%A6-image-1.jpg infographic2 An infographic about the role of 11-oxygenated androgens in endometriosis, including study overview, methods, key findings, and conclusions. It shows that approximately 190 million women are affected, with a focus on hormone analysis through blood draw, centrifuge, serum isolation, and steroid profiling. It highlights increased levels of 11KT and 11-hydroxyandrostendione in endometriosis and proposes a new model of endometriosis pathophysiology emphasizing androgen dependence. The graphic includes images of the female reproductive system, blood sampling, and hormone molecules. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b707ac1b-280e-4bfc-9504-ea5f22e5130e/Objective-Endovenous-thermoablation-%28EVTA%29-is-considered-the-reference%E2%80%A6-image-1.jpg infographic2 A medical infographic comparing outcomes of Endovenous Thermoablation versus catheter-directed foam sclerotherapy in treating Great Saphenous Vein Insufficiency, including study design, results, and practice implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/63f6ec45-d3a4-4e31-a811-3eb8047ae886/Objective-To-evaluate-central-arterial-stiffness%2C-endothelial-function%E2%80%A6-image-1.png infographic2 Poster titled 'Vascular Health in Women With Ovarian Endometriosis: Study Design & Key Findings' showing study overview, main findings, assessment tools, and summary of vascular impairment associated with endometriosis, including graphs and diagrams. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b22a2c5e-305f-4c38-9d50-1f54c518c730/Objective-Treatment-of-superficial-venous-insufficiency-has-been-assoc%E2%80%A6-image-1.png infographic2 Flowchart of a medical study comparing two treatments for vein conditions at Helsinki University Hospital from 2014-2015. Sections include study overview and design, treatment illustration, outcomes at 7 years, and a summary conclusion. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c579c1c2-4bb1-4462-b289-9f7b6f691071/Objectives-Great-saphenous-vein-%28GSV%29-incompetence-is-common%2C-but-nume%E2%80%A6-image-1.jpg infographic2 A detailed infographic explaining the process of managing great saphenous vein (GSV) incompetence, including sections on diagnosis, treatment options, decision framework, and future directions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e74a926b-ebdb-4a40-8185-edee2af66f14/Objectives-In-contrast-to-miRNA-expression%2C-little-attention-has-been%E2%80%A6-image-1.jpg infographic2 A detailed infographic explaining a scientific study on saliva piRNA profiling for endometriosis diagnosis. It includes sections on objective and study design, methodology workflow, piRNA identification, diagnostic performance, clinical correlation, and conclusions with various charts, icons, and text. The study involves saliva sample collection, RNA extraction, sequencing, molecular barcoding, and AI analysis to identify and validate piRNA biomarkers. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d9776790-458a-41d1-b914-9153895bd2f2/Pain-Mechanism-Therapeutic-Strategy-Evidence-Level-Key-Agents-Intervent%E2%80%A6-image-1.jpg infographic2 Chart displaying mechanism-based therapeutic strategies for chronic pelvic pain, listing pain mechanisms such as nociceptive, neuropathic, myofascial, nociplastic, neuroangiogenic, and endocannabinoid. It details therapeutic strategies, evidence levels, key agents and interventions, and references for each mechanism, with color coding indicating evidence strength from preclinical to high. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d6fcc8dd-276e-4673-934d-f20a37a17ac0/Panel-1-Context-and-the-case-for-a-new-name-The-term-polycystic-ovary-s%E2%80%A6-image-1.png infographic2 An infographic titled "The Case for Renaming Polycystic Ovary Syndrome (PCOS)." It discusses problems with the term PCOS, the process used for the name change, the proposed new name "Polyendocrine Metabolic Ovarian Syndrome," and the benefits of the new name. Sections include key issues with PCOS, the process involving patient voices, workshops, analyses, and a global agreement, the new name's rationale, and benefits such as accurate diagnosis, less stigma, better research, and worldwide adoption. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/ddd7b02c-7172-4e1b-bcc2-b334f3e898be/PCOS-vs.jpg infographic2 A comparative chart showing different diametric hormonal profiles of PCOS and endometriosis. It lists hormone levels such as testosterone, SHBG, LH, FSH, AMH, and local tissue androgens, with arrows indicating increased or decreased levels for each condition. Below, two panels depict the incidence of PCOS and endometriosis among women, and therapeutic implications include medications like Danazol, Spironolactone, and combined oral contraceptives. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9007e77e-6041-4d92-9b40-55d933c6a2ec/Pharmacokinetics-of-dienogest-Dienogest-is-almost-completely-absorbed-a%E2%80%A6-image-1.png infographic2 Diagram showing the process of oral administration of dienogest, a progesterone hormone. It depicts absorption in the gastrointestinal tract, binding to albumin, and its mechanism of preventing ovulation and reducing progesterone activity through weak progestational metabolites. The diagram includes a graph of serum concentration over time, showing peak levels at 2 mg dosage, with details about pharmacokinetics, clearance, and interaction with endogenous steroid transport proteins. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/89635270-4d08-426c-9bdb-aab5bc22fe93/Postmenopausal-women-experience-accelerated-metabolic-deterioration-dri%E2%80%A6-image-1+%281%29.jpg infographic2 Diagram showing benefits of GLP-1 receptor agonists in postmenopausal women for metabolic health. It includes three sections: 'Metabolic Benefits' with reduced body weight, dyslipidemia, blood pressure, inflammation, and improved insulin resistance; 'Mechanisms & Preclinical Evidence' with CNS effects, adipose tissue, Liraglutide, Estradiol, and a preclinical study showing prevention of fat gain; and 'Clinical & Cardiometabolic Outcomes' highlighting benefits like lower triglycerides, LDL-C, blood pressure, inflammation, visceral fat, weight loss efficacy, and the need for sparse data in this population. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4be5974f-fcf6-417f-9036-45400000b150/Postmenopausal-women-experience-accelerated-metabolic-deterioration-dri%E2%80%A6-image-1.jpg infographic2 Diagram explaining how GLP-1 receptor agonists benefit postmenopausal women by reducing body weight, visceral adiposity, dyslipidemia, blood pressure, inflammation, and insulin resistance. The diagram includes sections on metabolic benefits, mechanisms and preclinical evidence, and clinical outcomes, highlighting the role of liraglutide and estradiol in fat regulation, and showing graphs on cardiometabolic benefits and weight loss efficacy. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/80359b64-450f-477b-b0ff-4367d429ef3b/Purpose-Endometriosis%2C-a-prevalent-gynecological-condition%2C-significan%E2%80%A6-image-1.jpg infographic2 Diagram showing research on attachment styles, emotion regulation, and quality of life in women with endometriosis. Part A describes the study with Italian women, questionnaires, and assessments. Part B illustrates how secure, preoccupied, fearful, and dismissing attachment styles are associated with emotion regulation difficulties and quality of life. Part C explains the effects of different attachment styles on emotion regulation and quality of life, highlighting the importance of therapeutic interventions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8c3a6165-d880-4b31-8d62-ca19fda06c87/Recent-epidemiological-studies-have-highlighted-several-emerging-trends%E2%80%A6-image-1.jpg infographic2 Map showing global prevalence of endometriosis with world regions color-coded by prevalence rate. A legend explains prevalence scale from low to high. Another section lists major determinants like genetic susceptibility and chemical exposure, with icons of DNA strand and chemical flask. The disease burden and recent trends in endometriosis are illustrated with icons representing symptoms such as pelvic pain, infertility, and psychological disorders, along with epidemiological trends like rising urban prevalence and comorbidities with other conditions. The infographic details key pathophysiologic pathways involving endocrine-disrupting chemicals, microbiome dysbiosis, and chronic inflammation, each with relevant icons and explanations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/716e8390-e439-4e38-a92f-24d0145e9572/Research-question-Can-a-saliva-based-miRNA-signature-for-endometriosis%E2%80%A6-image-1.jpg infographic2 Flowchart-style infographic titled 'Study Design Overview' illustrating the process of collecting saliva samples from women with pelvic pain, conducting MRI scans for endometriosis diagnosis, and categorizing them into infertile or fertile groups. The infographic includes sections on methodology for miRNA extraction and sequencing, diagnostic performance showing the accuracy of a 34-miRNA signature in distinguishing infertile from fertile women, and clinical implications emphasizing non-invasive testing for endometriosis-associated infertility with a note on the need for external validation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/42aad746-21b7-46e0-8176-e2d54bf0bcce/Screening-Intervals-and-Preventive-Strategies-After-Hysterectomy-Th%E2%80%A6-image-1+%281%29.png infographic2 A chart titled 'Screening Intervals and Preventive Strategies After Hysterectomy' with sections on post-hysterectomy metabolic screening, preventive strategies, alternatives to hysterectomy for benign conditions, and ovarian conservation. It lists screening intervals for diabetes, dyslipidemia, hypertension, obesity, and ASCVD risk; preventive strategies like diet and exercise, smoking cessation, and statin therapy; alternatives to hysterectomy including medical therapies, procedures, and minimally invasive interventions; and ovarian conservation options with related notes. Abbreviations are explained at the bottom. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7c11385b-4cce-452c-b56d-0e66ffab4a3b/Screening-Intervals-and-Preventive-Strategies-After-Hysterectomy-Th%E2%80%A6-image-1.png infographic2 This infographic titled 'Screening Intervals and Preventive Strategies After Hysterectomy' is divided into four sections. The first section outlines postoperative screening for diabetes, dyslipidemia, hypertension, obesity, and ASCVD risk, with recommended intervals and notes. The second section describes preventive strategies including diet and exercise, smoking cessation, and statin therapy, with icons representing each approach. The third section offers alternatives to hysterectomy for benign conditions, listing medical therapies, hysteroscopic procedures, minimally invasive interventions, and myomectomy, with satisfaction and relief statistics. The fourth section discusses ovarian conservation, including ovarian preservation in premenopausal women, bilateral salpingo-oophorectomy (BSO), and strategies for preserving ovaries, with associated risks and benefits. The bottom includes abbreviations and references. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c30c97d9-e21d-4da1-a822-c547a705dca4/Section-2-systematically-presents-the-global-epidemiological-profile-of%E2%80%A6-image-1.jpg infographic2 Infographic titled 'Global Epidemiological Profile and Risk Factors of Endometriosis' with sections on prevalence by region, demographic age distribution, disease burden, key risk factors, and emerging trends. Includes maps, graphs, icons, and text. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/546a2e22-c382-4736-88b0-6ec6f81755e1/Several-distinct-patient-populations-stand-to-benefit-most-from-early-n%E2%80%A6-image-1.jpg infographic2 Infographic about Ziwig Endostest, a saliva-based diagnostic device for detecting superficial peritoneal endometriosis, with sections on access improvements, transgender and gender-diverse issues, infertility, disparities in Black women and minority groups, and testing for adolescents and young women. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0d10a6f5-f438-4fdc-9050-07e61eb9b6ca/The-search-interpreted-the-query-as-splenectomy-rather-than-hysterec%E2%80%A6-image-1.png infographic2 A detailed infographic showing the long-term metabolic and cardiovascular complications of hysterectomy, comparing scenarios of no surgery, hysterectomy with ovarian conservation, and hysterectomy with bilateral salpingo-oophorectomy. It highlights risks, clinical implications, and the impact of age on risk levels. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3f81ba79-c9dd-444e-b012-d476718c0bc0/This-matched-comparative-study-investigates-whether-unoperated-ovarian%E2%80%A6-image-1.jpg infographic2 Diagram comparing ovarian endometrioma group and control group, showing prevalence of tubal pathology and abnormalities, predictors, ROC curve, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f0ec63b3-8b31-4e19-8649-8b60608515df/This-systematic-review-and-meta-analysis-compared-cystectomy-and-ablati%E2%80%A6-image-1.jpg infographic2 Infographic comparing ovarian endometrioma treatments: traditional cystectomy versus ablative techniques like laser or diathermy. Includes diagrams of ovarian tissue, surgical procedures, outcome metrics, and future research directions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dbf2fb44-a120-4539-92c6-d93fbf656a22/Toxicity-The-reproductive-toxicological-studies-did-not-suggest-any-ter%E2%80%A6-image-1.png infographic2 A scientific infographic with three sections labeled A, B, and C. Section A highlights toxicological safety and in vivo results, showing that deniogest has no teratogenic, mutagenic, or carcinogenic effects in mice and rats. Section B indicates that deniogest does not initiate tumors in rat liver bioassays, with a photo of a rat liver and a preneoplastic assay. Section C explains the mechanism of metabolic stability in the human liver, illustrating the metabolism pathway of deniogest involving CYP450 enzymes with no reactive intermediates formation, indicating excellent metabolic stability. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/81f888fe-663c-4878-8b90-7388c6212b8d/USE-OF-SALIVA-IN-THE-DIAGNOSIS-OF-ENDOMETRIOSIS-Endometriosis-is-a-syst%E2%80%A6-image-1.jpg infographic2 Infographic with six sections about endometriosis and microbiology including diagrams, cell types, DNA, saliva analysis, and workflow steps. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/053da807-54e5-4ae0-9ce0-99494793d28e/watermarked_img_5827501480241178091.jpg infographic2 Infographic explaining endometriosis biomarker testing for earlier diagnosis. Sections include understanding diagnostic delay, breakthrough biomarker testing, how biomarkers transform care, and patient journey improvement. Visuals depict a woman confused, scientific methods, icons of patient care, and timeline of patient symptoms to wellbeing. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/18ba6079-d936-4a2d-b828-a98c97e8c90d/Where-Endotest%C2%AE-May-Fit-Clinically-The-test%27s-greatest-potential-value%E2%80%A6-image-2.jpg infographic2 Diagram explaining the clinical utility of Endotest for diagnosing superficial peritoneal endometriosis, showing the diagnostic pathway, gaps, and the Endotest solution with a saliva sample indicating a non-invasive, accurate diagnosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3a0414dd-e24e-43cd-9eae-06f26d2e1057/%23%23-Pregnancy-Complications-in-Endometriosis-Endometriosis-is-associated%E2%80%A6-image-1.png infographic2 Diagram showing pregnancy complications associated with endometriosis, including superficial endometriosis, malpresentation, preterm birth, placenta previa, cesarean delivery, deep infiltrating endometriosis, and adhesions. It also includes risk factors, effect sizes with odds ratios, and notes on peritoneal versus deep infiltrating endometriosis. Additionally, it depicts bowel perforation and uterine rupture, and provides information about spontaneous hemoperitoneum in pregnancy, with statistics and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/dcea3fa8-0224-456e-8ff8-5363890d70e0/%23%23%23-Practice-Guideline-The-American-College-of-Obstetricians-and-Gyne%E2%80%A6-image-1.png infographic2 Diagram illustrating the bidirectional vicioso cycle of insulin resistance, hyperandrogenism, and polycystic ovary syndrome spectrum. It depicts how insulin drives androgen excess and how androgens worsen insulin resistance in women with PCOS, with explanatory steps and a graph showing insulin sensitivity decline with increased free androgen index. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/97cf9df8-14e7-48db-8d35-651bf8140980/%E2%80%A2-Tubo-ovarian-cancer-prevention-in-BRCA1-2-carriers-is-shifting-from-u%E2%80%A6-image-1.png infographic2 Infographic detailing strategies for preventing tubo-ovarian cancer in BRCA1/2 carriers. It covers conceptual shift from uniform to individualized risk assessment, risk-reducing surgical options (salpingo-oophorectomy and delayed oophorectomy), and a decision-making framework that integrates genomic data, reproductive planning, quality of life, and patient preferences for personalized management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6f8a0cb2-b04b-455e-bada-d5e6b87c31a4/A-new-diagnostic-paradigm-Why-diagnosing-endometriosis-remains-difficul%E2%80%A6-image-1.jpg infographic2 Diagram illustrating the complex etiology and phenotypic heterogeneity of endometriosis, showing different mechanisms and locations of endometriosis such as ovarian endometrioma, superficial peritoneal endometriosis, and deep infiltrating endometriosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/aa0f36bc-67b4-4c8e-95d0-8fa69b67410c/Abstract-In-2024%2C-the-National-Academies-of-Sciences%2C-Engineering%2C-and%E2%80%A6-image-1.png infographic2 Diagram showing chronic conditions in women including thyroid issues, osteoporosis, arthritis, back pain, endometriosis, depression, autoimmune disease, migraine, cardiovascular disease, and diabetes. It highlights research gaps such as lack of sex-specific data, underrepresentation in clinical studies, and minimal integration with other conditions. Key life transitions like menopause and hormonal changes impact quality of life, affecting mobility, pain, and daily activities. Recommendations include advocating for improved diagnostics, increased research investment, stronger female representation in research, and comprehensive study designs. Investing in women's MSK health science can enable earlier diagnosis, effective treatment, cost savings, and improved quality of life for millions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f2275f7f-6de6-436c-8075-62f79e9a88ed/Adenomyosis-mainly-presents-as-two-distinct-phenotypes-focal-and-diffu%E2%80%A6-image-1.png infographic2 Diagram illustrating the systemic and heterogeneous nature of adenomyosis and endometriosis, including anatomical phenotypes like focal and diffuse adenomyosis, the systemic comorbidities such as cardiovascular disease, migraine, kidney issues, pregnancy complications, clinical presentation features including pelvic pain and bladder symptoms, and the diagnostic delay and impact on health. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/534f0a39-7289-4109-9068-cd651da0ea25/AMH-rebound-refers-to-the-phenomenon-where-anti-Mu%CC%88llerian-hormone-l%E2%80%A6-image-1.png infographic2 An educational infographic titled 'AMH Rebound: Mechanisms and Clinical Contexts'. It explains AMH rebound as the reappearance of detectable anti-Müllerian hormone after a period of undetectable levels. The infographic covers three main sections: 1) Menopausal Transition, showing hormone level changes over time; 2) Chemotherapy/Reproductive Toxicity, illustrating AMH trajectory during chemotherapy cycles and factors influencing recovery; 3) Transient AMH Fluctuations, discussing variability in fertility clinics, clinical advice, and the significance of low AMH rebound. Icons and charts depict hormone levels, demographic factors, and clinical recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a7877645-fd26-4972-8f11-1f10e1f851d2/Background-Alzheimer%27s-disease-is-more-prevalent-among-females.png infographic2 Infographic showing study design overview, variables and methods, key results, and conclusion summary on hormone therapy and cognitive performance in women aged 60 and older. Includes maps, graphs, and icons related to cognitive assessments and statistical analysis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/73fec5cf-cf8f-41f9-bd94-9dfd43b614bd/Background-Endometriosis-is-a-chronic-estrogen-dependent-inflammatory%E2%80%A6-image-1.png infographic2 Infographic on systematic reviews and meta-analyses of endometriosis from 2016 to 2026, including scope, key findings, clinical implications, and evidence grading. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8a162ffb-05fa-4d46-8f87-4a164a215266/BackgroundEndovenous-laser-ablation-%28EVLA%29-is-a-guideline-recommended-t%E2%80%A6-image-1+%281%29.png infographic2 Poster summarizing a clinical study on the design and patient allocation for an experiment comparing 1940-nm and 1470-nm EVLA treatments. It includes participant demographics, study procedures, endpoints, clinical outcomes, and conclusions with textual and graphical data. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/90d55383-87c8-4dcf-8a14-be807a5adcac/BackgroundEndovenous-laser-ablation-%28EVLA%29-is-a-guideline-recommended-t%E2%80%A6-image-1.jpg infographic2 Summary of a clinical study comparing 1940-nm laser and 1470-nm laser for endovenous laser ablation of great saphenous vein (GSV). Includes diagrams of vein treatment procedures, patient demographics, ultrasound outcomes at 12 months showing complete occlusion rates of 100% for both laser groups, and graphs on postoperative pain and sensory disturbances. Concludes no significant difference in efficacy between the two laser wavelengths. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c189052c-74fb-43ae-afac-2b63d2a956bf/BackgroundEndovenous-laser-ablation-%28EVLA%29-is-a-guideline-recommended-t%E2%80%A6-image-1.png infographic2 Summary of a clinical study comparing 1940-nm and 1470-nm lasers in multiple centers for vein treatment, with diagrams of laser fibers, ultrasound assessments at 3, 6, and 12 months, and data on improvements, complications, and clinical outcomes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/540c30d0-c6ca-49bb-a06a-b10e438efbba/Cardiovascular-disease-%28CVD%29-is-a-leading-cause-of-mortality-in-women%2C%E2%80%A6-image-1.png infographic2 Diagram illustrating hormonal changes during menopause, effects on vascular endothelial function, and increased risk of cardiovascular disease. It includes charts showing declining levels of estrogen and progesterone, increased follicle-stimulating hormone (FSH) and luteinizing hormone (LH), and their impact on endothelial cells. The pathways depict endothelial dysfunction, reduced nitric oxide production, oxidative stress, inflammation, vasodilation reduction, vascular stiffening, and atherosclerosis leading to higher cardiovascular disease risk. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/be8cef6e-62c5-45e8-8dfd-fd84029789fe/Cardiovascular-risk.png infographic2 Diagram titled 'Long-Term Health Risks in PCOS/PMOS' showing four sections on cardiovascular risk, insulin resistance, mental health disorders, and endometrial cancer. Each section lists risk factors, screening methods, and notes on associations, with icons and arrows indicating increased risk or links to PCOS/PMOS. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8ce5a4ab-7d7f-4337-812d-476b82e86416/Changes-in-Surveillance-and-Early-Detection-Prior-to-March-2023%2C-the-NC%E2%80%A6-image-1.png infographic2 An infographic titled "Changes in Surveillance and Early Detection of Ovarian Cancer in High-Risk Women". It is divided into four sections: 1) Historical NCCN-Recommended Screening showing women undergoing ultrasounds and serum CA125 tests every 6-12 months; 2) Emerging Evidence Challenging Current Paradigm with large RCTs and studies indicating no significant reduction in mortality from current screening methods; 3) Risk Algorithm Screening Outcomes showing screening results from 4,348 women, with 13 detected cancers, and 5 at stage I/II; 4) Emerging Alternatives: Liquid Biopsy illustrating potential for early detection via circulating tumor DNA, with notes on limitations and need for further development. A note at the bottom emphasizes the limited benefit of current surveillance and the need for new strategies. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1646f763-b216-42c9-b1fc-9b4c6279298b/Conclusions-The-present-SEUD%E2%80%93AIMIS-opinion-paper-supports-three-major-c%E2%80%A6-image-1.png infographic2 Flowchart detailing diagnosis and management of endometriosis, including steps for non-invasive diagnosis, personalized treatment options like hormonal therapy, ART, surgery, and long-term medication, with icons representing clinical history, imaging tests, patient characteristics, and treatment methods. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/602ca75a-a6d6-4ca0-b2ee-7fb22c782016/Effects-on-ART-outcomes-Endometriosis-may-reduce-IVF-success-rates.png infographic2 Infographic on the impact of endometriosis on ART outcomes and strategies to improve success, including IVF outcomes, dose effects, diagnostic challenges, egg donation effects, and supplementary ART strategies. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/9cd08a2a-d10b-476b-824f-b53d1ac9ddbb/Endometriosis-%28EM%29-is-a-chronic%2C-estrogen-dependent-inflammatory-disord%E2%80%A6-image-1.png infographic2 Diagram illustrating the interconnected mechanisms of endometriotic lesions, including oxidative stress, microbiome dysbiosis, and epigenetic dysregulation, and their impact on disease progression and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6132b1f2-0768-4855-a5d5-944e58baec31/Endometriosis-and-infertility-Endometriosis-and-infertility-are-closely%E2%80%A6-image-1.png infographic2 Diagram illustrating mechanisms of endometriosis-associated infertility, including ovarian alterations, reduced ovarian reserve, blastocyst quality effects, endometrial issues, epigenetic dysregulation, stem cell dysfunction, and systemic inflammation with microRNA involvement. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/075ff717-9859-4151-879e-85942954cdef/Endometriosis-is-defined-by-the-presence-of-endometrial-glands-and-stro%E2%80%A6-image-1.png infographic2 A medical infographic about gastrointestinal involvement in endometriosis, including statistics on site frequency, symptoms, and diagnosis methods, with a diagram of the female pelvic area highlighting common sites like the rectum and sigmoid colon. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4c371b24-62ce-402f-a9a1-e8d80b38ef01/Endometriosis-recurrence-and-prevention-strategies-Recurrence-of-endome%E2%80%A6-image-1.png infographic2 An infographic titled 'Endometriosis Recurrence and Prevention Strategies' with three sections. The first section overview shows a diagram of the female reproductive system highlighting endometriosis recurrence rates over 10 years with a graph. The second section compares surgical management options: ablation and excision, with descriptions of their benefits. The third section discusses prevention of deep infiltrating endometriosis recurrence, with risk percentages, a schematic of prevention strategies including complete excision, hormonal therapy, conservative procedures, and hysterectomy. Key takeaways are listed at the bottom. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fb4c91a2-dc63-4578-a3d1-4ed7a5474ab4/Epigenetics-describes-the-study-of-gene-expression-heritability-that-oc%E2%80%A6-image-1.png infographic2 Diagram illustrating the pathophysiology of PCOS/PMOS, including epigenetics, hyperandrogenism and insulin resistance, inflammation, and neuroendocrine signaling. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/249a9188-c65d-49ac-9159-a3a699a706f8/For-decades%2C-the-routine-removal-of-ovaries-during-radical-hys-terectom%E2%80%A6-image-1.png infographic2 A medical infographic comparing ovarian preservation and oophorectomy in cervical adenocarcinoma. The left side illustrates a historical surgery approach with radical hysterectomy and bilateral salpingo-oophorectomy. The center presents evidence review data showing no survival benefit from oophorectomy and improved outcomes with ovarian preservation, which has rare early-stage metastases. The right side discusses long-term health consequences of surgical menopause, including increased cardiovascular risk, osteoporosis, cognitive decline, and metabolic dysfunction, highlighting the need for careful preoperative counseling and a paradigm shift towards ovarian conservation in suitable women. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/38172987-d896-4320-b2f7-5e6ffb00f0af/From-26-countries-and-among-111-619-women-in-whom-menopause-was-uniform%E2%80%A6-image-1.png infographic2 A multi-part infographic on women's health. Section A shows a world map with countries color-coded by income levels, highlighting South Asian women having the highest prevalence of premature and early menopause. Section B illustrates increased cardiovascular disease risk for women under 40 and 40-44 years with early menopause, with hazard ratios above 1.0. Section C explains mechanisms behind increased risk, emphasizing low estrogen's impact on lipid profiles, endothelial function, visceral adiposity, and atherosclerosis. Section D presents prevalence variations by region and ethnicity, noting higher rates in South Asian women, and lists modifiable risk factors like overweight, smoking, poor diet, household air pollution, low education, and low grip strength. The infographic emphasizes the importance of CVD risk management in women with premature or early menopause. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/980ae165-c86a-48f7-8444-abccf4a4cde3/From-surgical-diagnosis-to-a-modern-clinical%E2%80%93radiological-approach-In-r%E2%80%A6-image-1.png infographic2 Diagram showing the evolution of endometriosis diagnosis from surgical methods to modern radiological approaches. It highlights advances such as TVUS, MRI, and salivary microRNA analysis, and emphasizes the role of imaging technology and decision-making pathways for treatment planning, diagnosis accuracy, and patient education. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/939cd33a-d440-4dc4-a39c-f68a920a4d16/In-recent-decades%2C-the-prevalence-of-overweight-and-obesity-has-increas%E2%80%A6-image-1.png infographic2 Infographic with six panels discussing obesity and pregnancy risks: 1) Global rise in overweight and obesity due to lifestyle and economic factors, showing a woman on couch, food, and money. 2) Positive impact of ART success on healthy weight, and negative effects of obesity on ART outcomes, illustrated by women and embryo images. 3) Quantitative risk increase of pregnancy loss with obesity, shown by bar graph and BMI categories. 4) Pathways of biological and pathophysiological effects leading to miscarriage, with diagrams of adipose tissue, hormonal changes, and inflammation. 5) Intergenerational pregnancy complications linked to obesity, such as gestational diabetes, hypertension, and preeclampsia, with illustrations of women and fetus. 6) Interventions for prevention including lifestyle modifications and medication, emphasizing lifestyle changes for reproductive outcomes and prioritization for women of reproductive age, with images of healthy foods, jogging, and a pink ribbon. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/2ca198d0-91eb-45e3-ba04-65556a6757c6/Individualized-Tubo-Ovarian-Cancer-Risk-in-Women-with-BRCA1-2-Pathogeni%E2%80%A6-image-1.png infographic2 A scientific infographic comparing the risk of tubo-ovarian cancer in women with BRCA1 and BRCA2 genetic variants. It includes detailed diagrams of the proteins, showing mutation locations, cluster regions, and regions associated with increased cancer risk. The infographic also summarizes lifetime risk percentages, median age at diagnosis, hazard ratios, and mutation class effects for both genes, along with clinical insights and key points about risk factors and counseling. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/49eefe23-29f7-45d5-9d36-f4b1e3c620d5/Influence-of-Parity%2C-Breastfeeding%2C-and-Oral-Contraceptives-Several-rep%E2%80%A6-image-1.png infographic2 Infographic showing the benefits of parity, breastfeeding, and oral contraceptive use for reducing ovarian cancer risk. Part 1 depicts parity with increased risk reduction for each birth, especially for women with BRCA1 mutations. Part 2 illustrates breastfeeding lowering ovarian cancer risk, and combined breastfeeding and oral contraceptive use providing additional risk reduction. Part 3 demonstrates oral contraceptives decreasing ovarian cancer risk, with longer use leading to greater reduction, but pre-1975 formulations increasing risk. The infographic emphasizes that parity, breastfeeding, and modern oral contraceptives each are associated with reduced tubo-ovarian cancer risk, especially when combined. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1afa9aa3-d1d3-4240-9bcd-e731f8366524/Integrating-a-highly-accurate-molecular-test-into-gynecology-shifts-the%E2%80%A6-image-1+%281%29.png infographic2 Flowchart illustrating the modernization of endometriosis diagnosis from surgical diagnosis to molecular triage. It compares the historical pathway of surgery with the modernized pathway using molecular diagnosis, including baseline evaluation, molecular triage with salivary miRNA test, targeted medical management, advanced mapping and single-surgery excision. The chart highlights key steps, benefits, limitations, and considerations for each approach. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8c922547-d005-472d-808a-a38319c36b63/Integrating-a-highly-accurate-molecular-test-into-gynecology-shifts-the%E2%80%A6-image-1+%282%29.png infographic2 Flowchart illustrating the modernized endometriosis diagnostic algorithm from surgical diagnosis to molecular triage, highlighting key steps and considerations in the diagnostic process. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/830d64e2-1f7e-4279-8e02-36d59491b41e/Integrating-a-highly-accurate-molecular-test-into-gynecology-shifts-the%E2%80%A6-image-1.png infographic2 Flowchart outlining the modern diagnostic process for endometriosis, starting with symptomatic patient presentation, using ultrasound and laparoscopy, salivary miRNA testing, miRNA testing, and preoperative imaging for management, highlighting limitations such as no anatomical mapping, surgery not replacing infertility treatment, variable cost and accessibility, and potential false negatives. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d5ad1461-05df-4a4b-8845-39eed6f7c071/Integrating-Multi-factorial-Risk-to-Individualize-Tubo-Ovarian-Cancer-R%E2%80%A6-image-1.png infographic2 Summary of a scientific infographic on ovarian cancer risk prediction, highlighting genetic factors, family history, tumor pathology, lifestyle factors, polygenic risk score, risk modeling updates, examples of recalibration, risk-reducing surgery guidelines, key messages, and limitations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/a59c80cc-6f64-4408-9cc0-e011c42143f3/Introduction-Endometriosis-is-a-highly-prevalent-chronic-inflammatory-d%E2%80%A6-image-1+%281%29.jpg infographic2 A comprehensive infographic illustrating an evidence-based framework for endometriosis management. It includes sections on disease impact icons showing pain, infertility, healthcare burden, and psychological distress; a new paradigm emphasizing inflammation, fertility, pain, ovary, cervix, and fallopian tube; diagnostic strategies with ultrasonographic mapping and MRI integration for earlier detection; management strategies featuring surgical, medical, and conservative therapies; pathophysiology mechanisms depicting ovarian, tubal, and endometrial tissue inflammation and epigenetic factors; and an integrated framework advocating early diagnosis, expert imaging, rational surgery, optimized therapy, and long-term recurrence prevention. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c2d2bdde-f7d4-4968-9fbe-22fd5ac3af51/Introduction-Endometriosis-is-a-highly-prevalent-chronic-inflammatory-d%E2%80%A6-image-1.jpg infographic2 An infographic presenting an integrated evidence-based framework for endometriosis management. It includes sections on disease impact icons, new paradigms showing inflammation and fertility issues in the female reproductive system, diagnostic strategies with ultrasound mapping and MRI, management strategies with surgery, therapy, and medical suppression, as well as pathophysiology mechanisms and the overall framework emphasizing early diagnosis, expert imaging, and tailored therapy to prevent long-term recurrence. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/32d17a58-462e-4d47-ba5f-f6209b209c9f/It-has-been-proved-that-lipids-have-an-effect-on-endometriosis%2C-and-the%E2%80%A6-image-1.png infographic2 A scientific infographic about Plasma Atherosclerosis Index (AIP) as a marker for endometriosis risk in US women. It includes maps, charts, and study data highlighting group separation, AIP calculation, statistical analysis, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c29e5dce-4238-4380-9ecb-9e8eb63749a2/Letrozole-2.png infographic2 Flowchart depicting a medical process for fertility treatment with steps, decision points, and instructions, including ultrasound, medication doses, and procedures for timing and follicle detection. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/0f8e5393-5c65-46d8-92db-366095596ce3/Limitations-of-surgery-However%2C-surgery-also-has-drawbacks.png infographic2 A scientific infographic titled 'Limitations of Surgical Approaches in Endometriosis and Ovarian Endometrioma (OMA) Treatment.' It is divided into three sections. The first shows a diagram of the pelvis with pain mechanisms, nerve plexuses, and post-surgery pain persistence. The second illustrates conservative surgery for deep infiltrating endometriosis, with a focus on adenomyotic uterus and the typical leaving of adenomyosis post-operation. The third section compares ovarian OMA excision with alternative approaches, including partial stripping with CO2 laser and cryopreservation, noting the challenges with ovarian tissue loss and ovarian reserve. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5fb6c44e-dc0d-48c5-8d5c-b7c46fa8da90/Lipiodol-HSG-can-be-performed-under-ultrasound-guidance%2C-with-comparabl%E2%80%A6-image-1.png infographic2 Diagram explaining the ultrasound-guided use of lipiodol HSG for unexplained infertility. It shows the procedure steps, including ultrasound guidance, lipiodol injection through patent fallopian tubes, and monitoring. The panel also highlights the target patient group—women under 39 with ovulatory function and no tubal pathology—along with outcome measures such as pregnancy rate and safety profile, and notes standard care practices. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5c87e4bb-ed46-4c13-ae68-f37e720ae740/Lipiodol-in-unexplained-infertility-Analyzed-query%2C-searched-for-eviden%E2%80%A6-image-1.jpg infographic2 Summary of research on lipiodol tubal flushing for unexplained infertility, including mechanism, clinical trial results, and clinical impact. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f6e17da3-21e5-4ed6-9f2e-13d826d589fc/Long-term-management-Endometriosis-is-a-chronic-condition-with-a-high-r%E2%80%A6-image-1.png infographic2 Infographic on long-term medical and complementary management of endometriosis, including medical suppression with medications like progestins and GnRH analogues, goal to prevent recurrence, and complementary approaches such as osteopathy, yoga, physiotherapy, sophrology, anti-inflammatory diet. Highlights that over 80% of patients use complementary approaches, which can reduce reliance on painkillers and improve chronic pelvic pain management. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4c50f14d-db2f-41ea-87af-2c404d2e72ef/Modification-of-Breast-and-Tubo-Ovarian-Cancer-Risk-by-Family-History-F%E2%80%A6-image-1.png infographic2 Charts comparing breast and ovarian cancer risk by family history, including risk percentages, hazard ratios, and conflicting evidence across studies. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/05f08bf3-4fb7-4a4b-b476-951276614537/MRI-as-a-complementary-modality-While-TVUS-is-the-first-line-imaging-to%E2%80%A6-image-1.png infographic2 Diagram comparing the roles of transvaginal ultrasound (TVUS) and MRI in diagnosing endometriosis. It shows imaging modalities, their strengths and limitations, and an integrated workflow for preoperative mapping, emphasizing MRI's detailed mapping and surgeon collaboration, with a training imperative for clinicians and sonographers. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/95bd058a-1ee7-4497-af62-8d6f5f9b7af8/Objective-This-study-aimed-to-evaluate-the-prevalence-of-urinary-sympt%E2%80%A6-image-1.png infographic2 A research infographic on urinary symptoms in women with parametrial endometriosis before and after surgery. It includes study design schematic, symptom prevalence pre- and post-surgery, subgroup analysis, and clinical implications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/36af55bf-3b4c-4f66-b79d-e744cc8959cb/Objective-To-characterize-the-prevalence-of-re-detectable-anti-Mulleri%E2%80%A6-image-1.png infographic2 A scientific infographic titled 'AMH Rebound and Ovarian Hormone Variation Across Menopause: SWAN Cohort Analysis.' It includes study design overview with multi-site hospitals, three graphs showing longitudinal hormone measurements (Undetectable AMH, AMH Rebound, E2 Rise) over time, factors linked to AMH rebound such as age, BMI, and FSH with respective values, a legend for hormones including AMH, Estradiol (E2), FSH, and Inhibin B, a summary indicating 54.2% had AMH rebound after undetectable, 48.6% had rebound with E2 rise, and a note on the impact of hormone rebounds on perimenopausal staging, and an illustration of a female doctor with a note on the importance of hormone rebound considerations during menopause transition. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/3a6dd35d-421d-409e-aa77-1d1d10811ebc/Objectives-To-analyze-the-association-between-primary-infertility-and%E2%80%A6-image-1.png infographic2 A diagram showing the association of primary infertility with infertility type and age of natural menopause. It includes a study overview with groups of women at risk for natural menopause, documents natural menopause and infertility, and compares age differences and fertility frequencies between groups, with statistical data and graphical results. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e712606f-7d87-4469-bf4b-e2692259ddd9/ObjectiveTo-achieve-a-better-understanding-of-whether-menopause-has-an%E2%80%A6-image-1.png infographic2 A scientific infographic titled 'Impact of Menopause on Hospital Admissions for Major Mental Health Conditions in Midlife Women (Australia 2022-2023)'. It includes study population data for women and men across different ages, graphs showing hospital admission rates for major depression, bipolar disorder, and schizophrenia in women, with higher rates in midlife and postmenopause. It also has sections listing major mental health conditions, data sources, key findings, and conclusions about the impact of menopause on mental health hospitalizations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6cc7eb14-fdf4-42af-b652-400d65d30cc0/PCOS-is-most-strongly-and-consistently-associated-with-an-increased-ris%E2%80%A6-image-1.png infographic2 Diagram showing links between polycystic ovary syndrome (PCOS) and different cancers. Endometrial cancer is strongly associated with PCOS, ovarian cancer has conflicting evidence, breast cancer has largely no association, and cervical cancer shows insufficient evidence. Symbols, arrows, and summaries highlight the strength and consistency of evidence for each cancer type. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/33861a05-944a-41fb-97ad-7bb3e80cd60e/PCOS-PMOS-pathophysiology.png infographic2 Diagram of hormonal regulation involving the pituitary gland, ovaries, pancreas, and liver, showing the effects of hormones like LH, FSH, insulin, and androgens on each organ, and pathways leading to hyperandrogenism and polycystic ovary morphology. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/6cedc4fb-4a7a-4ac9-8f14-e7ba71fc8fc6/Pelvic-pain-is-a-common-and-often-debilitating-experience-with-limited%E2%80%A6-image-1.png infographic2 Diagram summarizing a study on interpretation bias in pelvic pain. Features sections on study overview with groups of women with various pelvic conditions, a survey process, assessment of interpretation bias related to pelvic pain, key findings showing higher bias in pain groups, a schema linking bias to worse outcomes, and a conclusion that bias is linked to a range of pain-related conditions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c7244c63-d39a-40d2-b4d4-efcfc9de6839/Perimenopause%E2%80%94the-transitional-years-leading-to-menopause%E2%80%94is-characteri%E2%80%A6-image-1.png infographic2 A detailed infographic about perimenopause transition and hormonal fluctuations, including graphs of estrogen and progesterone levels, mood and cognitive risk over time, neurobiological mechanisms, treatment options, global and cultural context, and key research gaps. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/33db43ef-3b76-446a-ae7e-5be43ced66ed/Post-operative-hormonal-treatment-Post-operative-hormonal-treatment-is%E2%80%A6-image-1.png infographic2 Flowchart illustrating post-operative strategies to prevent endometriosis recurrence. It shows endometriosis surgery leading to three approaches: hormonal therapy, cyclical regimens, and emerging immunomodulation. Hormonal therapy includes combined oral contraceptives, progestin, LNG-IUS, GnRH agonist, and Dienogest, with a focus on continuous regimens for high effectiveness. Cyclical regimens are less effective due to discontinuation risks. Emerging strategies involve beta-blockers and COX-2 inhibitors aiming to reduce recurrence via immunomodulation, yet require more evidence. The chart highlights the importance of continuous hormonal therapy to reduce recurrence by approximately 60%, whereas therapy discontinuation increases the risk of rapid recurrence. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1300bb55-5968-44b2-a9e6-171679f2300f/Progestins-as-first-line-therapy-Among-the-available-medical-options%2C-p%E2%80%A6-image-1.png infographic2 Diagram presenting prostaglandins as first-line therapy for endometriosis, showing mechanisms of action, delivery methods, and benefits and limitations of various treatments. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e58bee2d-cd30-4d8e-9662-ed4e6d931251/Purpose-of-review-Perimenopause-is-a-clinically-distinct-stage-in-whic%E2%80%A6-image-1.png infographic2 Infographic titled "Complex Benign Gynecology in Perimenopausal Women" illustrating uterine and ovarian conditions, assessment, surgical options, and management strategies specific to perimenopausal women. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4b065792-4768-4530-8ed1-cfc3b028aa7d/Research-question-Do-endometrial-preparation-protocols-affect-pregnancy%E2%80%A6-image-1.png infographic2 A research poster titled 'Study Design of Endometrial Preparation in Overweight/Obese Women Undergoing FET' includes sections on protocol comparison, main outcomes, key statistical findings, and conclusion. It compares natural and artificial cycles in women with BMI ≥ 24 kg/m², using diagrams and bar charts to show pregnancy rates, statistical significance, and methodology details. The conclusion states that natural cycle FET yields higher pregnancy and live birth rates without increased complications. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/588385ec-3ceb-421d-b406-ce76f48911c3/Role-of-biomarkers.png infographic2 Diagram of emerging mechanisms, diagnostics, and therapies in PCOS/PMOS, covering diagnostic challenges, data-driven technologies, therapeutic innovations, gut microbiome interactions, metabolic therapy, predictive models, and drug discovery platforms. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8f029e79-b59d-47b8-89ba-0a551a960de4/Second-line-therapy-GnRH-analogues-and-oral-GnRH-antagonists-GnRH-agon%E2%80%A6-image-1.png infographic2 Infographic explaining second-line therapies for endometriosis, comparing GnRH agonists and oral GnRH antagonists. It highlights the benefits, limitations, and features of each treatment, including mode of administration, flare effect, symptom relief, side effects, and bone health impact, with a comparison table. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/c2458633-4f80-4f5a-90d9-8da7405d1e2c/Several-seminal-clinical-trials-have-evaluated-the-safety-and-efficacy%E2%80%A6-image-1+%281%29.png infographic2 A schematic timeline of landmark clinical trials related to menopause and cardiovascular disease risk, including key studies from 2002 to 2022, illustrating early versus late hormone therapy initiation, trial differences, and current guidelines indicating estrogen therapy is not supported for primary CVD prevention. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/8fcaf044-9a01-43c7-91f3-c5f51334c831/Several-seminal-clinical-trials-have-evaluated-the-safety-and-efficacy%E2%80%A6-image-1+%282%29.png infographic2 A detailed infographic about menopause and cardiovascular disease risk. It includes five sections: 1) Introduction with estrogen and menopause schematic illustrating increased cardiovascular risk; 2) Landmark clinical trial timelines on women's health initiative, early estrogen prevention study, and early versus late intervention trial with estrogen; 3) Timing hypothesis showing cardiovascular benefits of hormone therapy based on years since menopause; 4) Factors influencing trial outcomes such as health status, age, and hormone therapy administration; 5) Clinical position statement from the 2022 Menopause Society asserting current evidence does not support hormone therapy as primary prevention for cardiovascular disease. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/fdff1f6b-8893-4557-8969-f805e7767974/Several-seminal-clinical-trials-have-evaluated-the-safety-and-efficacy%E2%80%A6-image-1.png infographic2 Schematic timeline of landmark clinical trials related to menopause and cardiovascular disease risk, including studies from 2002 to 2022, with key points on trial types, hypotheses, differences, and conclusions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/bd602824-1c69-4338-912b-5c8cbb626015/Surgery-may-also-be-indicated-in-infertility%2C-but-only-after-a-comprehe%E2%80%A6-image-1.png infographic2 A medical infographic explaining surgical decision-making for infertility and endometriosis. Panel 1 shows a decision flowchart for surgery consideration. Panel 2 lists indications for surgery: Ovarian Endometrioma, Hydroasalpinx, and Endometriosis. Panel 3 compares pre- and post-surgery effects on uterine anatomy and inflammation. Panel 4 illustrates organ-threatening endometriosis requiring mandatory surgery, involving ureter, bowel, and lungs. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/f154e632-fb84-4371-96a5-277c1d76510e/Surgery-to-treat-hydrosalpinx-Disorders-of-the-fallopian-tubes-are-resp%E2%80%A6-image-1.png infographic2 Chart showing surgical treatment approaches for hydroasalpinx. It includes sections on pathophysiology, surgical outcomes, success rates by severity, and endometriosis consideration. Illustrations of salpingectomy, proximal occlusion, and tubal reconstruction are presented, along with statistics on pregnancy rates and treatment recommendations. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/52d0e986-4a62-43ab-ac6d-2097c91a6ef9/Surgical-Risk-Reduction-Approaches-and-Considerations-Risk-Reducing-Sal%E2%80%A6-image-1.png infographic2 A detailed infographic comparing surgical risk-reduction strategies for BRCA1/2 pathogenic variant carriers, including bilateral salpingo-oophorectomy (RSRO), salpingo-oophorectomy with delayed oophorectomy (SDO), and adjunct hormone therapy. Sections cover surgical strategies, clinical trial summaries, quality of life impacts, and considerations for hormone therapy with flowcharts, icons, and data. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4d500ce1-6502-4ee2-8fd9-8c198e3c3208/Systemic-estrogen-based-menopausal-hormone-therapy-%28MHT%29-is-generally%E2%80%A6-image-1.png infographic2 Clinical infographic on systemic MHT and breast cancer recurrence risk, therapy options, and decision-making process, including diagrams and text boxes. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/910559c7-1e18-448b-a3ed-3f6194bf1af2/terine-leiomyomas%2C-commonly-referred-to-as-myomas-or-fibroids%2C-are-the%E2%80%A6-image-1.png infographic2 An infographic about fibroid-related issues, divided into four sections: 1. Prevalence and anatomy showing 70-80% of women affected during reproductive years, with diagrams of the uterus. 2. Symptom spectrum depicting pelvic pressure causing pain, abnormal uterine bleeding, dysmenorrhea, infertility, and bloating. 3. Treatment modalities, including surgical options like laparoscopic cryomyolysis, and radiological options with embolization and MRI-guided focused ultrasound, plus medical options such as GnRH agonists, tranexamic acid, SERMs, and vitamin D. 4. Clinical need emphasizes the lack of therapies targeting fibroid-associated pain, with mechanisms poorly defined. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/b4e9c2e6-d884-47b2-a844-d7102b7c9fc0/The-appreciable-reduction-in-vascular-endothelial-function-observed-dur%E2%80%A6-image-1.png infographic2 A detailed infographic illustrating the impact of hormonal changes during menopause on vascular endothelial function and aging. It shows the transition from healthy endothelium, with high estrogen and progesterone levels, to dysfunctional endothelium with decreased hormonal levels after menopause. The diagram covers key protective effects of oestradiol, mechanisms of hormonal influence, and methods for hormone level quantification. It also discusses controlled hormone interventions, disbanding signaling pathways, and optimal timing for intervention to preserve endothelial function and reduce cardiovascular risks, emphasizing the need for advancing CVD prevention in menopausal women. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/7b2e0ff2-a5f4-4c80-a2c0-5452f3d6f91f/The-diagnosis-of-bladder-endometriosis-is-made-by-a-combination-of-clin%E2%80%A6-image-1.png infographic2 Flowchart detailing the diagnostic and therapeutic pathway for bladder endometriosis, including symptom assessment, imaging, biopsy, treatment options, and prognosis. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d1112458-2421-45ae-8422-6e0219371882/The-female-upper-reproductive-tract-%28comprising-the-endometrium%2C-fallop%E2%80%A6-image-1.png infographic2 An infographic titled "Pelvic Inflammatory Disease (PID): Pathogenesis, Clinical Features, and Management". It is divided into six sections: 1) Anatomical overview with illustrations of female reproductive organs; 2) Pathogenesis and clinical consequences showing infection, inflammation, tissue injury, scarring, and infertility; 3) Clinical manifestations listing symptoms such as dyspareunia, dysuria, abnormal vaginal discharge or bleeding, and lower abdominal pain, with note on nonspecific symptoms; 4) Diagnostic approach including clinical suspicion, testing methods like NAAT, ultrasound, and rule-out of other causes; 5) Treatment guide covering outpatient and inpatient management, with antibiotics and special notes; 6) Additional notes on management decisions and alternative regimens. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/96c12865-8c84-45c4-b680-9592f2778c1a/The-first-preclinical-models-of-vulvodynia-were-established-by-Farmer-e%E2%80%A6-image-1.png infographic2 Diagram illustrating preclinical models and mechanisms of vulvodynia, including infection-based and inflammation-based models, key pathophysiological features like nerve activation and cytokine release, and therapeutic insights such as NGF blockade and channel expression reduction. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/d6e9657b-aed9-45ae-a6d9-2aeb6569e8fc/The-presentation-of-PCOS-PMOS-is-extremely-heterogeneou infographic2 Flowchart titled 'Individualized Treatment for PCOS/PMOS' with sections covering diagnosis, metabolic considerations, reproductive considerations and transgenerational effects. Contains icons, checklists, and notes on treatments including hormonal management, lifestyle changes, medication, and risks associated with PCOS and its effects on offspring. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/5879478e-3354-4ce6-93e2-6cf90e0438ab/The-vascular-endothelium-is-a-single-layer-of-cells-lining-the-blood-ve%E2%80%A6-image-1.png infographic2 Diagram explaining vascular endothelial function, signaling, and assessment methods, including structures, key players, functional assessments, clinical implications, and hormonal modulation. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/4cdc4729-ea72-4295-b7a8-7c2f96a4f155/The-Ziwig-Endotest-is-currently-the-most-advanced-clinical-application%E2%80%A6-image-1.png infographic2 Infographic illustrating a diagnostic pathway for endometriosis. It includes steps like saliva-based liquid biopsy, microRNA sequencing with AI analysis, clinical validation with high sensitivity and specificity, and an accelerated clinical care pathway. The infographic highlights the use of saliva samples, AI-driven analysis, and non-invasive testing for early detection, with a note that imaging may still be required before surgery. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/18fb693a-f7d2-42f9-96c9-53a38697f693/These-are-two-distinct-treatment-approaches-for-hydrosalpinx-that-serve%E2%80%A6-image-1+%281%29.png infographic2 Chart comparing lipiodol tubal flushing and surgical management of hydrosalpinx. The left side shows lipiodol tubal flushing, used for women with patent or mildly affected tubes, highlighting mechanisms and safety notes. The right side details surgical options like salpingectomy, tubal occlusion, salpingostomy, aspiration, and hysteroscopic electrocoagulation, with their implications for IVF, risks, and success rates. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/016c5254-6c05-4e28-930e-9ff6ae57793e/These-are-two-distinct-treatment-approaches-for-hydrosalpinx-that-serve%E2%80%A6-image-1.png infographic2 Diagram comparing lipiodol tubal flushing with surgical management of hydrosalpinx. The left side shows a transvaginal catheter used for oil-based contrast tubal flushing, with evidence on increased pregnancy rates, ongoing pregnancy rate of 32.1%, and transient therapeutic benefits. It lists proposed mechanisms like debris removal and enhanced ciliary activity, and notes safety monitoring for thyroid issues. The right side depicts surgical procedures: salpingectomy, laparoscopic proximal tubal occlusion, salpingostomy, aspiration/sclerotherapy, and hysteroscopic electrocoagulation, with indications, advantages, and risks, including a focus on IVF outcomes and risks of ectopic pregnancy. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/70f0e9be-0e0a-421f-b187-5941ac915734/Treatment-Live-Birth-Ongoing-Pregnancy-Rate-Multiple-Pregnancy-Rate-C%E2%80%A6-image-1.png infographic2 Comparison chart of fertility treatments showing live birth and ongoing pregnancy rates, costs, and advantages for each method: Expectant management, Lipidol HSG, Clomiphene + IUI, Letrozone + IUI, Gonadotropins + IUI, and IVF. The chart includes icons representing pregnancy outcomes, cost estimates, and risk levels, with a legend explaining symbols and references for data sources. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/e90e0ece-40e6-467b-b027-40bd982424e9/ubo-ovarian-cancer-remains-one-of-the-most-lethal-gynecologic-malignanc%E2%80%A6-image-1+%281%29.png infographic2 Infographic overview of tubo-ovarian cancer, including epidemiology, risks, BRCA1/2 genetics and pathogenesis, and strategies for risk reduction, surveillance, and guideline variability across regions. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/13a4403b-93e6-4787-aa68-240ff1bff86b/ubo-ovarian-cancer-remains-one-of-the-most-lethal-gynecologic-malignanc%E2%80%A6-image-1.png infographic2 An infographic about tubo-ovarian cancer, detailing epidemiology and risks, BRCA1/2 genetics and pathogenesis, and risk-reducing strategies including primary prevention, alternative approaches, and surveillance. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/63dc458a-a777-45fe-9513-e80580b536f9/We-included-66-studies-in-the-systematic-review-and-52-%283644-participan%E2%80%A6-image-1.png infographic2 A chart showing the effects of lifestyle and pharmacological interventions on body composition in women with PCOS, including study design, control, lifestyle alone, various intervention arms, and outcomes such as BMI, waist circumference, and waist-to-hip ratio, with a summary of findings indicating body composition improvement. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/1497ebde-b69a-4fb4-8ff1-f39a000bd42e/What-2.jpg infographic2 Infographic showing menopause transition insights from 2.5 million women, including trends in visceral fat, atrial fibrillation, heart rate variability, arterial stiffness, and age-related awareness of menopause. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/623b4ee9-204d-4fa2-aee2-cb42dac66965/When-surgery-is-indicated-Within-this-framework%2C-surgery-is-indicated-i%E2%80%A6-image-1.png infographic2 Flowchart explaining the decision pathway for surgical intervention in deep infiltrating endometriosis, including criteria for continuing medical management, surgical indications such as pain, infertility, disease threatening organ function, symptomatic bowel, bladder or ureteral lesions, recurrent pneumothorax, thoracic endometriosis, ovarian endometriomas, and the role of imaging in surgical planning. https://images.squarespace-cdn.com/content/v1/69bc2d9c6524cb51f2448752/aa0e7565-5806-4087-8937-3c5a56440738/Where-Lipiodol-Fits-in-the-Algorithm-Lipiodol-HSG-serves-a-dual-diagnos%E2%80%A6-image-1.png infographic2 Flowchart titled 'Clinical Pathway: Placement of Lipiodol HSG in Unexplained Infertility Workup (<38 years)'. It shows steps starting with a woman under 38 with unexplained infertility, then initial tubal assessment, followed by either continuing usual care if pregnancy is achieved within 6 months or moving to treatment with clomiphene/Letrozole and IUI, with a decision to proceed to IVF if pregnancy isn't achieved.